"gene"	"adj.pval.treatment1"	"adj.pval.treatment2"	"adj.pval.treatment1_x_treatment2"	"scaffold"	"start"	"end"	"uniprot.id"	"uniprot_taxa.id"	"Uniprot.Name"	"GO.IDs"	"GO.Descript"
"PGEN_.00g000280"	1.71285378317722e-07	0.627146382426752	8.25221706959982e-06	"Scaffold_01"	402378	436712	"Q8ZXT3"	"Y1111_PYRAE"	"Uncharacterized protein PAE1111"	""	""
"PGEN_.00g001170"	0.000472789628747175	0.033074265646583	0.000541185065189269	"Scaffold_01"	2366888	2417042	"Q66HA5"	"C2D1A_RAT"	"Coiled-coil and C2 domain-containing protein 1A (Five prime repressor element under dual repression-binding protein 1) (FRE under dual repression-binding protein 1) (Freud-1)"	"GO:0000122; GO:0000978; GO:0001227; GO:0001650; GO:0005634; GO:0005815; GO:0005829; GO:0005886"	"cytosol [GO:0005829]; fibrillar center [GO:0001650]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of transcription by RNA polymerase II [GO:0000122]"
"PGEN_.00g002580"	0.0342995943922518	0.864424447338787	0.103760646590395	"Scaffold_01"	6245646	6316687	NA	NA	NA	NA	NA
"PGEN_.00g003320"	2.91715424921727e-14	0.0919591737758477	1.31809529355579e-13	"Scaffold_01"	8256420	8256734	NA	NA	NA	NA	NA
"PGEN_.00g003330"	1.44356797810951e-39	0.69566261327284	8.23140488263426e-05	"Scaffold_01"	8257067	8258104	NA	NA	NA	NA	NA
"PGEN_.00g003520"	0.0388651103174844	0.55474982847488	0.000768917623519648	"Scaffold_01"	8767297	8783750	NA	NA	NA	NA	NA
"PGEN_.00g004690"	3.26918455272985e-05	0.596170156848761	0.282190489068255	"Scaffold_01"	11962630	12021181	"Q9D7W5"	"MED8_MOUSE"	"Mediator of RNA polymerase II transcription subunit 8 (Activator-recruited cofactor 32 kDa component) (ARC32) (Mediator complex subunit 8)"	"GO:0000978; GO:0003712; GO:0005654; GO:0006357; GO:0016567; GO:0016592; GO:0070847"	"core mediator complex [GO:0070847]; mediator complex [GO:0016592]; nucleoplasm [GO:0005654]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coregulator activity [GO:0003712]; protein ubiquitination [GO:0016567]; regulation of transcription by RNA polymerase II [GO:0006357]"
"PGEN_.00g005480"	0.00659269629535707	0.844456997729494	0.943286910085403	"Scaffold_01"	13725578	13827565	"Q12857"	"NFIA_HUMAN"	"Nuclear factor 1 A-type (NF1-A) (Nuclear factor 1/A) (CCAAT-box-binding transcription factor) (CTF) (Nuclear factor I/A) (NF-I/A) (NFI-A) (TGGCA-binding protein)"	"GO:0000122; GO:0000790; GO:0000978; GO:0000981; GO:0001228; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0006260; GO:0006355; GO:0008134; GO:0019079; GO:0030054; GO:0045944; GO:0060074; GO:0072189"	"cell junction [GO:0030054]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription factor binding [GO:0008134]; DNA replication [GO:0006260]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; synapse maturation [GO:0060074]; ureter development [GO:0072189]; viral genome replication [GO:0019079]"
"PGEN_.00g006120"	0.00120707914284034	0.0711700933806135	0.0363605899148703	"Scaffold_01"	15441130	15455918	NA	NA	NA	NA	NA
"PGEN_.00g009320"	3.59103936455488e-06	0.0385197366673949	0.155112327117899	"Scaffold_01"	24301248	24318845	"Q6INU7"	"FRRS1_XENLA"	"Putative ferric-chelate reductase 1 (EC 1.-.-.-)"	"GO:0016021; GO:0016491"	"integral component of membrane [GO:0016021]; oxidoreductase activity [GO:0016491]"
"PGEN_.00g009870"	0.0428595998165402	0.954687641489269	0.21858132190129	"Scaffold_01"	26033012	26085862	"O14522"	"PTPRT_HUMAN"	"Receptor-type tyrosine-protein phosphatase T (R-PTP-T) (EC 3.1.3.48) (Receptor-type tyrosine-protein phosphatase rho) (RPTP-rho)"	"GO:0004725; GO:0005001; GO:0005886; GO:0005887; GO:0006470; GO:0007155; GO:0007156; GO:0007165; GO:0007169; GO:0008013; GO:0009986; GO:0016021; GO:0019903; GO:0030336; GO:0035335; GO:0042803; GO:0045294; GO:0045295; GO:0045296; GO:0070097; GO:0071354; GO:0097677; GO:1904893; GO:1990264"	"cell surface [GO:0009986]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cell adhesion [GO:0007155]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of receptor signaling pathway via STAT [GO:1904893]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]"
"PGEN_.00g010610"	1.78042371068993e-06	0.00748487336493934	8.35385281140744e-08	"Scaffold_01"	28029819	28037595	"O75581"	"LRP6_HUMAN"	"Low-density lipoprotein receptor-related protein 6 (LRP-6)"	"GO:0001702; GO:0001843; GO:0001933; GO:0003344; GO:0005041; GO:0005102; GO:0005109; GO:0005576; GO:0005623; GO:0005783; GO:0005886; GO:0005901; GO:0006469; GO:0007204; GO:0007268; GO:0009880; GO:0009952; GO:0009986; GO:0014029; GO:0014033; GO:0016021; GO:0016055; GO:0017147; GO:0019210; GO:0019534; GO:0021587; GO:0021794; GO:0021987; GO:0030326; GO:0030901; GO:0030917; GO:0031410; GO:0031901; GO:0034185; GO:0034392; GO:0035261; GO:0042475; GO:0042802; GO:0042803; GO:0042813; GO:0043025; GO:0043434; GO:0044335; GO:0044340; GO:0045202; GO:0045787; GO:0045893; GO:0045944; GO:0046849; GO:0048596; GO:0051091; GO:0060021; GO:0060026; GO:0060059; GO:0060070; GO:0060325; GO:0060349; GO:0060444; GO:0060535; GO:0071397; GO:0071542; GO:0071901; GO:0071936; GO:0072659; GO:0090009; GO:0090090; GO:0090118; GO:0090244; GO:0090245; GO:0098609; GO:1904886; GO:1904928; GO:1904948; GO:1904953; GO:1990851; GO:1990909"	"caveola [GO:0005901]; cell [GO:0005623]; cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; Wnt signalosome [GO:1990909]; Wnt-Frizzled-LRP5/6 complex [GO:1990851]; apolipoprotein binding [GO:0034185]; coreceptor activity involved in canonical Wnt signaling pathway [GO:1904928]; coreceptor activity involved in Wnt signaling pathway [GO:0071936]; frizzled binding [GO:0005109]; identical protein binding [GO:0042802]; kinase inhibitor activity [GO:0019210]; low-density lipoprotein particle receptor activity [GO:0005041]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; toxin transmembrane transporter activity [GO:0019534]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; anterior/posterior pattern specification [GO:0009952]; axis elongation involved in somitogenesis [GO:0090245]; beta-catenin destruction complex disassembly [GO:1904886]; bone morphogenesis [GO:0060349]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in neural crest cell differentiation [GO:0044335]; canonical Wnt signaling pathway involved in regulation of cell proliferation [GO:0044340]; cell-cell adhesion [GO:0098609]; cellular response to cholesterol [GO:0071397]; cerebellum morphogenesis [GO:0021587]; cerebral cortex development [GO:0021987]; chemical synaptic transmission [GO:0007268]; convergent extension [GO:0060026]; dopaminergic neuron differentiation [GO:0071542]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic limb morphogenesis [GO:0030326]; embryonic pattern specification [GO:0009880]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; external genitalia morphogenesis [GO:0035261]; face morphogenesis [GO:0060325]; gastrulation with mouth forming second [GO:0001702]; midbrain development [GO:0030901]; midbrain dopaminergic neuron differentiation [GO:1904948]; midbrain-hindbrain boundary development [GO:0030917]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; neural crest cell differentiation [GO:0014033]; neural crest formation [GO:0014029]; neural tube closure [GO:0001843]; odontogenesis of dentin-containing tooth [GO:0042475]; pericardium morphogenesis [GO:0003344]; positive regulation of cell cycle [GO:0045787]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; primitive streak formation [GO:0090009]; protein localization to plasma membrane [GO:0072659]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; response to peptide hormone [GO:0043434]; roof of mouth development [GO:0060021]; thalamus development [GO:0021794]; trachea cartilage morphogenesis [GO:0060535]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904953]; Wnt signaling pathway involved in somitogenesis [GO:0090244]"
"PGEN_.00g010970"	0.0342995943922518	0.000364638623555037	0.966960145863521	"Scaffold_01"	28799007	28814917	NA	NA	NA	NA	NA
"PGEN_.00g011710"	0.0134217701600827	0.339972943452401	0.973310732899346	"Scaffold_01"	30496151	30524602	"Q6PJG2"	"EMSA1_HUMAN"	"ELM2 and SANT domain-containing protein 1 (MIDEAS)"	"GO:0000118; GO:0000981; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0008134; GO:0044212"	"histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]"
"PGEN_.00g013900"	0.0120701589418665	0.890138793135651	0.45849472530356	"Scaffold_01"	35824608	35872288	"Q80TN7"	"NAV3_MOUSE"	"Neuron navigator 3 (Pore membrane and/or filament-interacting-like protein 1)"	"GO:0005524; GO:0005634; GO:0005635; GO:0005640; GO:0007026; GO:0007399; GO:0008017; GO:0022008; GO:0030336; GO:0031116; GO:0032703; GO:1905929"	"nuclear envelope [GO:0005635]; nuclear outer membrane [GO:0005640]; nucleus [GO:0005634]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; negative regulation of cell migration [GO:0030336]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of microtubule depolymerization [GO:0007026]; nervous system development [GO:0007399]; neurogenesis [GO:0022008]; positive regulation of invadopodium disassembly [GO:1905929]; positive regulation of microtubule polymerization [GO:0031116]"
"PGEN_.00g013990"	0.00895241108565018	0.228218306718994	0.29570037355161	"Scaffold_01"	36266074	36337869	"A2AVA0"	"SVEP1_MOUSE"	"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (Polydom)"	"GO:0003682; GO:0005509; GO:0005576; GO:0005615; GO:0005737; GO:0007155; GO:0016020"	"cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; cell adhesion [GO:0007155]"
"PGEN_.00g014370"	0.00406538124388367	0.00259954545912392	0.0104609373332842	"Scaffold_01"	37277926	37336883	"Q11002"	"CANA_DROME"	"Calpain-A (EC 3.4.22.-) (Calcium-activated neutral proteinase A) (CANP A) [Cleaved into: Calpain-A catalytic subunit]"	"GO:0004198; GO:0005509; GO:0005737; GO:0006508; GO:0007520; GO:0008340; GO:0008345; GO:0009953; GO:0015629; GO:0016322; GO:0016540; GO:0042335; GO:0043025; GO:0050832"	"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; neuronal cell body [GO:0043025]; calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; cuticle development [GO:0042335]; defense response to fungus [GO:0050832]; determination of adult lifespan [GO:0008340]; dorsal/ventral pattern formation [GO:0009953]; larval locomotory behavior [GO:0008345]; myoblast fusion [GO:0007520]; neuron remodeling [GO:0016322]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508]"
"PGEN_.00g015800"	0.0160140018578994	0.0113978152092618	4.87837697157983e-05	"Scaffold_01"	42028001	42054472	"O76840"	"PPN1_CAEEL"	"Papilin (Abnormal cell migration protein 6)"	"GO:0000902; GO:0002119; GO:0004867; GO:0005604; GO:0008233; GO:0009792; GO:0032504; GO:0048598"	"basement membrane [GO:0005604]; peptidase activity [GO:0008233]; serine-type endopeptidase inhibitor activity [GO:0004867]; cell morphogenesis [GO:0000902]; embryo development ending in birth or egg hatching [GO:0009792]; embryonic morphogenesis [GO:0048598]; multicellular organism reproduction [GO:0032504]; nematode larval development [GO:0002119]"
"PGEN_.00g016980"	5.70648076005526e-08	0.813369922513086	0.511771308245101	"Scaffold_01"	45797452	45797670	NA	NA	NA	NA	NA
"PGEN_.00g017150"	8.62841046075522e-08	9.65784742381606e-52	3.19003448244804e-07	"Scaffold_01"	46434018	46434647	NA	NA	NA	NA	NA
"PGEN_.00g017310"	3.14219525815894e-11	0.137950735410511	0.00012003851666389	"Scaffold_01"	46757099	46776661	NA	NA	NA	NA	NA
"PGEN_.00g017320"	0.0134026777318015	1.27753824225953e-09	3.14985863888405e-09	"Scaffold_01"	46778649	46781301	NA	NA	NA	NA	NA
"PGEN_.00g018080"	0.0308810087245901	0.0265996420031805	0.00866349482546986	"Scaffold_01"	48861199	48922414	"G5EFX6"	"SLIT1_CAEEL"	"Slit homolog 1 protein (Slt-1)"	"GO:0001764; GO:0005102; GO:0005509; GO:0005576; GO:0008201; GO:0016199; GO:0033563; GO:0048495; GO:0048843; GO:0097374; GO:1905489"	"extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; heparin binding [GO:0008201]; Roundabout binding [GO:0048495]; signaling receptor binding [GO:0005102]; axon midline choice point recognition [GO:0016199]; dorsal/ventral axon guidance [GO:0033563]; negative regulation of axon extension involved in axon guidance [GO:0048843]; neuron migration [GO:0001764]; regulation of sensory neuron axon guidance [GO:1905489]; sensory neuron axon guidance [GO:0097374]"
"PGEN_.00g018310"	0.00691207604588237	0.864502906692806	0.59351208345667	"Scaffold_01"	49450969	49487609	NA	NA	NA	NA	NA
"PGEN_.00g019550"	0.000596261541398903	0.69387305207028	0.567658073905439	"Scaffold_01"	53378406	53411787	"Q07954"	"LRP1_HUMAN"	"Prolow-density lipoprotein receptor-related protein 1 (LRP-1) (Alpha-2-macroglobulin receptor) (A2MR) (Apolipoprotein E receptor) (APOER) (CD antigen CD91) [Cleaved into: Low-density lipoprotein receptor-related protein 1 85 kDa subunit (LRP-85); Low-density lipoprotein receptor-related protein 1 515 kDa subunit (LRP-515); Low-density lipoprotein receptor-related protein 1 intracellular domain (LRPICD)]"	"GO:0001523; GO:0001540; GO:0002020; GO:0002265; GO:0003723; GO:0005041; GO:0005044; GO:0005509; GO:0005623; GO:0005634; GO:0005765; GO:0005769; GO:0005794; GO:0005856; GO:0005886; GO:0005887; GO:0005905; GO:0005925; GO:0006629; GO:0006898; GO:0006909; GO:0007041; GO:0007204; GO:0007205; GO:0007568; GO:0008283; GO:0010715; GO:0010875; GO:0010942; GO:0010977; GO:0014912; GO:0015026; GO:0016020; GO:0016323; GO:0016964; GO:0021987; GO:0030136; GO:0030178; GO:0030226; GO:0030425; GO:0030666; GO:0031623; GO:0032050; GO:0032092; GO:0032370; GO:0032374; GO:0032429; GO:0032593; GO:0032956; GO:0034185; GO:0035774; GO:0035909; GO:0038023; GO:0038024; GO:0042157; GO:0042953; GO:0043025; GO:0043235; GO:0043277; GO:0043395; GO:0043524; GO:0044242; GO:0044295; GO:0044877; GO:0045056; GO:0045177; GO:0045202; GO:0045807; GO:0048691; GO:0048694; GO:0050766; GO:0051481; GO:0051895; GO:0061642; GO:0070325; GO:0070374; GO:0097242; GO:0098797; GO:0150093; GO:0150094; GO:1900149; GO:1900223; GO:1903078; GO:1904109; GO:1904209; GO:1904646; GO:1904754; GO:1905049; GO:1905167; GO:2000587"	"apical part of cell [GO:0045177]; axonal growth cone [GO:0044295]; basolateral plasma membrane [GO:0016323]; cell [GO:0005623]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; early endosome [GO:0005769]; endocytic vesicle membrane [GO:0030666]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; insulin-responsive compartment [GO:0032593]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; receptor complex [GO:0043235]; synapse [GO:0045202]; alpha-2 macroglobulin receptor activity [GO:0016964]; amyloid-beta binding [GO:0001540]; apolipoprotein binding [GO:0034185]; apolipoprotein receptor activity [GO:0030226]; calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; clathrin heavy chain binding [GO:0032050]; coreceptor activity [GO:0015026]; heparan sulfate proteoglycan binding [GO:0043395]; lipoprotein particle receptor binding [GO:0070325]; low-density lipoprotein particle receptor activity [GO:0005041]; protease binding [GO:0002020]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; scavenger receptor activity [GO:0005044]; signaling receptor activity [GO:0038023]; aging [GO:0007568]; amyloid-beta clearance [GO:0097242]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; amyloid-beta clearance by transcytosis [GO:0150093]; aorta morphogenesis [GO:0035909]; apoptotic cell clearance [GO:0043277]; astrocyte activation involved in immune response [GO:0002265]; cell population proliferation [GO:0008283]; cellular lipid catabolic process [GO:0044242]; cellular response to amyloid-beta [GO:1904646]; cerebral cortex development [GO:0021987]; chemoattraction of axon [GO:0061642]; lipid metabolic process [GO:0006629]; lipoprotein metabolic process [GO:0042157]; lipoprotein transport [GO:0042953]; lysosomal transport [GO:0007041]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of metallopeptidase activity [GO:1905049]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron projection development [GO:0010977]; negative regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000587]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of Wnt signaling pathway [GO:0030178]; phagocytosis [GO:0006909]; positive regulation of amyloid-beta clearance [GO:1900223]; positive regulation of axon extension involved in regeneration [GO:0048691]; positive regulation of cell death [GO:0010942]; positive regulation of chemokine (C-C motif) ligand 2 secretion [GO:1904209]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of cholesterol import [GO:1904109]; positive regulation of collateral sprouting of injured axon [GO:0048694]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of endocytosis [GO:0045807]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of lipid transport [GO:0032370]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of phagocytosis [GO:0050766]; positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of Schwann cell migration [GO:1900149]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cholesterol transport [GO:0032374]; regulation of extracellular matrix disassembly [GO:0010715]; regulation of phospholipase A2 activity [GO:0032429]; retinoid metabolic process [GO:0001523]; transcytosis [GO:0045056]"
"PGEN_.00g021210"	0.000379649950671519	0.58914138250813	0.0050057820832895	"Scaffold_01"	57373663	57379868	"Q8K386"	"RAB15_MOUSE"	"Ras-related protein Rab-15"	"GO:0003924; GO:0005525; GO:0005768; GO:0005886; GO:0006886; GO:0006904; GO:0008021; GO:0009306; GO:0017157; GO:0032482; GO:0072659"	"endosome [GO:0005768]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; intracellular protein transport [GO:0006886]; protein localization to plasma membrane [GO:0072659]; protein secretion [GO:0009306]; Rab protein signal transduction [GO:0032482]; regulation of exocytosis [GO:0017157]; vesicle docking involved in exocytosis [GO:0006904]"
"PGEN_.00g024960"	2.31416964190717e-09	0.563458053843619	1.83380408240805e-05	"Scaffold_01"	69278011	69280314	"Q6BK42"	"DDI1_DEBHA"	"DNA damage-inducible protein 1 (EC 3.4.23.-)"	"GO:0000149; GO:0004190; GO:0005737; GO:0005886; GO:0009306; GO:0043130; GO:0043328; GO:0045740; GO:0072710"	"cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; aspartic-type endopeptidase activity [GO:0004190]; SNARE binding [GO:0000149]; ubiquitin binding [GO:0043130]; positive regulation of DNA replication [GO:0045740]; protein secretion [GO:0009306]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328]; response to hydroxyurea [GO:0072710]"
"PGEN_.00g026390"	4.94952395712254e-38	7.75389547332754e-50	0.00179118912946325	"Scaffold_01"	72980147	73044811	NA	NA	NA	NA	NA
"PGEN_.00g027060"	0.00120274161243738	0.593092526875084	0.433934876128032	"Scaffold_01"	74866940	74887584	"O95198"	"KLHL2_HUMAN"	"Kelch-like protein 2 (Actin-binding protein Mayven)"	"GO:0001726; GO:0003779; GO:0005737; GO:0005829; GO:0015629; GO:0016567; GO:0030027; GO:0031463; GO:0042802; GO:0043687"	"actin cytoskeleton [GO:0015629]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; ruffle [GO:0001726]; actin binding [GO:0003779]; identical protein binding [GO:0042802]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]"
"PGEN_.00g029230"	0.00344993907085948	2.01470601540817e-07	0.45849472530356	"Scaffold_01"	80283358	80335940	"Q8TAE6"	"PP14C_HUMAN"	"Protein phosphatase 1 regulatory subunit 14C (Kinase-enhanced PP1 inhibitor) (PKC-potentiated PP1 inhibitory protein) (Serologically defined breast cancer antigen NY-BR-81)"	"GO:0004865; GO:0005737; GO:0016020; GO:0042325"	"cytoplasm [GO:0005737]; membrane [GO:0016020]; protein serine/threonine phosphatase inhibitor activity [GO:0004865]; regulation of phosphorylation [GO:0042325]"
"PGEN_.00g030310"	5.64593899519752e-07	0.703745516037255	0.727523910637729	"Scaffold_01"	82898549	82941392	"Q9VCA2"	"ORCT_DROME"	"Organic cation transporter protein"	"GO:0006811; GO:0006915; GO:0016021; GO:0022857"	"integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; apoptotic process [GO:0006915]; ion transport [GO:0006811]"
"PGEN_.00g032130"	0.000113559048639118	0.852851238044373	0.0289107957316112	"Scaffold_01"	87434951	87441668	"O94766"	"B3GA3_HUMAN"	"Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3 (EC 2.4.1.135) (Beta-1,3-glucuronyltransferase 3) (Glucuronosyltransferase I) (GlcAT-I) (UDP-GlcUA:Gal beta-1,3-Gal-R glucuronyltransferase) (GlcUAT-I)"	"GO:0000139; GO:0005794; GO:0005801; GO:0006024; GO:0006486; GO:0015012; GO:0015018; GO:0015020; GO:0016020; GO:0016021; GO:0030203; GO:0043085; GO:0046872; GO:0050650; GO:0050651; GO:0070062; GO:0072542; GO:0090316"	"cis-Golgi network [GO:0005801]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity [GO:0015018]; glucuronosyltransferase activity [GO:0015020]; metal ion binding [GO:0046872]; protein phosphatase activator activity [GO:0072542]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; dermatan sulfate proteoglycan biosynthetic process [GO:0050651]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan metabolic process [GO:0030203]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; positive regulation of catalytic activity [GO:0043085]; positive regulation of intracellular protein transport [GO:0090316]; protein glycosylation [GO:0006486]"
"PGEN_.00g032730"	0.00238032440820857	0.48505209663346	6.24792851281504e-08	"Scaffold_01"	88433511	88434919	"Q552Z2"	"FNKE_DICDI"	"Probable serine/threonine-protein kinase fnkE (EC 2.7.11.1) (FNIP repeat-containing protein E)"	"GO:0004674; GO:0005524; GO:0046872"	"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]"
"PGEN_.00g034240"	1.92079324806683e-08	2.59879592352157e-38	0.00128118103071913	"Scaffold_02"	3271834	3272760	NA	NA	NA	NA	NA
"PGEN_.00g034500"	0.000190624302300185	0.395430148637166	5.02026203383189e-12	"Scaffold_02"	4049426	4050256	NA	NA	NA	NA	NA
"PGEN_.00g035080"	3.38493472583218e-27	0.973426373411381	5.3683857543841e-14	"Scaffold_02"	5299978	5302086	NA	NA	NA	NA	NA
"PGEN_.00g035120"	0.00974892555038963	0.922403770038865	0.383514619936731	"Scaffold_02"	5464063	5477585	"P12001"	"RL18_RAT"	"60S ribosomal protein L18"	"GO:0002181; GO:0003735; GO:0005791; GO:0022625; GO:0042788; GO:0045202; GO:0097421"	"cytosolic large ribosomal subunit [GO:0022625]; polysomal ribosome [GO:0042788]; rough endoplasmic reticulum [GO:0005791]; synapse [GO:0045202]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; liver regeneration [GO:0097421]"
"PGEN_.00g035130"	0.00974892555038963	0.922403770038865	0.383514619936731	"Scaffold_02"	5471221	5472197	"Q80TC5"	"POGK_MOUSE"	"Pogo transposable element with KRAB domain"	"GO:0003677; GO:0005634; GO:0006355; GO:0007275"	"nucleus [GO:0005634]; DNA binding [GO:0003677]; multicellular organism development [GO:0007275]; regulation of transcription, DNA-templated [GO:0006355]"
"PGEN_.00g036880"	9.69782695304373e-08	1.71331908483891e-09	5.00738589646284e-19	"Scaffold_02"	9717263	9781629	"Q68CJ6"	"SLIP_HUMAN"	"Nuclear GTPase SLIP-GC (EC 3.6.1.-) (Speckled-like pattern in the germinal center)"	"GO:0003924; GO:0005525; GO:0016607; GO:0033262; GO:0043066; GO:0071222"	"nuclear speck [GO:0016607]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; cellular response to lipopolysaccharide [GO:0071222]; negative regulation of apoptotic process [GO:0043066]; regulation of nuclear cell cycle DNA replication [GO:0033262]"
"PGEN_.00g037970"	0.0481237692861582	0.86102128423562	0.757194960470678	"Scaffold_02"	13106115	13114102	NA	NA	NA	NA	NA
"PGEN_.00g039860"	0.00495573090710472	0.196332303065498	0.00714338920981146	"Scaffold_02"	18544791	18549959	"P0C6F1"	"DYH2_MOUSE"	"Dynein heavy chain 2, axonemal (Axonemal beta dynein heavy chain 2) (Ciliary dynein heavy chain 2)"	"GO:0005524; GO:0005874; GO:0005930; GO:0007018; GO:0008569; GO:0030286; GO:0031514; GO:0036156; GO:0045505; GO:0051959"	"axoneme [GO:0005930]; dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule-based movement [GO:0007018]"
"PGEN_.00g042700"	0.023539132323468	0.811064891122452	0.313355864444021	"Scaffold_02"	26700167	26747288	"P52429"	"DGKE_HUMAN"	"Diacylglycerol kinase epsilon (DAG kinase epsilon) (EC 2.7.1.107) (Diglyceride kinase epsilon) (DGK-epsilon)"	"GO:0003951; GO:0004143; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0007205; GO:0008654; GO:0016020; GO:0016021; GO:0016301; GO:0030168; GO:0035556; GO:0046339; GO:0046486; GO:0046834; GO:0046872; GO:0050804; GO:0098978"	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; diacylglycerol kinase activity [GO:0004143]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]; diacylglycerol metabolic process [GO:0046339]; glycerolipid metabolic process [GO:0046486]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; modulation of chemical synaptic transmission [GO:0050804]; phospholipid biosynthetic process [GO:0008654]; platelet activation [GO:0030168]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]"
"PGEN_.00g043230"	0.0202733384749655	0.0466569006571067	0.000554615861507744	"Scaffold_02"	28163794	28217702	"Q9D4I2"	"MEII1_MOUSE"	"Meiosis inhibitor protein 1 (Meiosis defective protein 1)"	"GO:0005623; GO:0007141; GO:0007276; GO:0007286; GO:0045141; GO:0051321"	"cell [GO:0005623]; gamete generation [GO:0007276]; male meiosis I [GO:0007141]; meiotic cell cycle [GO:0051321]; meiotic telomere clustering [GO:0045141]; spermatid development [GO:0007286]"
"PGEN_.00g043790"	7.06995124504302e-28	4.24894266454276e-55	3.10546364728877e-20	"Scaffold_02"	29899614	29910977	"P97346"	"NXN_MOUSE"	"Nucleoredoxin (EC 1.8.1.8) (Protein Red-1)"	"GO:0001701; GO:0004791; GO:0005623; GO:0005634; GO:0005829; GO:0016055; GO:0030154; GO:0030178; GO:0031397; GO:0045454; GO:0047134; GO:0072358"	"cell [GO:0005623]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-disulfide reductase activity [GO:0047134]; thioredoxin-disulfide reductase activity [GO:0004791]; cardiovascular system development [GO:0072358]; cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; in utero embryonic development [GO:0001701]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of Wnt signaling pathway [GO:0030178]; Wnt signaling pathway [GO:0016055]"
"PGEN_.00g044020"	0.0291723487286201	0.149967444691797	6.3944289331898e-14	"Scaffold_02"	30569087	30571600	NA	NA	NA	NA	NA
"PGEN_.00g049230"	3.51843214943228e-35	0.397248409939461	4.54706449003701e-34	"Scaffold_02"	44783604	44801307	NA	NA	NA	NA	NA
"PGEN_.00g049950"	1.87911576006574e-198	2.00715810045396e-95	1.68619423765051e-18	"Scaffold_02"	46625003	46631377	"Q8NET6"	"CHSTD_HUMAN"	"Carbohydrate sulfotransferase 13 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 3) (Chondroitin 4-sulfotransferase 3) (C4ST-3) (C4ST3)"	"GO:0000139; GO:0001537; GO:0008146; GO:0016021; GO:0016051; GO:0030166; GO:0030206; GO:0047756"	"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; chondroitin sulfate biosynthetic process [GO:0030206]; proteoglycan biosynthetic process [GO:0030166]"
"PGEN_.00g050170"	0.0122988265832504	0.735261932419261	4.77101314052893e-11	"Scaffold_02"	47298190	47299423	NA	NA	NA	NA	NA
"PGEN_.00g051240"	3.26918455272985e-05	0.52615177618353	0.0607444221819488	"Scaffold_02"	50348448	50400042	"Q6YKA8"	"DRK_DROSI"	"Protein E(sev)2B (Downstream of receptor kinase) (Protein enhancer of sevenless 2B) (SH2-SH3 adapter protein drk)"	"GO:0001784; GO:0005070; GO:0005118; GO:0005154; GO:0005654; GO:0005886; GO:0007173; GO:0007265; GO:0007426; GO:0007427; GO:0007476; GO:0007605; GO:0007614; GO:0008293; GO:0008355; GO:0008543; GO:0030707; GO:0032991; GO:0045500; GO:0045793; GO:0048010; GO:0048260; GO:0070374; GO:0098793; GO:1904263"	"nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; protein-containing complex [GO:0032991]; epidermal growth factor receptor binding [GO:0005154]; phosphotyrosine residue binding [GO:0001784]; sevenless binding [GO:0005118]; SH3/SH2 adaptor activity [GO:0005070]; epidermal growth factor receptor signaling pathway [GO:0007173]; epithelial cell migration, open tracheal system [GO:0007427]; fibroblast growth factor receptor signaling pathway [GO:0008543]; imaginal disc-derived wing morphogenesis [GO:0007476]; olfactory learning [GO:0008355]; ovarian follicle cell development [GO:0030707]; positive regulation of cell size [GO:0045793]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of TORC1 signaling [GO:1904263]; Ras protein signal transduction [GO:0007265]; sensory perception of sound [GO:0007605]; sevenless signaling pathway [GO:0045500]; short-term memory [GO:0007614]; torso signaling pathway [GO:0008293]; tracheal outgrowth, open tracheal system [GO:0007426]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]"
"PGEN_.00g051380"	0.023370165655202	0.925616990581763	0.317739767034515	"Scaffold_02"	50647776	50682267	"Q5RDY1"	"NPL_PONAB"	"N-acetylneuraminate lyase (NALase) (EC 4.1.3.3) (N-acetylneuraminate pyruvate-lyase) (N-acetylneuraminic acid aldolase) (Sialate lyase) (Sialate-pyruvate lyase) (Sialic acid aldolase) (Sialic acid lyase)"	"GO:0005737; GO:0005975; GO:0008747; GO:0019262"	"cytoplasm [GO:0005737]; N-acetylneuraminate lyase activity [GO:0008747]; carbohydrate metabolic process [GO:0005975]; N-acetylneuraminate catabolic process [GO:0019262]"
"PGEN_.00g051410"	0.0496802460607271	0.0021590845086765	0.343836410900574	"Scaffold_02"	50737403	50741672	NA	NA	NA	NA	NA
"PGEN_.00g051490"	0.000251470147582387	0.901688534885714	0.289943235246011	"Scaffold_02"	51005310	51005879	NA	NA	NA	NA	NA
"PGEN_.00g053170"	3.24818486826933e-06	0.000123951533420904	2.69827859364204e-06	"Scaffold_02"	55381667	55443330	"Q8N695"	"SC5A8_HUMAN"	"Sodium-coupled monocarboxylate transporter 1 (Apical iodide transporter) (Electrogenic sodium monocarboxylate cotransporter) (Sodium iodide-related cotransporter) (Solute carrier family 5 member 8)"	"GO:0005886; GO:0006811; GO:0006915; GO:0008028; GO:0015129; GO:0015552; GO:0015913; GO:0016021; GO:0016324; GO:0022803; GO:0034356; GO:0070062; GO:0140161"	"apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; lactate transmembrane transporter activity [GO:0015129]; monocarboxylate:sodium symporter activity [GO:0140161]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; passive transmembrane transporter activity [GO:0022803]; propionate transmembrane transporter activity [GO:0015552]; apoptotic process [GO:0006915]; ion transport [GO:0006811]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; short-chain fatty acid import [GO:0015913]"
"PGEN_.00g054290"	9.95882521050073e-07	0.00126647401293014	0.490967333319064	"Scaffold_02"	58580204	58593548	"O43808"	"PM34_HUMAN"	"Peroxisomal membrane protein PMP34 (34 kDa peroxisomal membrane protein) (Solute carrier family 25 member 17)"	"GO:0000295; GO:0001561; GO:0005347; GO:0005777; GO:0005778; GO:0005779; GO:0006635; GO:0015217; GO:0015228; GO:0015230; GO:0015867; GO:0015908; GO:0016020; GO:0044610; GO:0051087; GO:0051724; GO:0080122"	"integral component of peroxisomal membrane [GO:0005779]; membrane [GO:0016020]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; adenine nucleotide transmembrane transporter activity [GO:0000295]; ADP transmembrane transporter activity [GO:0015217]; AMP transmembrane transporter activity [GO:0080122]; ATP transmembrane transporter activity [GO:0005347]; chaperone binding [GO:0051087]; coenzyme A transmembrane transporter activity [GO:0015228]; FAD transmembrane transporter activity [GO:0015230]; FMN transmembrane transporter activity [GO:0044610]; NAD transmembrane transporter activity [GO:0051724]; ATP transport [GO:0015867]; fatty acid alpha-oxidation [GO:0001561]; fatty acid beta-oxidation [GO:0006635]; fatty acid transport [GO:0015908]"
"PGEN_.00g054340"	0.00794733925807516	0.00458171613749135	0.00129299270640654	"Scaffold_02"	58737793	58738026	NA	NA	NA	NA	NA
"PGEN_.00g055620"	0.000520184480803001	0.619037622669197	0.671779134427608	"Scaffold_02"	62591387	62610230	"Q5R452"	"SAFB1_PONAB"	"Scaffold attachment factor B1 (SAF-B1)"	"GO:0000978; GO:0003682; GO:0003723; GO:0005634; GO:0006355; GO:0050684"	"nucleus [GO:0005634]; chromatin binding [GO:0003682]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of mRNA processing [GO:0050684]; regulation of transcription, DNA-templated [GO:0006355]"
"PGEN_.00g056380"	0.00252099700017631	0.231511914613222	0.461340012305311	"Scaffold_02"	65144099	65178970	"Q8C428"	"TMC7_MOUSE"	"Transmembrane channel-like protein 7"	"GO:0005216; GO:0005887; GO:0008381"	"integral component of plasma membrane [GO:0005887]; ion channel activity [GO:0005216]; mechanosensitive ion channel activity [GO:0008381]"
"PGEN_.00g061770"	3.95366850561955e-07	3.07815951475433e-05	7.01874126642679e-18	"Scaffold_03"	10777571	10781112	"Q6AZB8"	"HARB1_DANRE"	"Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)"	"GO:0004518; GO:0005634; GO:0005737; GO:0046872"	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]"
"PGEN_.00g062630"	0.00189961899382509	0.934560852240742	3.69347621092205e-07	"Scaffold_03"	13089701	13121485	"A0JMD4"	"TPC2_DANRE"	"Two pore calcium channel protein 2 (Voltage-dependent calcium channel protein TPC2)"	"GO:0005245; GO:0005623; GO:0005764; GO:0005765; GO:0006939; GO:0014866; GO:0016021; GO:0019722; GO:0034765; GO:0072345; GO:2000290"	"cell [GO:0005623]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; NAADP-sensitive calcium-release channel activity [GO:0072345]; voltage-gated calcium channel activity [GO:0005245]; calcium-mediated signaling [GO:0019722]; regulation of ion transmembrane transport [GO:0034765]; regulation of myotome development [GO:2000290]; skeletal myofibril assembly [GO:0014866]; smooth muscle contraction [GO:0006939]"
"PGEN_.00g062900"	0.0312816886945324	0.0481306399389377	0.000554615861507744	"Scaffold_03"	13950277	13996316	NA	NA	NA	NA	NA
"PGEN_.00g063860"	4.06839180138578e-07	0.146048062221335	2.21950279544421e-05	"Scaffold_03"	16121565	16194929	"P9WKC0"	"Y1425_MYCTO"	"Putative diacyglycerol O-acyltransferase MT1468 (EC 2.3.1.20) (Putative triacylglycerol synthase MT1468)"	"GO:0004144; GO:0006071; GO:0019432"	"diacylglycerol O-acyltransferase activity [GO:0004144]; glycerol metabolic process [GO:0006071]; triglyceride biosynthetic process [GO:0019432]"
"PGEN_.00g064740"	0.0122363281691047	0.785198974034576	0.0342548593273061	"Scaffold_03"	18809878	18851487	"Q5F471"	"PP6R3_CHICK"	"Serine/threonine-protein phosphatase 6 regulatory subunit 3 (SAPS domain family member 3)"	"GO:0019903; GO:0043666"	"protein phosphatase binding [GO:0019903]; regulation of phosphoprotein phosphatase activity [GO:0043666]"
"PGEN_.00g065450"	0.0338171625254814	0.221931319625655	0.00268735176049847	"Scaffold_03"	20906009	20921499	"Q9C0D5"	"TANC1_HUMAN"	"Protein TANC1 (Tetratricopeptide repeat, ankyrin repeat and coiled-coil domain-containing protein 1)"	"GO:0007520; GO:0008542; GO:0014069; GO:0030054; GO:0030425; GO:0043025; GO:0043679; GO:0097062"	"axon terminus [GO:0043679]; cell junction [GO:0030054]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; postsynaptic density [GO:0014069]; dendritic spine maintenance [GO:0097062]; myoblast fusion [GO:0007520]; visual learning [GO:0008542]"
"PGEN_.00g065610"	0.00120413896409299	0.636591075578648	0.862162343443607	"Scaffold_03"	21333575	21334232	NA	NA	NA	NA	NA
"PGEN_.00g065700"	8.34067118032795e-05	0.0450026932386791	0.700372600745351	"Scaffold_03"	21395485	21421405	"P80174"	"SODC_CARCR"	"Superoxide dismutase [Cu-Zn] (EC 1.15.1.1)"	"GO:0004784; GO:0005634; GO:0005737; GO:0046872"	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; superoxide dismutase activity [GO:0004784]"
"PGEN_.00g065870"	0.000138340027110179	0.0351611484662239	0.00521194087872873	"Scaffold_03"	21923906	22118212	"O75691"	"UTP20_HUMAN"	"Small subunit processome component 20 homolog (Down-regulated in metastasis protein) (Novel nucleolar protein 73) (NNP73) (Protein Key-1A6)"	"GO:0000447; GO:0000472; GO:0000480; GO:0003723; GO:0005654; GO:0005730; GO:0005737; GO:0005886; GO:0006364; GO:0008285; GO:0030686; GO:0030688; GO:0032040"	"90S preribosome [GO:0030686]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; preribosome, small subunit precursor [GO:0030688]; small-subunit processome [GO:0032040]; RNA binding [GO:0003723]; endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000480]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000472]; negative regulation of cell population proliferation [GO:0008285]; rRNA processing [GO:0006364]"
"PGEN_.00g066200"	3.39173440983547e-06	0.58090120071781	2.60359849557757e-05	"Scaffold_03"	23345122	23347681	NA	NA	NA	NA	NA
"PGEN_.00g066220"	1.07349416217621e-05	0.891395606672078	2.47133499907084e-06	"Scaffold_03"	23350020	23351543	NA	NA	NA	NA	NA
"PGEN_.00g067000"	0.000886276897611925	0.634109279495706	0.874542350551668	"Scaffold_03"	25276766	25286022	NA	NA	NA	NA	NA
"PGEN_.00g067330"	0.00823365922788139	0.655597478781302	0.0058723496525794	"Scaffold_03"	26080696	26139433	"Q8TDW5"	"SYTL5_HUMAN"	"Synaptotagmin-like protein 5"	"GO:0005543; GO:0006886; GO:0006887; GO:0016020; GO:0017137; GO:0046872; GO:0070382"	"exocytic vesicle [GO:0070382]; membrane [GO:0016020]; metal ion binding [GO:0046872]; phospholipid binding [GO:0005543]; Rab GTPase binding [GO:0017137]; exocytosis [GO:0006887]; intracellular protein transport [GO:0006886]"
"PGEN_.00g067680"	0.0138951038680062	0.0806742578295323	0.0603956651576528	"Scaffold_03"	27101958	27117373	NA	NA	NA	NA	NA
"PGEN_.00g068720"	3.7206938691062e-14	3.04824651422142e-09	6.4607005212228e-28	"Scaffold_03"	29524834	29525839	NA	NA	NA	NA	NA
"PGEN_.00g069450"	0.00654558973893187	0.222079767293808	0.260952091964737	"Scaffold_03"	32158794	32161618	"Q7Z5P9"	"MUC19_HUMAN"	"Mucin-19 (MUC-19)"	"GO:0002223; GO:0005576; GO:0005796; GO:0005886; GO:0016266"	"extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886]; O-glycan processing [GO:0016266]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]"
"PGEN_.00g069590"	0.0407238620458474	0.95466580006029	0.985968587121161	"Scaffold_03"	32333181	32346251	"Q5U2R1"	"DLP1_RAT"	"Decaprenyl-diphosphate synthase subunit 2 (EC 2.5.1.91) (All-trans-decaprenyl-diphosphate synthase subunit 2) (Decaprenyl pyrophosphate synthase subunit 2)"	"GO:0000010; GO:0005739; GO:0005829; GO:0006744; GO:0008299; GO:0046982; GO:0050347; GO:0050878; GO:0051290; GO:1990234"	"cytosol [GO:0005829]; mitochondrion [GO:0005739]; transferase complex [GO:1990234]; protein heterodimerization activity [GO:0046982]; trans-hexaprenyltranstransferase activity [GO:0000010]; trans-octaprenyltranstransferase activity [GO:0050347]; isoprenoid biosynthetic process [GO:0008299]; protein heterotetramerization [GO:0051290]; regulation of body fluid levels [GO:0050878]; ubiquinone biosynthetic process [GO:0006744]"
"PGEN_.00g069610"	0.000144644115395024	0.00282750347505024	2.59508908651369e-11	"Scaffold_03"	32387002	32406962	NA	NA	NA	NA	NA
"PGEN_.00g069870"	0.00382258393690529	0.149967444691797	0.416816280236536	"Scaffold_03"	32918963	32934808	NA	NA	NA	NA	NA
"PGEN_.00g070620"	0.00214147670492852	0.461720433589208	1.75185182866285e-08	"Scaffold_03"	35233150	35250484	"O96790"	"DPGN_DIPMA"	"Serine protease inhibitor dipetalogastin (Dipetalin) (Fragment)"	"GO:0004867; GO:0005576; GO:0050819"	"extracellular region [GO:0005576]; serine-type endopeptidase inhibitor activity [GO:0004867]; negative regulation of coagulation [GO:0050819]"
"PGEN_.00g073310"	0.000123724043025022	0.52615177618353	0.305520694394437	"Scaffold_03"	42863191	42875431	"P18172"	"DHGL_DROPS"	"Glucose dehydrogenase [FAD, quinone] (EC 1.1.5.9) [Cleaved into: Glucose dehydrogenase [FAD, quinone] short protein]"	"GO:0005576; GO:0016614; GO:0050660"	"extracellular region [GO:0005576]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]"
"PGEN_.00g074780"	1.64751441306265e-11	0.561359856154372	6.01294400175435e-18	"Scaffold_03"	47906607	47906957	NA	NA	NA	NA	NA
"PGEN_.00g075620"	0.014678909850144	0.00333687137929181	0.388175527214963	"Scaffold_03"	50571073	50595604	NA	NA	NA	NA	NA
"PGEN_.00g075760"	0.0420090399368827	0.0275330999195033	0.0823853137460449	"Scaffold_03"	50862089	50887817	"Q67FQ3"	"ARHB_XENLA"	"Low density lipoprotein receptor adapter protein 1-B (Autosomal recessive hypercholesterolemia protein homolog beta) (ARH beta) (xARH beta)"	"GO:0005737; GO:0006897; GO:0008203"	"cytoplasm [GO:0005737]; cholesterol metabolic process [GO:0008203]; endocytosis [GO:0006897]"
"PGEN_.00g075910"	0.024202204720855	0.293266770159254	0.0677616803009339	"Scaffold_03"	51264461	51265168	NA	NA	NA	NA	NA
"PGEN_.00g076180"	4.50704695633396e-05	0.677303399392791	2.49134297273664e-09	"Scaffold_03"	51960428	51967440	"Q8JHV9"	"BIR7A_XENLA"	"Baculoviral IAP repeat-containing protein 7-A (EC 2.3.2.27) (E3 ubiquitin-protein ligase EIAP-A) (Embryonic/Egg IAP) (xEIAP/XLX) (Inhibitor of apoptosis-like protein) (IAP-like protein) (RING-type E3 ubiquitin transferase EIAP-A) (XIAP homolog XLX) (XLX)"	"GO:0005737; GO:0007275; GO:0016740; GO:0043027; GO:0043066; GO:0043154; GO:0046872; GO:0051865"	"cytoplasm [GO:0005737]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; metal ion binding [GO:0046872]; transferase activity [GO:0016740]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; protein autoubiquitination [GO:0051865]"
"PGEN_.00g077070"	0.0479839768969098	0.722974837374853	0.033890904695957	"Scaffold_03"	54609767	54610342	NA	NA	NA	NA	NA
"PGEN_.00g077330"	0.00895241108565018	0.903909068427942	0.89016593540812	"Scaffold_03"	54909107	55002095	"Q8C5H1"	"ANO4_MOUSE"	"Anoctamin-4 (Transmembrane protein 16D)"	"GO:0005886; GO:0006821; GO:0016021; GO:0017128; GO:0046983; GO:0061589; GO:0061590; GO:0061591; GO:1902476"	"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; phospholipid scramblase activity [GO:0017128]; protein dimerization activity [GO:0046983]; calcium activated galactosylceramide scrambling [GO:0061591]; calcium activated phosphatidylcholine scrambling [GO:0061590]; calcium activated phosphatidylserine scrambling [GO:0061589]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]"
"PGEN_.00g077870"	0.00154012900867724	0.476213785855516	5.37665391455005e-14	"Scaffold_03"	56325773	56328346	NA	NA	NA	NA	NA
"PGEN_.00g078310"	0.0282720258767977	0.717104279031869	0.00746888456473829	"Scaffold_03"	57399874	57483677	"P35992"	"PTP10_DROME"	"Tyrosine-protein phosphatase 10D (EC 3.1.3.48) (Receptor-linked protein-tyrosine phosphatase 10D) (DPTP10D)"	"GO:0004725; GO:0005001; GO:0006470; GO:0007411; GO:0007417; GO:0007424; GO:0007616; GO:0008045; GO:0016021; GO:0030424; GO:0042059; GO:0045177; GO:0060446"	"apical part of cell [GO:0045177]; axon [GO:0030424]; integral component of membrane [GO:0016021]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axon guidance [GO:0007411]; branching involved in open tracheal system development [GO:0060446]; central nervous system development [GO:0007417]; long-term memory [GO:0007616]; motor neuron axon guidance [GO:0008045]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; open tracheal system development [GO:0007424]; protein dephosphorylation [GO:0006470]"
"PGEN_.00g079530"	5.7479533020798e-06	4.18445646807193e-05	0.966960145863521	"Scaffold_04"	2747237	2750703	NA	NA	NA	NA	NA
"PGEN_.00g080700"	0.00195129536677981	0.970130334987832	0.699316555767792	"Scaffold_04"	5730516	5769291	NA	NA	NA	NA	NA
"PGEN_.00g080870"	0.0145382405460513	0.237955633026324	3.65376527610571e-09	"Scaffold_04"	6303439	6316236	NA	NA	NA	NA	NA
"PGEN_.00g082390"	2.25861417678572e-06	0.250433612389597	0.0831613958475597	"Scaffold_04"	9894020	9900405	"Q8BR93"	"HARB1_MOUSE"	"Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)"	"GO:0004518; GO:0005634; GO:0005829; GO:0005886; GO:0034451; GO:0046872"	"centriolar satellite [GO:0034451]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]"
"PGEN_.00g082990"	2.25861417678572e-06	0.528845386010491	0.559496457644659	"Scaffold_04"	11114082	11123714	NA	NA	NA	NA	NA
"PGEN_.00g084590"	0.000789597213733952	2.67857614084234e-09	4.06322196838337e-07	"Scaffold_04"	15155960	15156208	NA	NA	NA	NA	NA
"PGEN_.00g085120"	0.00986427301005276	0.445335750674467	0.354606205412768	"Scaffold_04"	16334031	16343390	NA	NA	NA	NA	NA
"PGEN_.00g086030"	2.79816036976501e-06	0.575251745239636	0.0533411837317441	"Scaffold_04"	18737907	18762048	NA	NA	NA	NA	NA
"PGEN_.00g086530"	0	3.87009116652035e-169	2.44008024665326e-199	"Scaffold_04"	20248221	20253961	NA	NA	NA	NA	NA
"PGEN_.00g086580"	0.0220314620996701	0.349757597665189	0.887486196432348	"Scaffold_04"	20484091	20484405	NA	NA	NA	NA	NA
"PGEN_.00g087850"	0.000555622709839718	1.10151488021082e-06	0.0738695596257748	"Scaffold_04"	23621710	23634551	"Q9ULI3"	"HEG1_HUMAN"	"Protein HEG homolog 1"	"GO:0001570; GO:0001701; GO:0001886; GO:0001945; GO:0003017; GO:0003209; GO:0003222; GO:0003281; GO:0005509; GO:0005576; GO:0005911; GO:0007043; GO:0007507; GO:0009791; GO:0009897; GO:0016021; GO:0030324; GO:0035024; GO:0035264; GO:0048845; GO:0050878; GO:0055017; GO:0060039; GO:0090271; GO:1902414; GO:1905709; GO:2000299"	"cell-cell junction [GO:0005911]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; cardiac atrium morphogenesis [GO:0003209]; cardiac muscle tissue growth [GO:0055017]; cell-cell junction assembly [GO:0007043]; endothelial cell morphogenesis [GO:0001886]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; lung development [GO:0030324]; lymph circulation [GO:0003017]; lymph vessel development [GO:0001945]; multicellular organism growth [GO:0035264]; negative regulation of membrane permeability [GO:1905709]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of Rho-dependent protein serine/threonine kinase activity [GO:2000299]; pericardium development [GO:0060039]; positive regulation of fibroblast growth factor production [GO:0090271]; post-embryonic development [GO:0009791]; protein localization to cell junction [GO:1902414]; regulation of body fluid levels [GO:0050878]; vasculogenesis [GO:0001570]; venous blood vessel morphogenesis [GO:0048845]; ventricular septum development [GO:0003281]; ventricular trabecula myocardium morphogenesis [GO:0003222]"
"PGEN_.00g092010"	0.00105713928222354	0.663618016135141	7.75418638031046e-08	"Scaffold_04"	34431632	34477799	"P51816"	"AFF2_HUMAN"	"AF4/FMR2 family member 2 (Fragile X E mental retardation syndrome protein) (Fragile X mental retardation 2 protein) (FMR2P) (Protein FMR-2) (Protein Ox19)"	"GO:0002151; GO:0005634; GO:0006355; GO:0006397; GO:0007420; GO:0007611; GO:0008380; GO:0010468; GO:0010629; GO:0016607; GO:0035063; GO:0043484"	"nuclear speck [GO:0016607]; nucleus [GO:0005634]; G-quadruplex RNA binding [GO:0002151]; brain development [GO:0007420]; learning or memory [GO:0007611]; mRNA processing [GO:0006397]; negative regulation of gene expression [GO:0010629]; nuclear speck organization [GO:0035063]; regulation of gene expression [GO:0010468]; regulation of RNA splicing [GO:0043484]; regulation of transcription, DNA-templated [GO:0006355]; RNA splicing [GO:0008380]"
"PGEN_.00g094130"	4.46814934965274e-06	0.0522651896651286	0.469578209866963	"Scaffold_04"	40359195	40366858	NA	NA	NA	NA	NA
"PGEN_.00g094260"	0.000308427938349267	0.543182170350515	0.00370554307888189	"Scaffold_04"	40636488	40653674	NA	NA	NA	NA	NA
"PGEN_.00g095890"	0.00382299899021539	0.213175567886512	0.950975057638754	"Scaffold_04"	45509173	45513558	NA	NA	NA	NA	NA
"PGEN_.00g095900"	0.00836495783569952	0.459516378061118	0.591189627284116	"Scaffold_04"	45513581	45514510	NA	NA	NA	NA	NA
"PGEN_.00g096230"	0.00685520497308933	0.52615177618353	0.416792921457829	"Scaffold_04"	46322021	46334683	NA	NA	NA	NA	NA
"PGEN_.00g097040"	0.00224357422946872	0.530177357141194	0.20212983106131	"Scaffold_04"	48427705	48448324	NA	NA	NA	NA	NA
"PGEN_.00g097550"	7.05322613392785e-15	0.349760922881058	4.38801377538975e-27	"Scaffold_04"	49794445	49794803	NA	NA	NA	NA	NA
"PGEN_.00g100950"	0.00209953273862376	1.0073534243551e-17	0.0630178688853394	"Scaffold_04"	57885900	57886430	NA	NA	NA	NA	NA
"PGEN_.00g101020"	4.834369877021e-05	0.655597478781302	0.00146053868090002	"Scaffold_04"	57942638	57943782	NA	NA	NA	NA	NA
"PGEN_.00g101030"	0.00193661836844924	3.96202213405499e-39	1.22921960666354e-35	"Scaffold_04"	57953649	57955140	NA	NA	NA	NA	NA
"PGEN_.00g101830"	0.00154012900867724	0.872665328499164	0.16815942201758	"Scaffold_04"	60015206	60031655	"P53370"	"NUDT6_HUMAN"	"Nucleoside diphosphate-linked moiety X motif 6 (Nudix motif 6) (EC 3.6.1.-) (Antisense basic fibroblast growth factor) (Protein GFG)"	"GO:0005634; GO:0005737; GO:0005739; GO:0008285; GO:0035529; GO:0045786; GO:0047631; GO:0051287"	"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; ADP-ribose diphosphatase activity [GO:0047631]; NAD binding [GO:0051287]; NADH pyrophosphatase activity [GO:0035529]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]"
"PGEN_.00g103590"	9.44128905279227e-05	2.01326609544454e-06	0.404586462667148	"Scaffold_04"	64746021	64753853	NA	NA	NA	NA	NA
"PGEN_.00g104730"	0.000592312770877281	7.89564517961758e-08	8.41833900327538e-61	"Scaffold_05"	2521223	2525989	NA	NA	NA	NA	NA
"PGEN_.00g105400"	0.0485799963870943	0.692808563674087	0.220429163572822	"Scaffold_05"	4615002	4643207	"P06731"	"CEAM5_HUMAN"	"Carcinoembryonic antigen-related cell adhesion molecule 5 (Carcinoembryonic antigen) (CEA) (Meconium antigen 100) (CD antigen CD66e)"	"GO:0005576; GO:0005886; GO:0005887; GO:0006915; GO:0007156; GO:0007157; GO:0009986; GO:0010832; GO:0016323; GO:0016324; GO:0031225; GO:0034109; GO:0034235; GO:0042802; GO:0042803; GO:0043066; GO:0050900; GO:0070062; GO:0071575; GO:2000811"	"anchored component of membrane [GO:0031225]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; integral component of external side of plasma membrane [GO:0071575]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; GPI anchor binding [GO:0034235]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; apoptotic process [GO:0006915]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; homotypic cell-cell adhesion [GO:0034109]; leukocyte migration [GO:0050900]; negative regulation of anoikis [GO:2000811]; negative regulation of apoptotic process [GO:0043066]; negative regulation of myotube differentiation [GO:0010832]"
"PGEN_.00g106060"	0.000125725727689071	0.000908923306024851	0.564393085902567	"Scaffold_05"	6157016	6159052	NA	NA	NA	NA	NA
"PGEN_.00g108490"	9.37331072200299e-06	1.33248527549182e-06	0.0164634059263804	"Scaffold_05"	11321164	11322981	NA	NA	NA	NA	NA
"PGEN_.00g108510"	1.76365135483876e-05	0.0010229911204227	0.330663165345606	"Scaffold_05"	11325835	11347220	"B0KTX4"	"UBIG_PSEPG"	"Ubiquinone biosynthesis O-methyltransferase (2-polyprenyl-6-hydroxyphenol methylase) (EC 2.1.1.222) (3-demethylubiquinone 3-O-methyltransferase) (EC 2.1.1.64)"	"GO:0006744; GO:0008425; GO:0008689; GO:0032259"	"2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity [GO:0008425]; 3-demethylubiquinone-9 3-O-methyltransferase activity [GO:0008689]; methylation [GO:0032259]; ubiquinone biosynthetic process [GO:0006744]"
"PGEN_.00g110260"	3.76404193249992e-08	0.86000090138441	0.00521194087872873	"Scaffold_05"	15669855	15764255	"Q39565"	"DYHB_CHLRE"	"Dynein beta chain, flagellar outer arm"	"GO:0003777; GO:0005524; GO:0005737; GO:0005874; GO:0007018; GO:0030030; GO:0030286; GO:0031514"	"cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]; cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]"
"PGEN_.00g110640"	0.0367251017403069	0.575151800935484	0.119565008812147	"Scaffold_05"	16931361	16979731	"Q9R044"	"NPHN_RAT"	"Nephrin (Renal glomerulus-specific cell adhesion receptor)"	"GO:0000165; GO:0003094; GO:0005886; GO:0005925; GO:0007155; GO:0007254; GO:0007519; GO:0007520; GO:0016020; GO:0016021; GO:0017022; GO:0019904; GO:0030507; GO:0030838; GO:0032836; GO:0032991; GO:0035418; GO:0036057; GO:0042995; GO:0044062; GO:0045121; GO:0051393; GO:0072015"	"cell projection [GO:0042995]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; slit diaphragm [GO:0036057]; alpha-actinin binding [GO:0051393]; myosin binding [GO:0017022]; protein domain specific binding [GO:0019904]; spectrin binding [GO:0030507]; cell adhesion [GO:0007155]; glomerular basement membrane development [GO:0032836]; glomerular filtration [GO:0003094]; glomerular visceral epithelial cell development [GO:0072015]; JNK cascade [GO:0007254]; MAPK cascade [GO:0000165]; myoblast fusion [GO:0007520]; positive regulation of actin filament polymerization [GO:0030838]; protein localization to synapse [GO:0035418]; regulation of excretion [GO:0044062]; skeletal muscle tissue development [GO:0007519]"
"PGEN_.00g112130"	0.0403245681495575	0.0881923136011733	0.00352852949725831	"Scaffold_05"	21399886	21401034	NA	NA	NA	NA	NA
"PGEN_.00g116020"	0.00105066811206603	0.000145939294584597	0.455800506586844	"Scaffold_05"	32921146	32970923	"B3EWY8"	"SAAR2_ACRMI"	"Skeletal aspartic acid-rich protein 2 (Fragment)"	"GO:0016021"	"integral component of membrane [GO:0016021]"
"PGEN_.00g116710"	2.59268946275852e-83	1.47212029951078e-14	8.55872291008072e-32	"Scaffold_05"	34291625	34335232	"B3EWY9"	"MLP_ACRMI"	"Mucin-like protein (Fragment)"	"GO:0005509; GO:0007160; GO:0016021"	"integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; cell-matrix adhesion [GO:0007160]"
"PGEN_.00g118530"	0.0472815591056522	0.487318300129861	0.589732145371419	"Scaffold_05"	39981561	39982833	NA	NA	NA	NA	NA
"PGEN_.00g120380"	1.62252172053444e-06	0.0451359342816616	8.37241884463008e-06	"Scaffold_05"	45416815	45417542	NA	NA	NA	NA	NA
"PGEN_.00g124830"	0.000119434987462933	0.52169386436817	1.10395423066714e-05	"Scaffold_05"	56716258	56795358	"D3YXG0"	"HMCN1_MOUSE"	"Hemicentin-1 (Fibulin-6) (FIBL-6)"	"GO:0005509; GO:0005576; GO:0005604; GO:0005913; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0009617; GO:0030054; GO:0032154; GO:0038023; GO:0042803; GO:0050839; GO:0051301; GO:0062023"	"basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]"
"PGEN_.00g125020"	0.000348581109631806	0.801452081918626	0.0195931144572676	"Scaffold_05"	57307339	57370001	NA	NA	NA	NA	NA
"PGEN_.00g125310"	0.0206454835707426	0.0276946901235372	2.36311489432789e-05	"Scaffold_05"	58046068	58110568	NA	NA	NA	NA	NA
"PGEN_.00g125870"	0.00482829313376137	0.160197911245436	0.523021821920293	"Scaffold_05"	59790862	59791964	NA	NA	NA	NA	NA
"PGEN_.00g125980"	3.34085839973592e-05	0.917668733200342	0.522421196310023	"Scaffold_05"	60020238	60020537	NA	NA	NA	NA	NA
"PGEN_.00g126360"	0.0268730458679299	0.706229490419898	0.139670925376763	"Scaffold_05"	60831216	60831908	NA	NA	NA	NA	NA
"PGEN_.00g126370"	0.00161527440418979	0.367156657337824	9.11016322213949e-08	"Scaffold_05"	60832377	60837710	NA	NA	NA	NA	NA
"PGEN_.00g126640"	2.17140615704825e-06	0.00231521284851464	7.71626634612031e-28	"Scaffold_05"	61611337	61611922	NA	NA	NA	NA	NA
"PGEN_.00g127230"	1.13574222047521e-11	9.07392821166048e-08	1.4219645468309e-91	"Scaffold_05"	62825525	62833060	NA	NA	NA	NA	NA
"PGEN_.00g127610"	0.0155330990849932	0.947523234932992	0.155032259591758	"Scaffold_05"	63527463	63527780	NA	NA	NA	NA	NA
"PGEN_.00g129780"	4.83736660831317e-28	0.0476599553158026	4.89774619225082e-20	"Scaffold_06"	2364924	2385026	"P61315"	"G3ST3_MOUSE"	"Galactose-3-O-sulfotransferase 3 (Gal3ST-3) (EC 2.8.2.-) (Beta-galactose-3-O-sulfotransferase 3) (Gal-beta-1, 3-GalNAc 3'-sulfotransferase 3)"	"GO:0001733; GO:0009247; GO:0016021; GO:0032580; GO:0050694"	"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; galactose 3-O-sulfotransferase activity [GO:0050694]; galactosylceramide sulfotransferase activity [GO:0001733]; glycolipid biosynthetic process [GO:0009247]"
"PGEN_.00g130160"	0.00584581123472313	0.0113978152092618	0.0413563140748495	"Scaffold_06"	3270606	3274261	"Q8BR93"	"HARB1_MOUSE"	"Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)"	"GO:0004518; GO:0005634; GO:0005829; GO:0005886; GO:0034451; GO:0046872"	"centriolar satellite [GO:0034451]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]"
"PGEN_.00g130840"	0.00214147670492852	0.108094483690144	0.112410131966742	"Scaffold_06"	4845322	4845705	NA	NA	NA	NA	NA
"PGEN_.00g133000"	0.00120274161243738	0.31639334178795	9.8194129222033e-05	"Scaffold_06"	10182526	10182777	NA	NA	NA	NA	NA
"PGEN_.00g137880"	0.00935085739631613	0.10150064575873	0.0006230016308053	"Scaffold_06"	21770803	21771318	NA	NA	NA	NA	NA
"PGEN_.00g137910"	0.0423974599220278	0.00631915530013053	1.1587931392213e-05	"Scaffold_06"	21904708	21936513	"P46023"	"GR101_LYMST"	"G-protein coupled receptor GRL101"	"GO:0004930; GO:0005886; GO:0016021"	"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]"
"PGEN_.00g139370"	0.00219144901843305	0.785198974034576	0.950322537239316	"Scaffold_06"	25275700	25386965	"Q7TNF8"	"RIMB1_MOUSE"	"Peripheral-type benzodiazepine receptor-associated protein 1 (PRAX-1) (Peripheral benzodiazepine receptor-interacting protein) (PBR-IP) (RIMS-binding protein 1) (RIM-BP1) (TSPO-associated protein 1)"	"GO:0005737; GO:0005739; GO:0030156; GO:0044305; GO:0098978; GO:0099626"	"calyx of Held [GO:0044305]; cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739]; benzodiazepine receptor binding [GO:0030156]; voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels [GO:0099626]"
"PGEN_.00g139540"	4.07777145671402e-09	0.156145790550324	3.57404847000573e-11	"Scaffold_06"	25730920	25732298	NA	NA	NA	NA	NA
"PGEN_.00g139560"	0.000313529746738533	0.123737982422903	1.91809658133796e-11	"Scaffold_06"	25734949	25736806	NA	NA	NA	NA	NA
"PGEN_.00g139570"	1.19743318569004e-07	0.000287743175805685	2.82253228439773e-15	"Scaffold_06"	25736847	25737710	NA	NA	NA	NA	NA
"PGEN_.00g140310"	4.17125095690759e-30	3.73305983521273e-29	2.09822654101435e-31	"Scaffold_06"	28097745	28112985	NA	NA	NA	NA	NA
"PGEN_.00g140750"	0.00120274161243738	0.782055057223361	0.242231759207134	"Scaffold_06"	28911987	28927659	"A8TX70"	"CO6A5_HUMAN"	"Collagen alpha-5(VI) chain (Collagen alpha-1(XXIX) chain) (von Willebrand factor A domain-containing protein 4)"	"GO:0005576; GO:0005581; GO:0007155; GO:0030020; GO:0062023"	"collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; cell adhesion [GO:0007155]"
"PGEN_.00g141850"	0.0450149960216759	0.811064891122452	0.0407364231531465	"Scaffold_06"	31906739	31908838	NA	NA	NA	NA	NA
"PGEN_.00g143270"	1.41081904054638e-23	0.0327472628487409	0.0480764529375252	"Scaffold_06"	36978300	36978638	NA	NA	NA	NA	NA
"PGEN_.00g144010"	0.0303377984229243	0.865636776087306	0.133108298014679	"Scaffold_06"	38470229	38473298	NA	NA	NA	NA	NA
"PGEN_.00g144300"	9.1147549104123e-06	0.261783107216424	0.956634240250275	"Scaffold_06"	39219154	39219912	NA	NA	NA	NA	NA
"PGEN_.00g144390"	0.00526286367910407	0.153213620530429	0.099139471452148	"Scaffold_06"	39385314	39394680	NA	NA	NA	NA	NA
"PGEN_.00g144710"	0.0275446329255006	0.538308087692507	0.207864463967275	"Scaffold_06"	40327749	40339556	NA	NA	NA	NA	NA
"PGEN_.00g145190"	3.40798141973213e-33	0.801460375859917	0.479971619073906	"Scaffold_06"	41616265	41632711	NA	NA	NA	NA	NA
"PGEN_.00g145440"	0.000256232755323912	0.970130334987832	0.253131734566161	"Scaffold_06"	42086097	42109014	"P49025"	"CTRO_MOUSE"	"Citron Rho-interacting kinase (CRIK) (EC 2.7.11.1) (Rho-interacting, serine/threonine-protein kinase 21)"	"GO:0000070; GO:0000086; GO:0000278; GO:0000281; GO:0001726; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005773; GO:0005829; GO:0005856; GO:0005886; GO:0007030; GO:0007091; GO:0007283; GO:0008064; GO:0015629; GO:0016358; GO:0017124; GO:0018107; GO:0030165; GO:0030496; GO:0030866; GO:0031032; GO:0031985; GO:0032154; GO:0032467; GO:0035556; GO:0043025; GO:0045665; GO:0046872; GO:0048699; GO:0050774; GO:0051402; GO:0097110"	"actin cytoskeleton [GO:0015629]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; Golgi cisterna [GO:0031985]; midbody [GO:0030496]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; vacuole [GO:0005773]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; PDZ domain binding [GO:0030165]; protein serine/threonine kinase activity [GO:0004674]; scaffold protein binding [GO:0097110]; SH3 domain binding [GO:0017124]; actomyosin structure organization [GO:0031032]; cortical actin cytoskeleton organization [GO:0030866]; dendrite development [GO:0016358]; G2/M transition of mitotic cell cycle [GO:0000086]; generation of neurons [GO:0048699]; Golgi organization [GO:0007030]; intracellular signal transduction [GO:0035556]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; mitotic cell cycle [GO:0000278]; mitotic cytokinesis [GO:0000281]; mitotic sister chromatid segregation [GO:0000070]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of neuron differentiation [GO:0045665]; neuron apoptotic process [GO:0051402]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of cytokinesis [GO:0032467]; regulation of actin polymerization or depolymerization [GO:0008064]; spermatogenesis [GO:0007283]"
"PGEN_.00g146770"	0.000192698179603051	0.52615177618353	0.141810076239568	"Scaffold_06"	45397839	45405685	NA	NA	NA	NA	NA
"PGEN_.00g147090"	0.00242655024459626	0.944359184812895	3.2042151417379e-08	"Scaffold_06"	46418832	46437930	NA	NA	NA	NA	NA
"PGEN_.00g148640"	0.00703981630764293	0.654129184171344	0.240527848446732	"Scaffold_06"	51195024	51197173	NA	NA	NA	NA	NA
"PGEN_.00g149640"	1.38677054382198e-07	6.01388082433149e-56	5.32340461854331e-148	"Scaffold_06"	53208943	53234353	"Q80YX1"	"TENA_MOUSE"	"Tenascin (TN) (Hexabrachion) (Tenascin-C) (TN-C)"	"GO:0001968; GO:0005576; GO:0005604; GO:0005614; GO:0005615; GO:0007155; GO:0007162; GO:0007528; GO:0008284; GO:0009612; GO:0010628; GO:0014012; GO:0031012; GO:0031175; GO:0042060; GO:0042475; GO:0045471; GO:0045545; GO:0060447; GO:0060739; GO:0060740; GO:0062023; GO:0071300; GO:0071305; GO:0071774; GO:0071799; GO:0098966"	"basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; interstitial matrix [GO:0005614]; perisynaptic extracellular matrix [GO:0098966]; fibronectin binding [GO:0001968]; syndecan binding [GO:0045545]; bud outgrowth involved in lung branching [GO:0060447]; cell adhesion [GO:0007155]; cellular response to prostaglandin D stimulus [GO:0071799]; cellular response to retinoic acid [GO:0071300]; cellular response to vitamin D [GO:0071305]; mesenchymal-epithelial cell signaling involved in prostate gland development [GO:0060739]; negative regulation of cell adhesion [GO:0007162]; neuromuscular junction development [GO:0007528]; neuron projection development [GO:0031175]; odontogenesis of dentin-containing tooth [GO:0042475]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; prostate gland epithelium morphogenesis [GO:0060740]; response to ethanol [GO:0045471]; response to fibroblast growth factor [GO:0071774]; response to mechanical stimulus [GO:0009612]; wound healing [GO:0042060]"
"PGEN_.00g150000"	1.11744811093604e-06	4.02670968014434e-11	2.4880437051519e-10	"Scaffold_06"	54115055	54118574	NA	NA	NA	NA	NA
"PGEN_.00g152680"	0.0150133214810577	0.619037622669197	0.0620183938448077	"Scaffold_06"	61402590	61437197	"Q3V0L5"	"LRC43_MOUSE"	"Leucine-rich repeat-containing protein 43"	""	""
"PGEN_.00g153140"	0.000386799032975092	0.780116538379108	0.348844122801969	"Scaffold_07"	1037155	1079880	"Q12955"	"ANK3_HUMAN"	"Ankyrin-3 (ANK-3) (Ankyrin-G)"	"GO:0000281; GO:0005200; GO:0005623; GO:0005764; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0006888; GO:0007009; GO:0007016; GO:0007165; GO:0007409; GO:0007528; GO:0008092; GO:0009925; GO:0009986; GO:0010628; GO:0010650; GO:0010765; GO:0010960; GO:0014704; GO:0014731; GO:0016020; GO:0016323; GO:0016328; GO:0016529; GO:0019228; GO:0030018; GO:0030315; GO:0030425; GO:0030507; GO:0030674; GO:0031594; GO:0033268; GO:0034112; GO:0042383; GO:0043001; GO:0043005; GO:0043034; GO:0043194; GO:0043266; GO:0044325; GO:0045184; GO:0045211; GO:0045296; GO:0045838; GO:0071286; GO:0071709; GO:0072659; GO:0072660; GO:0090314; GO:0099612; GO:1900827; GO:1902260; GO:2000651; GO:2001259"	"axon initial segment [GO:0043194]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell [GO:0005623]; cell surface [GO:0009986]; costamere [GO:0043034]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; lysosome [GO:0005764]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; node of Ranvier [GO:0033268]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; T-tubule [GO:0030315]; Z disc [GO:0030018]; cadherin binding [GO:0045296]; cytoskeletal protein binding [GO:0008092]; ion channel binding [GO:0044325]; protein binding, bridging [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; axonogenesis [GO:0007409]; cellular response to magnesium ion [GO:0071286]; cytoskeletal anchoring at plasma membrane [GO:0007016]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; establishment of protein localization [GO:0045184]; Golgi to plasma membrane protein transport [GO:0043001]; magnesium ion homeostasis [GO:0010960]; maintenance of protein location in plasma membrane [GO:0072660]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; neuromuscular junction development [GO:0007528]; neuronal action potential [GO:0019228]; plasma membrane organization [GO:0007009]; positive regulation of cation channel activity [GO:2001259]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transport [GO:0043266]; signal transduction [GO:0007165]"
"PGEN_.00g153440"	6.84830894587353e-19	2.59581582735686e-07	6.67787014226734e-08	"Scaffold_07"	1957825	2067352	"O77245"	"E75_METEN"	"Nuclear hormone receptor E75 (Nuclear receptor subfamily 1 group D member 3)"	"GO:0003700; GO:0003707; GO:0005634; GO:0008270; GO:0043565"	"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]"
"PGEN_.00g153580"	1.88449978655404e-06	2.9718332216925e-06	1.21621757236028e-06	"Scaffold_07"	2326054	2404467	"Q3UCV8"	"OTUL_MOUSE"	"Ubiquitin thioesterase otulin (EC 3.4.19.12) (Deubiquitinating enzyme otulin) (OTU domain-containing deubiquitinase with linear linkage specificity) (Ubiquitin thioesterase Gumby)"	"GO:0002040; GO:0004843; GO:0005737; GO:0008234; GO:0010803; GO:0016055; GO:0032088; GO:0045087; GO:0050728; GO:0060828; GO:0070431; GO:1990108"	"cytoplasm [GO:0005737]; cysteine-type peptidase activity [GO:0008234]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; innate immune response [GO:0045087]; negative regulation of inflammatory response [GO:0050728]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070431]; protein linear deubiquitination [GO:1990108]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; sprouting angiogenesis [GO:0002040]; Wnt signaling pathway [GO:0016055]"
"PGEN_.00g159410"	0.000209454126966302	0.000480009654521462	0.45849472530356	"Scaffold_07"	18189222	18258026	NA	NA	NA	NA	NA
"PGEN_.00g164020"	0.00120274161243738	0.137950735410511	2.01768191001814e-05	"Scaffold_07"	30603488	30671660	"P16066"	"ANPRA_HUMAN"	"Atrial natriuretic peptide receptor 1 (EC 4.6.1.2) (Atrial natriuretic peptide receptor type A) (ANP-A) (ANPR-A) (NPR-A) (Guanylate cyclase A) (GC-A)"	"GO:0001653; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005886; GO:0006182; GO:0007165; GO:0007166; GO:0007168; GO:0007589; GO:0008217; GO:0008528; GO:0010753; GO:0016021; GO:0016525; GO:0016941; GO:0017046; GO:0019901; GO:0019934; GO:0030308; GO:0035810; GO:0035815; GO:0042417; GO:0042562; GO:0043114; GO:0043235; GO:0048662; GO:0097746; GO:1903779"	"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; G protein-coupled peptide receptor activity [GO:0008528]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; hormone binding [GO:0042562]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; body fluid secretion [GO:0007589]; cell surface receptor signaling pathway [GO:0007166]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; dopamine metabolic process [GO:0042417]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell growth [GO:0030308]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of cGMP-mediated signaling [GO:0010753]; positive regulation of renal sodium excretion [GO:0035815]; positive regulation of urine volume [GO:0035810]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of blood pressure [GO:0008217]; regulation of blood vessel diameter [GO:0097746]; regulation of cardiac conduction [GO:1903779]; regulation of vascular permeability [GO:0043114]; signal transduction [GO:0007165]"
"PGEN_.00g164830"	1.85228631307814e-06	2.60287899951082e-06	8.02690866582086e-06	"Scaffold_07"	33281542	33281937	NA	NA	NA	NA	NA
"PGEN_.00g165230"	7.16758688557994e-17	0.149967444691797	6.35586328034082e-241	"Scaffold_07"	34059828	34064039	"Q8IWY4"	"SCUB1_HUMAN"	"Signal peptide, CUB and EGF-like domain-containing protein 1"	"GO:0005509; GO:0005615; GO:0005886; GO:0006954; GO:0007512; GO:0007596; GO:0009791; GO:0009897; GO:0009986; GO:0019897; GO:0022617; GO:0042802; GO:0045446; GO:0045880; GO:0046982; GO:0051260"	"cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; extrinsic component of plasma membrane [GO:0019897]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; adult heart development [GO:0007512]; blood coagulation [GO:0007596]; endothelial cell differentiation [GO:0045446]; extracellular matrix disassembly [GO:0022617]; inflammatory response [GO:0006954]; positive regulation of smoothened signaling pathway [GO:0045880]; post-embryonic development [GO:0009791]; protein homooligomerization [GO:0051260]"
"PGEN_.00g166050"	3.46147822930175e-15	0.597670979153719	0.307854845255453	"Scaffold_07"	36713742	36714423	NA	NA	NA	NA	NA
"PGEN_.00g166530"	0.032172898006061	0.395430148637166	0.152296733183819	"Scaffold_07"	37881004	37904577	"Q29RK9"	"MOB3B_BOVIN"	"MOB kinase activator 3B (Mob1 homolog 2b) (Mps one binder kinase activator-like 2B)"	"GO:0035330; GO:0046872"	"metal ion binding [GO:0046872]; regulation of hippo signaling [GO:0035330]"
"PGEN_.00g166930"	7.65772386196685e-05	0.000310273157478472	0.588833385361193	"Scaffold_07"	39388645	39503142	"Q6DCC6"	"GTPB6_XENLA"	"Putative GTP-binding protein 6"	"GO:0005525; GO:0046872"	"GTP binding [GO:0005525]; metal ion binding [GO:0046872]"
"PGEN_.00g166960"	0.000960443634992504	0.108136253686463	0.522421196310023	"Scaffold_07"	39517604	39527641	NA	NA	NA	NA	NA
"PGEN_.00g167390"	0.000115467611700821	0.0709571818549223	0.417666845289677	"Scaffold_07"	40237854	40240070	"Q96DM1"	"PGBD4_HUMAN"	"PiggyBac transposable element-derived protein 4"	""	""
"PGEN_.00g167890"	2.45422345256617e-17	1.94054698114293e-84	8.41240723396327e-36	"Scaffold_07"	41687471	41690284	"Q91755"	"GRIK2_XENLA"	"Glutamate receptor ionotropic, kainate 2 (GluK2) (Glutamate receptor 6) (GluR-6) (GluR6) (Fragment)"	"GO:0005234; GO:0016021; GO:0030054; GO:0038023; GO:0045211"	"cell junction [GO:0030054]; integral component of membrane [GO:0016021]; postsynaptic membrane [GO:0045211]; extracellularly glutamate-gated ion channel activity [GO:0005234]; signaling receptor activity [GO:0038023]"
"PGEN_.00g168070"	4.29756140460474e-09	6.03312872558528e-08	0.00120152606832838	"Scaffold_07"	42236821	42237171	NA	NA	NA	NA	NA
"PGEN_.00g170010"	3.02077191359046e-06	6.31917333986687e-09	1.65545240782881e-06	"Scaffold_08"	5050520	5055437	NA	NA	NA	NA	NA
"PGEN_.00g171020"	0.00121377860523756	0.314910735124238	0.700372600745351	"Scaffold_08"	7646702	7649949	"Q9H1P6"	"CT085_HUMAN"	"Uncharacterized protein C20orf85"	""	""
"PGEN_.00g171760"	0.0291362868801118	0.759760478069273	0.184914499405542	"Scaffold_08"	9562221	9617008	"Q96MM6"	"HS12B_HUMAN"	"Heat shock 70 kDa protein 12B"	"GO:0005524"	"ATP binding [GO:0005524]"
"PGEN_.00g171780"	0.0497186275857521	0.0237031168935883	0.0239922577794556	"Scaffold_08"	9763601	9786077	"P97363"	"SPTC2_MOUSE"	"Serine palmitoyltransferase 2 (EC 2.3.1.50) (Long chain base biosynthesis protein 2) (LCB 2) (Long chain base biosynthesis protein 2a) (LCB2a) (Serine-palmitoyl-CoA transferase 2) (SPT 2)"	"GO:0004758; GO:0005739; GO:0006686; GO:0016021; GO:0017059; GO:0030148; GO:0030170; GO:0046511; GO:0046512; GO:0046513; GO:0060612; GO:1904504"	"integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; serine C-palmitoyltransferase complex [GO:0017059]; pyridoxal phosphate binding [GO:0030170]; serine C-palmitoyltransferase activity [GO:0004758]; adipose tissue development [GO:0060612]; ceramide biosynthetic process [GO:0046513]; positive regulation of lipophagy [GO:1904504]; sphinganine biosynthetic process [GO:0046511]; sphingolipid biosynthetic process [GO:0030148]; sphingomyelin biosynthetic process [GO:0006686]; sphingosine biosynthetic process [GO:0046512]"
"PGEN_.00g173150"	0.00759087129508861	1.4430836198908e-06	0.013919169819324	"Scaffold_08"	14196292	14207757	NA	NA	NA	NA	NA
"PGEN_.00g173770"	0.014278302837697	0.698267310994543	0.000296315785090986	"Scaffold_08"	15823646	15823918	NA	NA	NA	NA	NA
"PGEN_.00g173890"	0.0120701589418665	0.988357836392412	0.966813093162296	"Scaffold_08"	16073705	16083764	"Q99L88"	"SNTB1_MOUSE"	"Beta-1-syntrophin (59 kDa dystrophin-associated protein A1 basic component 1) (DAPA1B) (Syntrophin-2)"	"GO:0003779; GO:0005198; GO:0005516; GO:0005737; GO:0005856; GO:0016010; GO:0030054; GO:0030165; GO:0032991; GO:0042383; GO:0045202"	"cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dystrophin-associated glycoprotein complex [GO:0016010]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; synapse [GO:0045202]; actin binding [GO:0003779]; calmodulin binding [GO:0005516]; PDZ domain binding [GO:0030165]; structural molecule activity [GO:0005198]"
"PGEN_.00g175550"	0.000531508578166095	1.83984992482806e-05	0.000125459863131163	"Scaffold_08"	20144628	20151783	"Q2TAD9"	"CYR1B_XENLA"	"Cysteine and histidine-rich protein 1-B"	"GO:0005737; GO:0008270"	"cytoplasm [GO:0005737]; zinc ion binding [GO:0008270]"
"PGEN_.00g175660"	5.07542342251513e-11	0.763088090179181	9.9120957510985e-06	"Scaffold_08"	20500779	20535991	"Q9BZ19"	"ANR60_HUMAN"	"Ankyrin repeat domain-containing protein 60"	""	""
"PGEN_.00g179060"	0.0028385370423	0.818375654287426	0.0619618487890738	"Scaffold_08"	29608722	29609806	"P30304"	"MPIP1_HUMAN"	"M-phase inducer phosphatase 1 (EC 3.1.3.48) (Dual specificity phosphatase Cdc25A)"	"GO:0000079; GO:0000082; GO:0000086; GO:0004721; GO:0004725; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0008283; GO:0009314; GO:0010971; GO:0016579; GO:0019901; GO:0034644; GO:0045931; GO:0051087; GO:0051301; GO:0051726; GO:0110032"	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chaperone binding [GO:0051087]; phosphoprotein phosphatase activity [GO:0004721]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; cell division [GO:0051301]; cell population proliferation [GO:0008283]; cellular response to UV [GO:0034644]; G1/S transition of mitotic cell cycle [GO:0000082]; G2/M transition of mitotic cell cycle [GO:0000086]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of G2/MI transition of meiotic cell cycle [GO:0110032]; positive regulation of mitotic cell cycle [GO:0045931]; protein deubiquitination [GO:0016579]; regulation of cell cycle [GO:0051726]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; response to radiation [GO:0009314]"
"PGEN_.00g179400"	0.0354025024726618	0.349760922881058	0.19486472074326	"Scaffold_08"	30467205	30474440	"Q9C0G6"	"DYH6_HUMAN"	"Dynein heavy chain 6, axonemal (Axonemal beta dynein heavy chain 6) (Ciliary dynein heavy chain 6)"	"GO:0005524; GO:0005737; GO:0005874; GO:0005929; GO:0007018; GO:0008569; GO:0030286; GO:0045505; GO:0051959"	"cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule-based movement [GO:0007018]"
"PGEN_.00g180330"	0.00120707914284034	0.0376259519178317	0.00352901763039914	"Scaffold_08"	32604271	32628380	NA	NA	NA	NA	NA
"PGEN_.00g181470"	0.00823365922788139	0.801460375859917	0.2548140511032	"Scaffold_08"	35562712	35565587	NA	NA	NA	NA	NA
"PGEN_.00g182320"	0.0127238382169891	0.783461080889111	0.056861505543449	"Scaffold_08"	37635750	37726425	NA	NA	NA	NA	NA
"PGEN_.00g183880"	2.87991809996169e-05	0.0495739314487863	0.00336735401712515	"Scaffold_08"	41644440	41659729	"P21894"	"SYAC_BOMMO"	"Alanine--tRNA ligase, cytoplasmic (EC 6.1.1.7) (Alanyl-tRNA synthetase) (AlaRS)"	"GO:0000049; GO:0004813; GO:0005524; GO:0005737; GO:0006419; GO:0008270"	"cytoplasm [GO:0005737]; alanine-tRNA ligase activity [GO:0004813]; ATP binding [GO:0005524]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]; alanyl-tRNA aminoacylation [GO:0006419]"
"PGEN_.00g185140"	0.00603567664725091	0.000359812968992996	3.5126614000258e-05	"Scaffold_08"	45059602	45075597	NA	NA	NA	NA	NA
"PGEN_.00g185830"	8.337003757607e-06	0.192045597442309	0.0237580334150565	"Scaffold_08"	46812540	46813022	NA	NA	NA	NA	NA
"PGEN_.00g185930"	2.67815699025227e-52	7.45174369366425e-19	8.2690094718429e-11	"Scaffold_08"	46977668	46977979	NA	NA	NA	NA	NA
"PGEN_.00g186170"	0.000152873753681959	0.561337931469331	3.25879607187475e-22	"Scaffold_08"	47597455	47626960	"P82251"	"BAT1_HUMAN"	"b(0,+)-type amino acid transporter 1 (b(0,+)AT1) (Glycoprotein-associated amino acid transporter b0,+AT1) (Solute carrier family 7 member 9)"	"GO:0005886; GO:0005887; GO:0006865; GO:0015175; GO:0015179; GO:0015184; GO:0015804; GO:0015811; GO:0016324; GO:0031526; GO:0042605; GO:0050900; GO:0065003"	"apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; L-amino acid transmembrane transporter activity [GO:0015179]; L-cystine transmembrane transporter activity [GO:0015184]; neutral amino acid transmembrane transporter activity [GO:0015175]; peptide antigen binding [GO:0042605]; amino acid transport [GO:0006865]; L-cystine transport [GO:0015811]; leukocyte migration [GO:0050900]; neutral amino acid transport [GO:0015804]; protein-containing complex assembly [GO:0065003]"
"PGEN_.00g186290"	2.42634609159395e-08	0.453203400363245	1.72626831055716e-08	"Scaffold_08"	47925610	47932879	NA	NA	NA	NA	NA
"PGEN_.00g186540"	0.0176847494258643	6.50347069539141e-07	0.602192955908998	"Scaffold_08"	48646138	48646503	NA	NA	NA	NA	NA
"PGEN_.00g187930"	0.0179089121565921	0.010996866296987	0.950322537239316	"Scaffold_08"	53205499	53232168	"Q8NCN5"	"PDPR_HUMAN"	"Pyruvate dehydrogenase phosphatase regulatory subunit, mitochondrial (PDPr)"	"GO:0005737; GO:0005739; GO:0005759; GO:0010510; GO:0016491"	"cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; oxidoreductase activity [GO:0016491]; regulation of acetyl-CoA biosynthetic process from pyruvate [GO:0010510]"
"PGEN_.00g189050"	0.00179792194315546	0.561359856154372	0.365946942348161	"Scaffold_08"	56336398	56356245	"Q9BTX7"	"TTPAL_HUMAN"	"Alpha-tocopherol transfer protein-like"	"GO:0016020"	"membrane [GO:0016020]"
"PGEN_.00g190430"	1.78042371068993e-06	5.43751877981233e-09	7.13610149754777e-10	"Scaffold_08"	59613122	59676228	"O75096"	"LRP4_HUMAN"	"Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7)"	"GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0016021; GO:0016055; GO:0030279; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0044853; GO:0048813; GO:0050731; GO:0050771; GO:0050808; GO:0051124; GO:0051290; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150094; GO:1901631; GO:1904395"	"cell surface [GO:0009986]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060]; apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; endocytosis [GO:0006897]; hair follicle development [GO:0001942]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; protein heterotetramerization [GO:0051290]; proximal/distal pattern formation [GO:0009954]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic growth at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055]"
"PGEN_.00g190710"	1.13574222047521e-11	0.955481719686864	9.42961169662965e-05	"Scaffold_08"	60442351	60451215	NA	NA	NA	NA	NA
"PGEN_.00g191430"	6.18139122724214e-07	0.942143115281924	0.00521194087872873	"Scaffold_09"	1112393	1116493	NA	NA	NA	NA	NA
"PGEN_.00g191470"	1.09120135915432e-05	0.673701728906533	0.519973349793069	"Scaffold_09"	1220647	1225964	NA	NA	NA	NA	NA
"PGEN_.00g192580"	0.00479357772464134	0.42022858253505	0.21121465352298	"Scaffold_09"	3781889	3793910	NA	NA	NA	NA	NA
"PGEN_.00g193010"	0.0219082800360186	4.06137242532216e-05	0.000658530655455569	"Scaffold_09"	4847684	4864676	"Q3UTY6"	"THSD4_MOUSE"	"Thrombospondin type-1 domain-containing protein 4 (A disintegrin and metalloproteinase with thrombospondin motifs-like protein 6) (ADAMTS-like protein 6) (ADAMTSL-6) (ADAMTS-like protein 4) (ADAMTSL-4)"	"GO:0001527; GO:0008233; GO:0031012; GO:0048251"	"extracellular matrix [GO:0031012]; microfibril [GO:0001527]; peptidase activity [GO:0008233]; elastic fiber assembly [GO:0048251]"
"PGEN_.00g193350"	0.00120274161243738	0.959904898057582	0.537829682595366	"Scaffold_09"	6046177	6055975	NA	NA	NA	NA	NA
"PGEN_.00g193550"	0.00772965214431453	0.983544306573788	0.979139941400741	"Scaffold_09"	6700637	6701146	NA	NA	NA	NA	NA
"PGEN_.00g193590"	0.000152873753681959	7.89564517961758e-08	0.0013449568999918	"Scaffold_09"	6762215	6762706	NA	NA	NA	NA	NA
"PGEN_.00g194750"	0.00294717433052795	0.00133042112649971	0.00084059929309399	"Scaffold_09"	10310658	10311496	NA	NA	NA	NA	NA
"PGEN_.00g194760"	5.41752365011091e-06	0.0440728121759044	3.6818760863098e-05	"Scaffold_09"	10315046	10324136	NA	NA	NA	NA	NA
"PGEN_.00g195420"	0.0285285943620896	0.34778535944831	0.779696043448375	"Scaffold_09"	12235665	12336543	"P06684"	"CO5_MOUSE"	"Complement C5 (Hemolytic complement) [Cleaved into: Complement C5 beta chain; Complement C5 alpha chain; C5a anaphylatoxin; Complement C5 alpha' chain]"	"GO:0001701; GO:0004866; GO:0005579; GO:0005615; GO:0006954; GO:0006957; GO:0006958; GO:0010575; GO:0010760; GO:0019835; GO:0045766; GO:0090197"	"extracellular space [GO:0005615]; membrane attack complex [GO:0005579]; endopeptidase inhibitor activity [GO:0004866]; complement activation, alternative pathway [GO:0006957]; complement activation, classical pathway [GO:0006958]; cytolysis [GO:0019835]; in utero embryonic development [GO:0001701]; inflammatory response [GO:0006954]; negative regulation of macrophage chemotaxis [GO:0010760]; positive regulation of angiogenesis [GO:0045766]; positive regulation of chemokine secretion [GO:0090197]; positive regulation of vascular endothelial growth factor production [GO:0010575]"
"PGEN_.00g196640"	0.0254059373467389	0.213175567886512	0.434334130948206	"Scaffold_09"	15824384	15857366	"Q9P3U1"	"YKX5_SCHPO"	"Uncharacterized RNA-binding protein C328.05"	"GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0005829; GO:0016973; GO:0071014; GO:0071028; GO:1990904; GO:2000815"	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; ribonucleoprotein complex [GO:1990904]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; nuclear mRNA surveillance [GO:0071028]; poly(A)+ mRNA export from nucleus [GO:0016973]; regulation of mRNA stability involved in response to oxidative stress [GO:2000815]"
"PGEN_.00g196810"	0.000789597213733952	0.0818455016761511	0.0019789115543566	"Scaffold_09"	16120937	16151698	"Q9NVE4"	"CCD87_HUMAN"	"Coiled-coil domain-containing protein 87"	"GO:0007283; GO:0007338; GO:0030154; GO:1905516; GO:2000344"	"cell differentiation [GO:0030154]; positive regulation of acrosome reaction [GO:2000344]; positive regulation of fertilization [GO:1905516]; single fertilization [GO:0007338]; spermatogenesis [GO:0007283]"
"PGEN_.00g196820"	0.0453622855408114	0.256672850065938	0.0181008758678907	"Scaffold_09"	16163120	16203131	NA	NA	NA	NA	NA
"PGEN_.00g197680"	2.1803133586828e-05	0.108094483690144	0.033936008120786	"Scaffold_09"	19259544	19259813	NA	NA	NA	NA	NA
"PGEN_.00g198010"	9.64008062951475e-218	5.46602432030074e-250	3.52517785171167e-36	"Scaffold_09"	20195697	20233222	"P05099"	"MATN1_CHICK"	"Cartilage matrix protein (Matrilin-1)"	"GO:0003429; GO:0005201; GO:0005509; GO:0005615; GO:0031012; GO:0062023"	"collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; growth plate cartilage chondrocyte morphogenesis [GO:0003429]"
"PGEN_.00g198290"	8.19323689470071e-58	0.0394132252514478	0.00479165863705261	"Scaffold_09"	21131080	21133028	NA	NA	NA	NA	NA
"PGEN_.00g199580"	5.87693242773219e-05	0.0107963405310809	0.00171780376851462	"Scaffold_09"	24927413	24953480	"P46935"	"NEDD4_MOUSE"	"E3 ubiquitin-protein ligase NEDD4 (EC 2.3.2.26) (HECT-type E3 ubiquitin transferase NEDD4) (Neural precursor cell expressed developmentally down-regulated protein 4) (NEDD-4)"	"GO:0000122; GO:0000151; GO:0000209; GO:0000785; GO:0002250; GO:0003151; GO:0003197; GO:0004842; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0005902; GO:0005938; GO:0006511; GO:0006513; GO:0006622; GO:0007528; GO:0008022; GO:0010766; GO:0010768; GO:0014068; GO:0016020; GO:0016567; GO:0019089; GO:0019871; GO:0019904; GO:0030948; GO:0031175; GO:0031623; GO:0031698; GO:0032801; GO:0035255; GO:0042110; GO:0042391; GO:0042921; GO:0043130; GO:0043161; GO:0043162; GO:0043197; GO:0044111; GO:0045121; GO:0045732; GO:0046824; GO:0048471; GO:0048514; GO:0048814; GO:0050807; GO:0050815; GO:0050816; GO:0050847; GO:0061630; GO:0070063; GO:0070064; GO:0070534; GO:0098978; GO:0099149; GO:0099524; GO:0099576; GO:1901016; GO:2000650"	"cell cortex [GO:0005938]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; membrane raft [GO:0045121]; microvillus [GO:0005902]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic cytosol [GO:0099524]; ubiquitin ligase complex [GO:0000151]; beta-2 adrenergic receptor binding [GO:0031698]; ionotropic glutamate receptor binding [GO:0035255]; phosphoserine residue binding [GO:0050815]; phosphothreonine residue binding [GO:0050816]; proline-rich region binding [GO:0070064]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; RNA polymerase binding [GO:0070063]; sodium channel inhibitor activity [GO:0019871]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; adaptive immune response [GO:0002250]; blood vessel morphogenesis [GO:0048514]; development involved in symbiotic interaction [GO:0044111]; endocardial cushion development [GO:0003197]; glucocorticoid receptor signaling pathway [GO:0042921]; negative regulation of sodium ion transmembrane transporter activity [GO:2000650]; negative regulation of sodium ion transport [GO:0010766]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage [GO:0010768]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; neuromuscular junction development [GO:0007528]; neuron projection development [GO:0031175]; outflow tract morphogenesis [GO:0003151]; positive regulation of nucleocytoplasmic transport [GO:0046824]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein catabolic process [GO:0045732]; progesterone receptor signaling pathway [GO:0050847]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein targeting to lysosome [GO:0006622]; protein ubiquitination [GO:0016567]; receptor catabolic process [GO:0032801]; receptor internalization [GO:0031623]; regulation of dendrite morphogenesis [GO:0048814]; regulation of membrane potential [GO:0042391]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; regulation of potassium ion transmembrane transporter activity [GO:1901016]; regulation of protein catabolic process at postsynapse, modulating synaptic transmission [GO:0099576]; regulation of synapse organization [GO:0050807]; T cell activation [GO:0042110]; transmission of virus [GO:0019089]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]"
"PGEN_.00g200730"	1.96227842648146e-07	0.771103687562895	0.000402527038853393	"Scaffold_09"	29151844	29167025	NA	NA	NA	NA	NA
"PGEN_.00g201860"	0.00011318659547475	3.31394508288016e-05	0.00166451719349831	"Scaffold_09"	32352782	32354762	NA	NA	NA	NA	NA
"PGEN_.00g202150"	0.0127119103528974	0.212909992381084	0.161702951913375	"Scaffold_09"	32940310	32984314	"P81178"	"ALDH2_MESAU"	"Aldehyde dehydrogenase, mitochondrial (EC 1.2.1.3) (ALDH class 2) (ALDH-E2) (ALDH1)"	"GO:0004029; GO:0005759; GO:0006068; GO:0043878; GO:0051287"	"mitochondrial matrix [GO:0005759]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; NAD binding [GO:0051287]; ethanol catabolic process [GO:0006068]"
"PGEN_.00g202160"	0.00555633751053965	0.597368080608092	0.0436676584975291	"Scaffold_09"	32979278	32979538	NA	NA	NA	NA	NA
"PGEN_.00g203100"	2.39791303434867e-12	2.29358502904735e-08	0.00131840401225298	"Scaffold_09"	35711968	35717966	NA	NA	NA	NA	NA
"PGEN_.00g203340"	0.010308444614397	0.596170156848761	0.560166669370698	"Scaffold_09"	36039731	36080013	"Q32L09"	"SHFL_BOVIN"	"Shiftless antiviral inhibitor of ribosomal frameshifting protein homolog (SHFL) (Repressor of yield of DENV protein homolog) (RyDEN)"	"GO:0000932; GO:0003723; GO:0005634; GO:0005737; GO:0006449; GO:0034340; GO:0034341; GO:0034342; GO:0043022; GO:0045071; GO:0051607; GO:0075523; GO:1990825; GO:2001125"	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; P-body [GO:0000932]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; sequence-specific mRNA binding [GO:1990825]; defense response to virus [GO:0051607]; negative regulation of translational frameshifting [GO:2001125]; negative regulation of viral genome replication [GO:0045071]; regulation of translational termination [GO:0006449]; response to interferon-gamma [GO:0034341]; response to type I interferon [GO:0034340]; response to type III interferon [GO:0034342]; viral translational frameshifting [GO:0075523]"
"PGEN_.00g204030"	0.0104396596149712	0.293475010921427	0.0363605899148703	"Scaffold_09"	37854550	37860901	NA	NA	NA	NA	NA
"PGEN_.00g204470"	0.00549808825847918	0.37798687971179	0.854914676728467	"Scaffold_10"	450153	503366	"P41221"	"WNT5A_HUMAN"	"Protein Wnt-5a"	"GO:0000187; GO:0001736; GO:0001756; GO:0001837; GO:0001938; GO:0001947; GO:0002053; GO:0002088; GO:0002741; GO:0003323; GO:0003402; GO:0003408; GO:0003700; GO:0005109; GO:0005115; GO:0005125; GO:0005543; GO:0005576; GO:0005615; GO:0005788; GO:0005796; GO:0005886; GO:0007223; GO:0007257; GO:0007411; GO:0007442; GO:0007494; GO:0008584; GO:0008595; GO:0009986; GO:0010033; GO:0010595; GO:0010628; GO:0010800; GO:0010820; GO:0010976; GO:0016055; GO:0019904; GO:0021891; GO:0030182; GO:0030216; GO:0030324; GO:0030514; GO:0030665; GO:0030666; GO:0030669; GO:0031012; GO:0032092; GO:0032148; GO:0032729; GO:0032755; GO:0033138; GO:0034613; GO:0035567; GO:0036342; GO:0036517; GO:0036518; GO:0038031; GO:0040037; GO:0042060; GO:0042733; GO:0043032; GO:0043066; GO:0043122; GO:0044212; GO:0045080; GO:0045165; GO:0045198; GO:0045599; GO:0045732; GO:0045745; GO:0045766; GO:0045778; GO:0045807; GO:0045836; GO:0045892; GO:0045893; GO:0045944; GO:0048018; GO:0048022; GO:0048146; GO:0048341; GO:0048570; GO:0048706; GO:0048806; GO:0048843; GO:0048850; GO:0050680; GO:0050718; GO:0050727; GO:0050729; GO:0050807; GO:0051092; GO:0051216; GO:0051885; GO:0051964; GO:0060028; GO:0060029; GO:0060065; GO:0060067; GO:0060068; GO:0060070; GO:0060071; GO:0060157; GO:0060324; GO:0060340; GO:0060599; GO:0060638; GO:0060686; GO:0060744; GO:0060750; GO:0060760; GO:0060762; GO:0060775; GO:0060809; GO:0060907; GO:0061024; GO:0061036; GO:0061347; GO:0061348; GO:0061349; GO:0061350; GO:0061354; GO:0062009; GO:0070062; GO:0070245; GO:0071222; GO:0071277; GO:0071300; GO:0071346; GO:0071425; GO:0071560; GO:0072201; GO:0090009; GO:0090037; GO:0090090; GO:0090103; GO:0090179; GO:0090630; GO:0097325; GO:0098794; GO:0098978; GO:0099054; GO:0099068; GO:0099175; GO:0099566; GO:0150012; GO:1900020; GO:1901216; GO:1902379; GO:1902474; GO:1903827; GO:1904469; GO:1904861; GO:1904862; GO:1904934; GO:1904938; GO:1904953; GO:1904955; GO:2000049; GO:2000052; GO:2000484"	"cell surface [GO:0009986]; clathrin-coated endocytic vesicle membrane [GO:0030669]; clathrin-coated vesicle membrane [GO:0030665]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; chemoattractant activity involved in axon guidance [GO:1902379]; cytokine activity [GO:0005125]; DNA-binding transcription factor activity [GO:0003700]; frizzled binding [GO:0005109]; phospholipid binding [GO:0005543]; protein domain specific binding [GO:0019904]; receptor ligand activity [GO:0048018]; receptor tyrosine kinase-like orphan receptor binding [GO:0005115]; transcription regulatory region DNA binding [GO:0044212]; activation of GTPase activity [GO:0090630]; activation of JUN kinase activity [GO:0007257]; activation of MAPK activity [GO:0000187]; activation of protein kinase B activity [GO:0032148]; anterior/posterior axis specification, embryo [GO:0008595]; axon guidance [GO:0007411]; canonical Wnt signaling pathway [GO:0060070]; cartilage development [GO:0051216]; cell fate commitment [GO:0045165]; cellular protein localization [GO:0034613]; cellular response to calcium ion [GO:0071277]; cellular response to interferon-gamma [GO:0071346]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to retinoic acid [GO:0071300]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cervix development [GO:0060067]; chemoattraction of serotonergic neuron axon [GO:0036517]; chemorepulsion of dopaminergic neuron axon [GO:0036518]; cochlea morphogenesis [GO:0090103]; convergent extension involved in axis elongation [GO:0060028]; convergent extension involved in organogenesis [GO:0060029]; embryonic digit morphogenesis [GO:0042733]; embryonic skeletal system development [GO:0048706]; epithelial cell proliferation involved in mammary gland duct elongation [GO:0060750]; epithelial to mesenchymal transition [GO:0001837]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of planar polarity [GO:0001736]; excitatory synapse assembly [GO:1904861]; face development [GO:0060324]; genitalia development [GO:0048806]; heart looping [GO:0001947]; hematopoietic stem cell proliferation [GO:0071425]; hindgut morphogenesis [GO:0007442]; hypophysis morphogenesis [GO:0048850]; inhibitory synapse assembly [GO:1904862]; keratinocyte differentiation [GO:0030216]; lateral sprouting involved in mammary gland duct morphogenesis [GO:0060599]; lens development in camera-type eye [GO:0002088]; lung development [GO:0030324]; male gonad development [GO:0008584]; mammary gland branching involved in thelarche [GO:0060744]; melanocyte proliferation [GO:0097325]; membrane organization [GO:0061024]; mesenchymal-epithelial cell signaling [GO:0060638]; mesodermal to mesenchymal transition involved in gastrulation [GO:0060809]; midgut development [GO:0007494]; negative regulation of apoptotic process [GO:0043066]; negative regulation of axon extension involved in axon guidance [GO:0048843]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell proliferation in midbrain [GO:1904934]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of melanin biosynthetic process [GO:0048022]; negative regulation of mesenchymal cell proliferation [GO:0072201]; negative regulation of prostatic bud formation [GO:0060686]; negative regulation of synapse assembly [GO:0051964]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron differentiation [GO:0030182]; non-canonical Wnt signaling pathway [GO:0035567]; non-canonical Wnt signaling pathway via JNK cascade [GO:0038031]; notochord morphogenesis [GO:0048570]; olfactory bulb interneuron development [GO:0021891]; optic cup formation involved in camera-type eye development [GO:0003408]; paraxial mesoderm formation [GO:0048341]; planar cell polarity pathway involved in axis elongation [GO:0003402]; planar cell polarity pathway involved in axon guidance [GO:1904938]; planar cell polarity pathway involved in cardiac muscle tissue morphogenesis [GO:0061350]; planar cell polarity pathway involved in cardiac right atrium morphogenesis [GO:0061349]; planar cell polarity pathway involved in gastrula mediolateral intercalation [GO:0060775]; planar cell polarity pathway involved in midbrain dopaminergic neuron differentiation [GO:1904955]; planar cell polarity pathway involved in neural tube closure [GO:0090179]; planar cell polarity pathway involved in outflow tract morphogenesis [GO:0061347]; planar cell polarity pathway involved in pericardium morphogenesis [GO:0061354]; planar cell polarity pathway involved in ventricular septum morphogenesis [GO:0061348]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cartilage development [GO:0061036]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of chemokine biosynthetic process [GO:0045080]; positive regulation of cytokine secretion involved in immune response [GO:0002741]; positive regulation of endocytosis [GO:0045807]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; positive regulation of gene expression [GO:0010628]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-1 beta secretion [GO:0050718]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 secretion [GO:2000484]; positive regulation of macrophage activation [GO:0043032]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of meiotic nuclear division [GO:0045836]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of neuron death [GO:1901216]; positive regulation of neuron projection arborization [GO:0150012]; positive regulation of neuron projection development [GO:0010976]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of non-canonical Wnt signaling pathway [GO:2000052]; positive regulation of ossification [GO:0045778]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein binding [GO:0032092]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein kinase C activity [GO:1900020]; positive regulation of protein kinase C signaling [GO:0090037]; positive regulation of protein localization to synapse [GO:1902474]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of T cell chemotaxis [GO:0010820]; positive regulation of thymocyte apoptotic process [GO:0070245]; positive regulation of timing of anagen [GO:0051885]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of tumor necrosis factor secretion [GO:1904469]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; post-anal tail morphogenesis [GO:0036342]; postsynapse assembly [GO:0099068]; presynapse assembly [GO:0099054]; primitive streak formation [GO:0090009]; regulation of branching involved in mammary gland duct morphogenesis [GO:0060762]; regulation of cellular protein localization [GO:1903827]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of inflammatory response [GO:0050727]; regulation of postsynapse organization [GO:0099175]; regulation of postsynaptic cytosolic calcium ion concentration [GO:0099566]; regulation of synapse organization [GO:0050807]; response to organic substance [GO:0010033]; secondary palate development [GO:0062009]; somitogenesis [GO:0001756]; type B pancreatic cell development [GO:0003323]; urinary bladder development [GO:0060157]; uterus development [GO:0060065]; vagina development [GO:0060068]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904953]; Wnt signaling pathway, calcium modulating pathway [GO:0007223]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]; wound healing [GO:0042060]"
"PGEN_.00g206120"	0.0374351229217807	0.00596158424419133	0.923804829113665	"Scaffold_10"	5136765	5137073	NA	NA	NA	NA	NA
"PGEN_.00g206240"	0.000772659065668784	0.0807446078724963	0.00148061483830358	"Scaffold_10"	5646436	5675953	"J9VY90"	"LAC1_CRYNH"	"Laccase-1 (EC 1.10.3.2) (Diphenol oxidase 1)"	"GO:0005507; GO:0005576; GO:0005618; GO:0052716"	"cell wall [GO:0005618]; extracellular region [GO:0005576]; copper ion binding [GO:0005507]; hydroquinone:oxygen oxidoreductase activity [GO:0052716]"
"PGEN_.00g206250"	0.026523036214944	0.339972943452401	0.0294295518460727	"Scaffold_10"	5676066	5711762	"Q9DC53"	"CPNE8_MOUSE"	"Copine-8 (Copine VIII)"	"GO:0005544; GO:0005886; GO:0071277"	"plasma membrane [GO:0005886]; calcium-dependent phospholipid binding [GO:0005544]; cellular response to calcium ion [GO:0071277]"
"PGEN_.00g206320"	0.0299265578537563	0.864502906692806	0.818986307791015	"Scaffold_10"	6044854	6046044	NA	NA	NA	NA	NA
"PGEN_.00g207850"	0.0173520942903725	0.262006862511673	0.857962115256516	"Scaffold_10"	9950424	9981211	"Q86I06"	"NEK3_DICDI"	"Probable serine/threonine-protein kinase nek3 (EC 2.7.11.1) (Never in mitosis protein A-related protein kinase 3) (NimA-related protein kinase 3)"	"GO:0004674; GO:0005524; GO:0005737; GO:0023014; GO:0032147"	"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; activation of protein kinase activity [GO:0032147]; signal transduction by protein phosphorylation [GO:0023014]"
"PGEN_.00g207910"	2.25861417678572e-06	0.821023226408464	0.0374691219898065	"Scaffold_10"	10042133	10115253	"Q8IPH9"	"SLOB_DROME"	"Slowpoke-binding protein"	"GO:0004672; GO:0005737; GO:0005886; GO:0007274; GO:0032780; GO:0042391; GO:0042594; GO:0043271; GO:0045202; GO:0050804"	"cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; synapse [GO:0045202]; protein kinase activity [GO:0004672]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of ATPase activity [GO:0032780]; negative regulation of ion transport [GO:0043271]; neuromuscular synaptic transmission [GO:0007274]; regulation of membrane potential [GO:0042391]; response to starvation [GO:0042594]"
"PGEN_.00g208420"	8.34067118032795e-05	0.45733018036077	0.420852660372938	"Scaffold_10"	11112293	11113880	NA	NA	NA	NA	NA
"PGEN_.00g208580"	1.03136977839068e-38	0.314910735124238	3.8494403659649e-72	"Scaffold_10"	11353032	11413765	"Q3L254"	"WNT7B_CHICK"	"Protein Wnt-7b"	"GO:0005109; GO:0005615; GO:0016055; GO:0021871; GO:0030182; GO:0045165; GO:0046330; GO:0048018; GO:0048144; GO:0060070; GO:0070307; GO:0071300; GO:0072089"	"extracellular space [GO:0005615]; frizzled binding [GO:0005109]; receptor ligand activity [GO:0048018]; canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cellular response to retinoic acid [GO:0071300]; fibroblast proliferation [GO:0048144]; forebrain regionalization [GO:0021871]; lens fiber cell development [GO:0070307]; neuron differentiation [GO:0030182]; positive regulation of JNK cascade [GO:0046330]; stem cell proliferation [GO:0072089]; Wnt signaling pathway [GO:0016055]"
"PGEN_.00g208810"	0.0423974599220278	0.00164789459010138	0.0578998102813533	"Scaffold_10"	12101130	12209456	"O75051"	"PLXA2_HUMAN"	"Plexin-A2 (Semaphorin receptor OCT)"	"GO:0001756; GO:0002116; GO:0005886; GO:0005887; GO:0007162; GO:0008360; GO:0017154; GO:0021915; GO:0021935; GO:0030334; GO:0042802; GO:0043087; GO:0050772; GO:0051642; GO:0060037; GO:0060174; GO:0071526; GO:1902287"	"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116]; identical protein binding [GO:0042802]; semaphorin receptor activity [GO:0017154]; centrosome localization [GO:0051642]; cerebellar granule cell precursor tangential migration [GO:0021935]; limb bud formation [GO:0060174]; negative regulation of cell adhesion [GO:0007162]; neural tube development [GO:0021915]; pharyngeal system development [GO:0060037]; positive regulation of axonogenesis [GO:0050772]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; semaphorin-plexin signaling pathway [GO:0071526]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; somitogenesis [GO:0001756]"
"PGEN_.00g211360"	0.00100121387281593	0.206913504480766	0.0185620103630995	"Scaffold_10"	19115289	19174093	"Q9BXW9"	"FACD2_HUMAN"	"Fanconi anemia group D2 protein (Protein FACD2)"	"GO:0000793; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006281; GO:0007129; GO:0007276; GO:0010332; GO:0016604; GO:0034599; GO:0036297; GO:0045589; GO:0048854; GO:0050727; GO:0051090; GO:0070182; GO:0097150; GO:2000348"	"condensed chromosome [GO:0000793]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA polymerase binding [GO:0070182]; brain morphogenesis [GO:0048854]; cellular response to oxidative stress [GO:0034599]; DNA repair [GO:0006281]; gamete generation [GO:0007276]; interstrand cross-link repair [GO:0036297]; neuronal stem cell population maintenance [GO:0097150]; regulation of CD40 signaling pathway [GO:2000348]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of inflammatory response [GO:0050727]; regulation of regulatory T cell differentiation [GO:0045589]; response to gamma radiation [GO:0010332]; synapsis [GO:0007129]"
"PGEN_.00g211830"	4.01904499928186e-09	0.15880710215687	9.42502300001256e-33	"Scaffold_10"	21025397	21043857	"P16056"	"MET_MOUSE"	"Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met)"	"GO:0000122; GO:0000187; GO:0001764; GO:0001886; GO:0001889; GO:0001890; GO:0004672; GO:0004713; GO:0004714; GO:0005008; GO:0005524; GO:0005615; GO:0005737; GO:0005886; GO:0005887; GO:0007169; GO:0007268; GO:0007420; GO:0007517; GO:0007519; GO:0008013; GO:0009925; GO:0010628; GO:0010629; GO:0010800; GO:0010801; GO:0010828; GO:0010976; GO:0014069; GO:0014812; GO:0014902; GO:0016020; GO:0017154; GO:0019903; GO:0030182; GO:0030317; GO:0030425; GO:0030534; GO:0031016; GO:0031116; GO:0032675; GO:0033138; GO:0035024; GO:0036126; GO:0042593; GO:0042802; GO:0043005; GO:0043025; GO:0043235; GO:0043274; GO:0043548; GO:0044877; GO:0045211; GO:0045740; GO:0045840; GO:0045944; GO:0046777; GO:0048012; GO:0048754; GO:0050775; GO:0050804; GO:0050918; GO:0051450; GO:0051497; GO:0051897; GO:0055013; GO:0060048; GO:0060076; GO:0060079; GO:0060665; GO:0061436; GO:0070495; GO:0071526; GO:0071635; GO:0072593; GO:1900407; GO:1900745; GO:1901299; GO:1905098; GO:2001028"	"basal plasma membrane [GO:0009925]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; excitatory synapse [GO:0060076]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; receptor complex [GO:0043235]; sperm flagellum [GO:0036126]; ATP binding [GO:0005524]; beta-catenin binding [GO:0008013]; hepatocyte growth factor-activated receptor activity [GO:0005008]; identical protein binding [GO:0042802]; phosphatidylinositol 3-kinase binding [GO:0043548]; phospholipase binding [GO:0043274]; protein kinase activity [GO:0004672]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase activity [GO:0004713]; protein-containing complex binding [GO:0044877]; semaphorin receptor activity [GO:0017154]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; activation of MAPK activity [GO:0000187]; adult behavior [GO:0030534]; brain development [GO:0007420]; branching morphogenesis of an epithelial tube [GO:0048754]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; chemical synaptic transmission [GO:0007268]; endothelial cell morphogenesis [GO:0001886]; establishment of skin barrier [GO:0061436]; excitatory postsynaptic potential [GO:0060079]; flagellated sperm motility [GO:0030317]; glucose homeostasis [GO:0042593]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; liver development [GO:0001889]; modulation of chemical synaptic transmission [GO:0050804]; muscle cell migration [GO:0014812]; muscle organ development [GO:0007517]; myoblast proliferation [GO:0051450]; myotube differentiation [GO:0014902]; negative regulation of gene expression [GO:0010629]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of hydrogen peroxide-mediated programmed cell death [GO:1901299]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of stress fiber assembly [GO:0051497]; negative regulation of thrombin-activated receptor signaling pathway [GO:0070495]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta production [GO:0071635]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; pancreas development [GO:0031016]; placenta development [GO:0001890]; positive chemotaxis [GO:0050918]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of DNA replication [GO:0045740]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose transmembrane transport [GO:0010828]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of neuron projection development [GO:0010976]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autophosphorylation [GO:0046777]; reactive oxygen species metabolic process [GO:0072593]; regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling [GO:0060665]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of interleukin-6 production [GO:0032675]; semaphorin-plexin signaling pathway [GO:0071526]; skeletal muscle tissue development [GO:0007519]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]"
"PGEN_.00g213360"	0.00414119254851334	0.149967444691797	0.864764194147284	"Scaffold_10"	24403902	24509214	"Q14995"	"NR1D2_HUMAN"	"Nuclear receptor subfamily 1 group D member 2 (Orphan nuclear hormone receptor BD73) (Rev-erb alpha-related receptor) (RVR) (Rev-erb-beta) (V-erbA-related protein 1-related) (EAR-1R)"	"GO:0000122; GO:0000790; GO:0000976; GO:0000977; GO:0000978; GO:0000981; GO:0000987; GO:0001227; GO:0003707; GO:0004879; GO:0005634; GO:0005654; GO:0005737; GO:0006355; GO:0006367; GO:0007275; GO:0008134; GO:0008270; GO:0009755; GO:0019216; GO:0030154; GO:0030374; GO:0033993; GO:0038023; GO:0042752; GO:0045892; GO:0045893; GO:0045944; GO:0048512; GO:0050727; GO:0050728; GO:0055088; GO:0090575; GO:0097009; GO:2001014"	"cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; nuclear receptor activity [GO:0004879]; nuclear receptor transcription coactivator activity [GO:0030374]; proximal promoter sequence-specific DNA binding [GO:0000987]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; signaling receptor activity [GO:0038023]; steroid hormone receptor activity [GO:0003707]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; circadian behavior [GO:0048512]; energy homeostasis [GO:0097009]; hormone-mediated signaling pathway [GO:0009755]; lipid homeostasis [GO:0055088]; multicellular organism development [GO:0007275]; negative regulation of inflammatory response [GO:0050728]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of circadian rhythm [GO:0042752]; regulation of inflammatory response [GO:0050727]; regulation of lipid metabolic process [GO:0019216]; regulation of skeletal muscle cell differentiation [GO:2001014]; regulation of transcription, DNA-templated [GO:0006355]; response to lipid [GO:0033993]; transcription initiation from RNA polymerase II promoter [GO:0006367]"
"PGEN_.00g214680"	0.0481237692861582	0.849230482691658	0.954562249454622	"Scaffold_10"	28176027	28176344	NA	NA	NA	NA	NA
"PGEN_.00g215680"	1.90631104485379e-12	0.0949217553106191	5.72261117644018e-05	"Scaffold_10"	30482539	30569120	"Q24270"	"CAC1D_DROME"	"Voltage-dependent calcium channel type D subunit alpha-1 (DmCa1D)"	"GO:0005245; GO:0005891; GO:0006816; GO:0006936; GO:0016322; GO:0016323; GO:0016324; GO:0019722; GO:0034765; GO:0042045; GO:0046872; GO:0070509; GO:0070588"	"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; voltage-gated calcium channel complex [GO:0005891]; metal ion binding [GO:0046872]; voltage-gated calcium channel activity [GO:0005245]; calcium ion import [GO:0070509]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium-mediated signaling [GO:0019722]; epithelial fluid transport [GO:0042045]; muscle contraction [GO:0006936]; neuron remodeling [GO:0016322]; regulation of ion transmembrane transport [GO:0034765]"
"PGEN_.00g216570"	0.00238032440820857	0.972043114851193	0.85595645226191	"Scaffold_10"	33120854	33173519	"Q9JME2"	"CHSTB_MOUSE"	"Carbohydrate sulfotransferase 11 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1) (C4S-1) (C4ST-1) (C4ST1)"	"GO:0000139; GO:0001537; GO:0001701; GO:0002063; GO:0007585; GO:0008146; GO:0009791; GO:0016021; GO:0016051; GO:0030166; GO:0030204; GO:0030206; GO:0030326; GO:0030512; GO:0033037; GO:0036342; GO:0042127; GO:0042733; GO:0043066; GO:0047756; GO:0048589; GO:0048703; GO:0048704; GO:0050659; GO:0051216"	"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate metabolic process [GO:0030204]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system morphogenesis [GO:0048704]; embryonic viscerocranium morphogenesis [GO:0048703]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585]"
"PGEN_.00g220440"	0.000392815992675603	0.364217971200052	0.0347005724812329	"Scaffold_10"	43055658	43089902	NA	NA	NA	NA	NA
"PGEN_.00g220460"	6.85695290435679e-20	0.771103687562895	0.000332979055024844	"Scaffold_10"	43116886	43117749	NA	NA	NA	NA	NA
"PGEN_.00g220560"	2.56559300898401e-13	0.0438851569428797	0.511276364382711	"Scaffold_10"	43341952	43342467	NA	NA	NA	NA	NA
"PGEN_.00g224670"	0.00191592071943769	0.597670979153719	0.00145585543504892	"Scaffold_11"	21430	33788	"Q24307"	"DIAP2_DROME"	"Death-associated inhibitor of apoptosis 2 (Apoptosis 2 inhibitor) (IAP homolog A) (IAP-like protein) (ILP) (dILP) (Inhibitor of apoptosis 2)"	"GO:0004842; GO:0005634; GO:0005737; GO:0005829; GO:0006511; GO:0006964; GO:0008270; GO:0016567; GO:0022416; GO:0031398; GO:0031625; GO:0043027; GO:0043066; GO:0043154; GO:0043281; GO:0045087; GO:0048471; GO:0050829; GO:0061057; GO:0061630; GO:0070534; GO:0070936; GO:0089720; GO:1990001"	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; caspase binding [GO:0089720]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; chaeta development [GO:0022416]; defense response to Gram-negative bacterium [GO:0050829]; inhibition of cysteine-type endopeptidase activity involved in apoptotic process [GO:1990001]; innate immune response [GO:0045087]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; peptidoglycan recognition protein signaling pathway [GO:0061057]; positive regulation of biosynthetic process of antibacterial peptides active against Gram-negative bacteria [GO:0006964]; positive regulation of protein ubiquitination [GO:0031398]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein ubiquitination [GO:0016567]; regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043281]; ubiquitin-dependent protein catabolic process [GO:0006511]"
"PGEN_.00g227520"	0.01038450755642	0.844456997729494	0.199706684371924	"Scaffold_11"	9517456	9568849	"Q17LW0"	"MYO7A_AEDAE"	"Myosin-VIIa (Protein crinkled)"	"GO:0003774; GO:0005524; GO:0005737; GO:0007605; GO:0008407; GO:0016459; GO:0030048; GO:0030898; GO:0032027; GO:0035317; GO:0048800; GO:0051015"	"cytoplasm [GO:0005737]; myosin complex [GO:0016459]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; motor activity [GO:0003774]; myosin light chain binding [GO:0032027]; actin filament-based movement [GO:0030048]; antennal morphogenesis [GO:0048800]; chaeta morphogenesis [GO:0008407]; imaginal disc-derived wing hair organization [GO:0035317]; sensory perception of sound [GO:0007605]"
"PGEN_.00g228140"	0.00275119088588968	0.4579001617365	0.0021295570073196	"Scaffold_11"	10814466	10820244	"O15164"	"TIF1A_HUMAN"	"Transcription intermediary factor 1-alpha (TIF1-alpha) (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRIM24) (RING finger protein 82) (RING-type E3 ubiquitin transferase TIF1-alpha) (Tripartite motif-containing protein 24)"	"GO:0002039; GO:0003682; GO:0003713; GO:0004672; GO:0004842; GO:0005102; GO:0005634; GO:0005654; GO:0005719; GO:0005726; GO:0005829; GO:0006366; GO:0008270; GO:0008285; GO:0016567; GO:0016922; GO:0030163; GO:0031647; GO:0034056; GO:0042981; GO:0045892; GO:0045893; GO:0046777; GO:0055074; GO:0061630; GO:0070562; GO:0070577; GO:0071391; GO:1901796"	"cytosol [GO:0005829]; nuclear euchromatin [GO:0005719]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; chromatin binding [GO:0003682]; estrogen response element binding [GO:0034056]; lysine-acetylated histone binding [GO:0070577]; nuclear receptor binding [GO:0016922]; p53 binding [GO:0002039]; protein kinase activity [GO:0004672]; signaling receptor binding [GO:0005102]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; calcium ion homeostasis [GO:0055074]; cellular response to estrogen stimulus [GO:0071391]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein catabolic process [GO:0030163]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of protein stability [GO:0031647]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of vitamin D receptor signaling pathway [GO:0070562]; transcription by RNA polymerase II [GO:0006366]"
"PGEN_.00g228650"	0.0445644606480047	0.00195030763925554	0.000187959792335434	"Scaffold_11"	12326227	12333009	"Q56R14"	"TRI33_XENLA"	"E3 ubiquitin-protein ligase TRIM33 (EC 2.3.2.27) (Ectodermin) (RING-type E3 ubiquitin transferase TRIM33) (Transcription intermediary factor 1-gamma) (TIF1-gamma) (Tripartite motif-containing protein 33)"	"GO:0003677; GO:0005634; GO:0008270; GO:0016567; GO:0016740"	"nucleus [GO:0005634]; DNA binding [GO:0003677]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; protein ubiquitination [GO:0016567]"
"PGEN_.00g230620"	8.76118839374329e-09	0.260076070451925	5.16145708987451e-06	"Scaffold_11"	18400504	18451055	"A6QP05"	"DHR12_BOVIN"	"Dehydrogenase/reductase SDR family member 12 (EC 1.1.-.-) (Short-chain dehydrogenase/reductase family 40C member 1)"	"GO:0016491"	"oxidoreductase activity [GO:0016491]"
"PGEN_.00g231770"	5.26145303244884e-46	1.03829268871114e-23	6.87310962916746e-19	"Scaffold_11"	22208396	22220228	NA	NA	NA	NA	NA
"PGEN_.00g232340"	3.76913784824275e-12	0.0125246904800798	2.78552848049891e-12	"Scaffold_11"	24120523	24179210	"Q8C0W1"	"ANMY1_MOUSE"	"Ankyrin repeat and MYND domain-containing protein 1"	"GO:0046872"	"metal ion binding [GO:0046872]"
"PGEN_.00g233360"	3.13137481516856e-15	5.01625188404943e-60	5.15525605229357e-07	"Scaffold_11"	26583481	26583714	NA	NA	NA	NA	NA
"PGEN_.00g233890"	8.87915097404896e-08	0.138087828377131	0.455800506586844	"Scaffold_11"	27924750	27949966	NA	NA	NA	NA	NA
"PGEN_.00g234140"	0.0188778438260643	0.597670979153719	0.872407337452472	"Scaffold_11"	28344507	28366653	NA	NA	NA	NA	NA
"PGEN_.00g234210"	0.00120274161243738	0.722974837374853	0.233437739323013	"Scaffold_11"	28556809	28586868	NA	NA	NA	NA	NA
"PGEN_.00g234920"	6.47449880113536e-06	0.160760371715348	7.78396200029728e-08	"Scaffold_11"	30429298	30430197	NA	NA	NA	NA	NA
"PGEN_.00g236910"	0.00932642606527654	0.324901573463044	0.000772448234112723	"Scaffold_11"	36476009	36477371	"Q9VN27"	"LIPT2_DROME"	"Putative lipoyltransferase 2, mitochondrial (EC 2.3.1.181) (Lipoate-protein ligase B) (Lipoyl/octanoyl transferase) (Octanoyl-[acyl-carrier-protein]-protein N-octanoyltransferase)"	"GO:0005739; GO:0009249; GO:0033819; GO:0102555"	"mitochondrion [GO:0005739]; lipoyl(octanoyl) transferase activity [GO:0033819]; octanoyl transferase activity (acting on glycine-cleavage complex H protein) [GO:0102555]; protein lipoylation [GO:0009249]"
"PGEN_.00g237150"	0.0312816886945324	0.954466992566052	0.589732145371419	"Scaffold_11"	37110048	37301714	"Q8WSR4"	"ITPR_PATPE"	"Inositol 1,4,5-trisphosphate receptor (ApIP3R)"	"GO:0005220; GO:0005789; GO:0007275; GO:0007338; GO:0016021; GO:0070679"	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; inositol 1,4,5 trisphosphate binding [GO:0070679]; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO:0005220]; multicellular organism development [GO:0007275]; single fertilization [GO:0007338]"
"PGEN_.00g237190"	0.00121377860523756	0.619037622669197	0.78773971952717	"Scaffold_11"	37392889	37425575	"O15550"	"KDM6A_HUMAN"	"Lysine-specific demethylase 6A (EC 1.14.11.-) (Histone demethylase UTX) (Ubiquitously-transcribed TPR protein on the X chromosome) (Ubiquitously-transcribed X chromosome tetratricopeptide repeat protein)"	"GO:0000790; GO:0000978; GO:0001701; GO:0001843; GO:0003007; GO:0003016; GO:0003682; GO:0005634; GO:0005654; GO:0006338; GO:0010628; GO:0031490; GO:0032525; GO:0035097; GO:0035264; GO:0042802; GO:0043565; GO:0044666; GO:0046872; GO:0048333; GO:0048570; GO:0051213; GO:0051568; GO:0060070; GO:0071558; GO:0072358"	"histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; dioxygenase activity [GO:0051213]; histone demethylase activity (H3-K27 specific) [GO:0071558]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; canonical Wnt signaling pathway [GO:0060070]; cardiovascular system development [GO:0072358]; chromatin remodeling [GO:0006338]; heart morphogenesis [GO:0003007]; histone H3-K4 methylation [GO:0051568]; in utero embryonic development [GO:0001701]; mesodermal cell differentiation [GO:0048333]; multicellular organism growth [GO:0035264]; neural tube closure [GO:0001843]; notochord morphogenesis [GO:0048570]; positive regulation of gene expression [GO:0010628]; respiratory system process [GO:0003016]; somite rostral/caudal axis specification [GO:0032525]"
"PGEN_.00g237520"	3.48503358596652e-10	5.31716454607257e-10	4.14206655053566e-07	"Scaffold_11"	38636260	38649071	"P61315"	"G3ST3_MOUSE"	"Galactose-3-O-sulfotransferase 3 (Gal3ST-3) (EC 2.8.2.-) (Beta-galactose-3-O-sulfotransferase 3) (Gal-beta-1, 3-GalNAc 3'-sulfotransferase 3)"	"GO:0001733; GO:0009247; GO:0016021; GO:0032580; GO:0050694"	"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; galactose 3-O-sulfotransferase activity [GO:0050694]; galactosylceramide sulfotransferase activity [GO:0001733]; glycolipid biosynthetic process [GO:0009247]"
"PGEN_.00g237720"	0.0471286759679849	0.813369922513086	0.350458725527943	"Scaffold_11"	39251236	39251523	NA	NA	NA	NA	NA
"PGEN_.00g238280"	0.00490615018216145	0.425823405563083	0.435471122511226	"Scaffold_11"	40767193	40778903	"Q9D8Z1"	"ASCC1_MOUSE"	"Activating signal cointegrator 1 complex subunit 1 (ASC-1 complex subunit p50) (Trip4 complex subunit p50)"	"GO:0003723; GO:0005634; GO:0005667; GO:0006281; GO:0006355; GO:0016607; GO:0031594"	"neuromuscular junction [GO:0031594]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; RNA binding [GO:0003723]; DNA repair [GO:0006281]; regulation of transcription, DNA-templated [GO:0006355]"
"PGEN_.00g240010"	0.0234336864953918	0.11978568592276	0.171913119619912	"Scaffold_11"	45152791	45162406	NA	NA	NA	NA	NA
"PGEN_.00g240250"	1.70328722726089e-10	0.00516900149830957	0.591934073675286	"Scaffold_11"	45677023	45691915	"P04052"	"RPB1_DROME"	"DNA-directed RNA polymerase II subunit RPB1 (RNA polymerase II subunit B1) (EC 2.7.7.6) (DNA-directed RNA polymerase III largest subunit)"	"GO:0003677; GO:0003899; GO:0005634; GO:0005665; GO:0005700; GO:0005703; GO:0006366; GO:0046872"	"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome puff [GO:0005703]; RNA polymerase II, core complex [GO:0005665]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; transcription by RNA polymerase II [GO:0006366]"
"PGEN_.00g240940"	2.07558498594906e-11	0.000334317906301211	0.238043425566496	"Scaffold_11"	47366761	47375556	NA	NA	NA	NA	NA
"PGEN_.00g241080"	0.000890590169261001	0.929571831406455	9.55398031802924e-05	"Scaffold_11"	47937051	47937344	NA	NA	NA	NA	NA
"PGEN_.00g242340"	0.0218132619432483	0.492057924631854	0.00988894840851175	"Scaffold_11"	51359268	51378202	"Q01705"	"NOTC1_MOUSE"	"Neurogenic locus notch homolog protein 1 (Notch 1) (Motch A) (mT14) (p300) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)]"	"GO:0000122; GO:0000139; GO:0000978; GO:0001228; GO:0001669; GO:0001701; GO:0001708; GO:0001726; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002051; GO:0002052; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003197; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003256; GO:0003264; GO:0003270; GO:0003273; GO:0003332; GO:0003344; GO:0003682; GO:0003700; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005789; GO:0005794; GO:0005829; GO:0005856; GO:0005886; GO:0005887; GO:0005912; GO:0006357; GO:0006959; GO:0007050; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007409; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0008544; GO:0008593; GO:0009912; GO:0009986; GO:0010001; GO:0010468; GO:0010614; GO:0010628; GO:0010629; GO:0010718; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0019899; GO:0021515; GO:0021915; GO:0030027; GO:0030154; GO:0030182; GO:0030216; GO:0030279; GO:0030324; GO:0030326; GO:0030334; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031410; GO:0031490; GO:0031960; GO:0032495; GO:0032496; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042127; GO:0042246; GO:0043065; GO:0043086; GO:0043235; GO:0043565; GO:0045070; GO:0045165; GO:0045596; GO:0045603; GO:0045607; GO:0045608; GO:0045618; GO:0045662; GO:0045665; GO:0045668; GO:0045687; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0045967; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048663; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048845; GO:0048873; GO:0050434; GO:0050678; GO:0050679; GO:0050767; GO:0050768; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060411; GO:0060412; GO:0060528; GO:0060548; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061314; GO:0061344; GO:0061384; GO:0061419; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071372; GO:0071944; GO:0072017; GO:0072044; GO:0072144; GO:0072602; GO:0090051; GO:0090090; GO:0097150; GO:0120163; GO:1901189; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000737; GO:2000811; GO:2000974; GO:2001027"	"acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; lamellipodium [GO:0030027]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ruffle [GO:0001726]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; Notch binding [GO:0005112]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transmembrane signaling receptor activity [GO:0004888]; animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell cycle arrest [GO:0007050]; cell differentiation [GO:0030154]; cell differentiation in spinal cord [GO:0021515]; cell fate commitment [GO:0045165]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; endocardial cell differentiation [GO:0060956]; endocardial cushion development [GO:0003197]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermis development [GO:0008544]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; glial cell differentiation [GO:0010001]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-4 secretion [GO:0072602]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell death [GO:0060548]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of growth rate [GO:0045967]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neural tube development [GO:0021915]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003270]; oligodendrocyte differentiation [GO:0048709]; osteoblast fate commitment [GO:0002051]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of ephrin receptor signaling pathway [GO:1901189]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061419]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of viral genome replication [GO:0045070]; positive regulation of viral transcription [GO:0050434]; prostate gland epithelium morphogenesis [GO:0060740]; pulmonary valve morphogenesis [GO:0003184]; regulation of cardioblast proliferation [GO:0003264]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of gene expression [GO:0010468]; regulation of inner ear auditory receptor cell differentiation [GO:0045607]; regulation of neurogenesis [GO:0050767]; regulation of Notch signaling pathway [GO:0008593]; regulation of somitogenesis [GO:0014807]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation [GO:0003256]; response to corticosteroid [GO:0031960]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; tissue regeneration [GO:0042246]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous blood vessel morphogenesis [GO:0048845]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222]"
"PGEN_.00g242750"	0.00464502685265674	0.00181312170258801	5.37189771607897e-09	"Scaffold_12"	1179324	1252062	"A6H5Z3"	"EXC6B_MOUSE"	"Exocyst complex component 6B (Exocyst complex component Sec15B) (SEC15-like protein 2)"	"GO:0000145; GO:0006887; GO:0006893; GO:0006904"	"exocyst [GO:0000145]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; vesicle docking involved in exocytosis [GO:0006904]"
"PGEN_.00g243110"	1.83038777718119e-06	0.304761331370285	0.00693109598255974	"Scaffold_12"	1964008	2014260	"Q6QHF9"	"PAOX_HUMAN"	"Peroxisomal N(1)-acetyl-spermine/spermidine oxidase (EC 1.5.3.13) (Polyamine oxidase)"	"GO:0005782; GO:0005829; GO:0006596; GO:0006598; GO:0006625; GO:0009446; GO:0009447; GO:0016491; GO:0046203; GO:0046208; GO:0046592; GO:0052899; GO:0052901; GO:0052902; GO:0052903; GO:0052904; GO:1901307"	"cytosol [GO:0005829]; peroxisomal matrix [GO:0005782]; N(1),N(12)-diacetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity [GO:0052899]; N1-acetylspermidine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity [GO:0052904]; N1-acetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity [GO:0052903]; oxidoreductase activity [GO:0016491]; polyamine oxidase activity [GO:0046592]; spermidine:oxygen oxidoreductase (3-aminopropanal-forming) activity [GO:0052902]; spermine:oxygen oxidoreductase (spermidine-forming) activity [GO:0052901]; polyamine biosynthetic process [GO:0006596]; polyamine catabolic process [GO:0006598]; positive regulation of spermidine biosynthetic process [GO:1901307]; protein targeting to peroxisome [GO:0006625]; putrescine biosynthetic process [GO:0009446]; putrescine catabolic process [GO:0009447]; spermidine catabolic process [GO:0046203]; spermine catabolic process [GO:0046208]"
"PGEN_.00g243120"	0.000138507239598722	0.176584761407447	0.580190693625506	"Scaffold_12"	2015031	2025800	NA	NA	NA	NA	NA
"PGEN_.00g243470"	0.0169762802702018	0.496957046514654	0.416792921457829	"Scaffold_12"	2736617	2739986	NA	NA	NA	NA	NA
"PGEN_.00g243810"	0.00326345023811354	0.695341115015561	0.0337538482409067	"Scaffold_12"	3465794	3506694	"Q13231"	"CHIT1_HUMAN"	"Chitotriosidase-1 (EC 3.2.1.14) (Chitinase-1)"	"GO:0000272; GO:0004553; GO:0004568; GO:0005576; GO:0005615; GO:0005737; GO:0005764; GO:0006032; GO:0006955; GO:0008061; GO:0008843; GO:0009617; GO:0035580; GO:0043312; GO:0044245; GO:1904724"	"cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]; chitin binding [GO:0008061]; chitinase activity [GO:0004568]; endochitinase activity [GO:0008843]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; chitin catabolic process [GO:0006032]; immune response [GO:0006955]; neutrophil degranulation [GO:0043312]; polysaccharide catabolic process [GO:0000272]; polysaccharide digestion [GO:0044245]; response to bacterium [GO:0009617]"
"PGEN_.00g245230"	0.00406538124388367	0.748532915352646	0.692328684561833	"Scaffold_12"	7439124	7439684	NA	NA	NA	NA	NA
"PGEN_.00g245610"	0.000606726858768233	0.785198974034576	0.53691156510412	"Scaffold_12"	8350405	8507926	"Q8N2E2"	"VWDE_HUMAN"	"von Willebrand factor D and EGF domain-containing protein"	"GO:0005102; GO:0005576; GO:0009986; GO:0048856"	"cell surface [GO:0009986]; extracellular region [GO:0005576]; signaling receptor binding [GO:0005102]; anatomical structure development [GO:0048856]"
"PGEN_.00g245880"	0.00495573090710472	0.972596539767452	0.514102311383818	"Scaffold_12"	9154713	9227764	"O75923"	"DYSF_HUMAN"	"Dysferlin (Dystrophy-associated fer-1-like protein) (Fer-1-like protein 1)"	"GO:0001525; GO:0001778; GO:0001938; GO:0002280; GO:0002281; GO:0005509; GO:0005543; GO:0005544; GO:0005634; GO:0005768; GO:0005769; GO:0005770; GO:0005794; GO:0005874; GO:0005886; GO:0006071; GO:0006906; GO:0006936; GO:0008017; GO:0010629; GO:0016021; GO:0019915; GO:0030027; GO:0030139; GO:0030315; GO:0030659; GO:0033292; GO:0034451; GO:0042177; GO:0042383; GO:0043014; GO:0043403; GO:0045444; GO:0045785; GO:0048747; GO:0050663; GO:0050765; GO:0070062; GO:0071470; GO:0090023; GO:0090279; GO:0098857; GO:1901842; GO:1902915"	"centriolar satellite [GO:0034451]; cytoplasmic vesicle membrane [GO:0030659]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; late endosome [GO:0005770]; membrane microdomain [GO:0098857]; microtubule [GO:0005874]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; alpha-tubulin binding [GO:0043014]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; microtubule binding [GO:0008017]; phospholipid binding [GO:0005543]; angiogenesis [GO:0001525]; cellular response to osmotic stress [GO:0071470]; cytokine secretion [GO:0050663]; fat cell differentiation [GO:0045444]; glycerol metabolic process [GO:0006071]; lipid storage [GO:0019915]; macrophage activation involved in immune response [GO:0002281]; monocyte activation involved in immune response [GO:0002280]; muscle contraction [GO:0006936]; muscle fiber development [GO:0048747]; negative regulation of gene expression [GO:0010629]; negative regulation of high voltage-gated calcium channel activity [GO:1901842]; negative regulation of phagocytosis [GO:0050765]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein polyubiquitination [GO:1902915]; plasma membrane repair [GO:0001778]; positive regulation of cell adhesion [GO:0045785]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of neutrophil chemotaxis [GO:0090023]; regulation of calcium ion import [GO:0090279]; skeletal muscle tissue regeneration [GO:0043403]; T-tubule organization [GO:0033292]; vesicle fusion [GO:0006906]"
"PGEN_.00g245920"	0.00191592071943769	0.0724069180772028	0.0407364231531465	"Scaffold_12"	9268299	9326841	"Q99973"	"TEP1_HUMAN"	"Telomerase protein component 1 (Telomerase-associated protein 1) (Telomerase protein 1) (p240) (p80 telomerase homolog)"	"GO:0000722; GO:0000781; GO:0002039; GO:0003720; GO:0003723; GO:0005524; GO:0005697; GO:0005737; GO:0016363; GO:0019899; GO:0070034; GO:1990904"	"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; ribonucleoprotein complex [GO:1990904]; telomerase holoenzyme complex [GO:0005697]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; p53 binding [GO:0002039]; RNA binding [GO:0003723]; telomerase activity [GO:0003720]; telomerase RNA binding [GO:0070034]; telomere maintenance via recombination [GO:0000722]"
"PGEN_.00g247270"	0.0342995943922518	0.314910735124238	0.00170573288238234	"Scaffold_12"	12894966	12917488	"P49580"	"ACHE_XENLA"	"Acetylcholine receptor subunit epsilon"	"GO:0004888; GO:0016021; GO:0022848; GO:0030054; GO:0045211"	"cell junction [GO:0030054]; integral component of membrane [GO:0016021]; postsynaptic membrane [GO:0045211]; acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]"
"PGEN_.00g250590"	0.0198573938494407	0.954687641489269	0.373961953435684	"Scaffold_12"	23444797	23468408	"P34284"	"FBXL_CAEEL"	"F-box/LRR-repeat protein fbxl-1 (F-box and leucine-rich repeat protein 1)"	"GO:0005929; GO:0006511; GO:0016567; GO:0019005; GO:0030424; GO:0030425; GO:0031146; GO:0035882; GO:0043053; GO:0043204; GO:1905909; GO:2000746"	"axon [GO:0030424]; cilium [GO:0005929]; dendrite [GO:0030425]; perikaryon [GO:0043204]; SCF ubiquitin ligase complex [GO:0019005]; dauer entry [GO:0043053]; defecation rhythm [GO:0035882]; protein ubiquitination [GO:0016567]; regulation of dauer entry [GO:1905909]; regulation of defecation rhythm [GO:2000746]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]"
"PGEN_.00g251410"	0.00363580554992035	0.366539883637865	0.460655218956041	"Scaffold_12"	26342977	26367799	"Q9P2N6"	"KANL3_HUMAN"	"KAT8 regulatory NSL complex subunit 3 (NSL complex protein NSL3) (Non-specific lethal 3 homolog) (Serum inhibited-related protein) (Testis development protein PRTD)"	"GO:0000123; GO:0005634; GO:0005654; GO:0043231; GO:0043981; GO:0043982; GO:0043984; GO:0044545"	"histone acetyltransferase complex [GO:0000123]; intracellular membrane-bounded organelle [GO:0043231]; NSL complex [GO:0044545]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]"
"PGEN_.00g252460"	0.0259378703733112	0.689866031085536	0.427127586108293	"Scaffold_12"	29714451	29728380	"Q29RL1"	"CF206_BOVIN"	"Cilia- and flagella-associated protein 206"	"GO:0001534; GO:0003341; GO:0031514; GO:0035082"	"motile cilium [GO:0031514]; radial spoke [GO:0001534]; axoneme assembly [GO:0035082]; cilium movement [GO:0003341]"
"PGEN_.00g252700"	1.84444702566956e-06	0.190198447299144	1.11918630034627e-08	"Scaffold_12"	30351169	30367057	"Q9ESQ5"	"TRPM4_RAT"	"Transient receptor potential cation channel subfamily M member 4 (Calcium-activated non-selective cation channel 1) (Long transient receptor potential channel 4) (LTrpC-4) (LTrpC4) (MLS2s) (Melastatin-like 2)"	"GO:0002250; GO:0002407; GO:0002724; GO:0005227; GO:0005262; GO:0005509; GO:0005516; GO:0005524; GO:0005623; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0006816; GO:0007204; GO:0008284; GO:0010460; GO:0016925; GO:0019722; GO:0030502; GO:0034706; GO:0035774; GO:0042310; GO:0043025; GO:0044214; GO:0045600; GO:0045668; GO:0045907; GO:0051289; GO:0071318; GO:0086045; GO:0086047; GO:0086048; GO:0086091; GO:0089717; GO:0090263; GO:0098662; GO:0098719; GO:0098911; GO:1903949; GO:1904179; GO:1904199"	"cell [GO:0005623]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; sodium channel complex [GO:0034706]; spanning component of membrane [GO:0089717]; spanning component of plasma membrane [GO:0044214]; ATP binding [GO:0005524]; calcium activated cation channel activity [GO:0005227]; calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; adaptive immune response [GO:0002250]; calcium ion transport [GO:0006816]; calcium-mediated signaling [GO:0019722]; cellular response to ATP [GO:0071318]; dendritic cell chemotaxis [GO:0002407]; inorganic cation transmembrane transport [GO:0098662]; membrane depolarization during AV node cell action potential [GO:0086045]; membrane depolarization during bundle of His cell action potential [GO:0086048]; membrane depolarization during Purkinje myocyte cell action potential [GO:0086047]; negative regulation of bone mineralization [GO:0030502]; negative regulation of osteoblast differentiation [GO:0045668]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of atrial cardiac muscle cell action potential [GO:1903949]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of heart rate [GO:0010460]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of regulation of vascular smooth muscle cell membrane depolarization [GO:1904199]; positive regulation of vasoconstriction [GO:0045907]; protein homotetramerization [GO:0051289]; protein sumoylation [GO:0016925]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of T cell cytokine production [GO:0002724]; regulation of ventricular cardiac muscle cell action potential [GO:0098911]; sodium ion import across plasma membrane [GO:0098719]; vasoconstriction [GO:0042310]"
"PGEN_.00g252770"	1.04372725733055e-12	0.717411387090808	0.253454974438225	"Scaffold_12"	30498877	30511673	NA	NA	NA	NA	NA
"PGEN_.00g254040"	4.68814188872239e-06	0.0216187938492748	0.00149914844166769	"Scaffold_12"	34738980	34756462	"Q6ZQY2"	"LR74B_HUMAN"	"Leucine-rich repeat-containing protein 74B"	""	""
"PGEN_.00g254310"	0.000171130794634691	2.57241722967766e-08	0.0042318161271332	"Scaffold_12"	35497998	35536495	"Q8C261"	"NCKX5_MOUSE"	"Sodium/potassium/calcium exchanger 5 (Na(+)/K(+)/Ca(2+)-exchange protein 5) (Solute carrier family 24 member 5)"	"GO:0005262; GO:0005623; GO:0005802; GO:0006874; GO:0008273; GO:0015293; GO:0016021; GO:0030318; GO:0034220; GO:0042470; GO:0048022; GO:0050896; GO:0070588"	"cell [GO:0005623]; integral component of membrane [GO:0016021]; melanosome [GO:0042470]; trans-Golgi network [GO:0005802]; calcium channel activity [GO:0005262]; calcium, potassium:sodium antiporter activity [GO:0008273]; symporter activity [GO:0015293]; calcium ion transmembrane transport [GO:0070588]; cellular calcium ion homeostasis [GO:0006874]; ion transmembrane transport [GO:0034220]; melanocyte differentiation [GO:0030318]; negative regulation of melanin biosynthetic process [GO:0048022]; response to stimulus [GO:0050896]"
"PGEN_.00g254640"	4.71706500970534e-05	0.954687641489269	0.000853898458144791	"Scaffold_12"	36667135	36667713	NA	NA	NA	NA	NA
"PGEN_.00g254650"	0.0134405597636135	0.31042689001931	9.69680309747081e-05	"Scaffold_12"	36667854	36668426	NA	NA	NA	NA	NA
"PGEN_.00g254790"	0.0275446329255006	0.75161753024005	0.253495145732042	"Scaffold_12"	37077650	37235290	"P14730"	"WFD18_RAT"	"WAP four-disulfide core domain protein 18 (Extracellular peptidase inhibitor) (Protein WDNM1) (Fragment)"	"GO:0005576; GO:0030414"	"extracellular region [GO:0005576]; peptidase inhibitor activity [GO:0030414]"
"PGEN_.00g255630"	6.72811598031134e-05	0.0405894384362303	0.353202462882919	"Scaffold_12"	39464432	39570305	"Q7TT36"	"AGRA3_MOUSE"	"Adhesion G protein-coupled receptor A3 (G-protein coupled receptor 125)"	"GO:0004930; GO:0007166; GO:0009897; GO:0016021"	"external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; G protein-coupled receptor activity [GO:0004930]; cell surface receptor signaling pathway [GO:0007166]"
"PGEN_.00g255890"	0.0156922260607501	0.00103199221193803	0.260952091964737	"Scaffold_12"	40175151	40206337	"Q9ERQ8"	"CAH7_MOUSE"	"Carbonic anhydrase 7 (EC 4.2.1.1) (Carbonate dehydratase VII) (Carbonic anhydrase VII) (CA-VII)"	"GO:0004089; GO:0005623; GO:0005829; GO:0008270; GO:0032230; GO:0032849; GO:2001225"	"cell [GO:0005623]; cytosol [GO:0005829]; carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]; positive regulation of cellular pH reduction [GO:0032849]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; regulation of chloride transport [GO:2001225]"
"PGEN_.00g257960"	0.00209237303712918	0.0440728121759044	0.234863824922143	"Scaffold_12"	46197835	46216413	"Q0X0A5"	"MARH5_CHLAE"	"E3 ubiquitin-protein ligase MARCH5 (EC 2.3.2.27) (Membrane-associated RING finger protein 5) (Membrane-associated RING-CH protein V) (MARCH-V) (RING-type E3 ubiquitin transferase MARCH5)"	"GO:0004842; GO:0005741; GO:0005783; GO:0005789; GO:0008270; GO:0016021; GO:0051865; GO:0090140; GO:0090344"	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; negative regulation of cell aging [GO:0090344]; protein autoubiquitination [GO:0051865]; regulation of mitochondrial fission [GO:0090140]"
"PGEN_.00g261240"	0.00407017601865373	0.0912010622579017	0.00424262289786718	"Scaffold_13"	4223676	4325173	"P25107"	"PTH1R_DIDVI"	"Parathyroid hormone/parathyroid hormone-related peptide receptor (PTH/PTHrP type I receptor) (PTH/PTHr receptor) (Parathyroid hormone 1 receptor) (PTH1 receptor)"	"GO:0004991; GO:0005887; GO:0007166; GO:0007188; GO:0007189; GO:0017046; GO:0042803; GO:0043621"	"integral component of plasma membrane [GO:0005887]; parathyroid hormone receptor activity [GO:0004991]; peptide hormone binding [GO:0017046]; protein homodimerization activity [GO:0042803]; protein self-association [GO:0043621]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell surface receptor signaling pathway [GO:0007166]"
"PGEN_.00g264700"	0.0386834941254979	0.970589147658766	0.515724201462302	"Scaffold_13"	13578879	13639233	"Q9WV18"	"GABR1_MOUSE"	"Gamma-aminobutyric acid type B receptor subunit 1 (GABA-B receptor 1) (GABA-B-R1) (GABA-BR1) (GABABR1) (Gb1)"	"GO:0001649; GO:0004965; GO:0005615; GO:0005737; GO:0005789; GO:0005887; GO:0007193; GO:0007194; GO:0007214; GO:0008021; GO:0008134; GO:0008285; GO:0014048; GO:0014049; GO:0014053; GO:0016020; GO:0030054; GO:0030673; GO:0031966; GO:0032811; GO:0033602; GO:0038037; GO:0038039; GO:0042734; GO:0043005; GO:0043025; GO:0043197; GO:0043198; GO:0043231; GO:0045121; GO:0045211; GO:0046982; GO:0050805; GO:0060124; GO:0097060; GO:0098685; GO:0098793; GO:0098978; GO:0098982; GO:0099055; GO:0099056; GO:0099579; GO:0150099; GO:1902710; GO:1990430"	"axolemma [GO:0030673]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; G protein-coupled receptor dimeric complex [GO:0038037]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrial membrane [GO:0031966]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic membrane [GO:0097060]; synaptic vesicle [GO:0008021]; extracellular matrix protein binding [GO:1990430]; G protein-coupled GABA receptor activity [GO:0004965]; G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential [GO:0099579]; protein heterodimerization activity [GO:0046982]; transcription factor binding [GO:0008134]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of adenylate cyclase activity [GO:0007194]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of dopamine secretion [GO:0033602]; negative regulation of epinephrine secretion [GO:0032811]; negative regulation of gamma-aminobutyric acid secretion [GO:0014053]; negative regulation of synaptic transmission [GO:0050805]; neuron-glial cell signaling [GO:0150099]; osteoblast differentiation [GO:0001649]; positive regulation of glutamate secretion [GO:0014049]; positive regulation of growth hormone secretion [GO:0060124]; regulation of glutamate secretion [GO:0014048]"
"PGEN_.00g266260"	0.000350719441604581	0.968633101056069	3.41247688355424e-17	"Scaffold_13"	17932937	17935935	NA	NA	NA	NA	NA
"PGEN_.00g266480"	0.00082359420012081	0.673701728906533	0.120815830775603	"Scaffold_13"	18230602	18234935	NA	NA	NA	NA	NA
"PGEN_.00g267920"	0.00191592071943769	0.989391241056912	9.69680309747081e-05	"Scaffold_13"	23282109	23289994	NA	NA	NA	NA	NA
"PGEN_.00g269250"	0.00206370997941644	0.366539883637865	0.0006230016308053	"Scaffold_13"	26552097	26588309	"Q9JJK2"	"LANC2_MOUSE"	"LanC-like protein 2 (Testis-specific adriamycin sensitivity protein)"	"GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0009789; GO:0010314; GO:0030864; GO:0032266; GO:0045892; GO:0070273"	"cortical actin cytoskeleton [GO:0030864]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; catalytic activity [GO:0003824]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of abscisic acid-activated signaling pathway [GO:0009789]"
"PGEN_.00g269390"	0.00121377860523756	0.928210869672753	0.523835832176551	"Scaffold_13"	26711477	26790375	"Q95M17"	"CHIA_BOVIN"	"Acidic mammalian chitinase (AMCase) (EC 3.2.1.14) (Chitin-binding protein b04) (CBPb04)"	"GO:0000272; GO:0002376; GO:0002532; GO:0004568; GO:0005576; GO:0005615; GO:0005737; GO:0006032; GO:0006915; GO:0008061; GO:0090197"	"cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; chitin binding [GO:0008061]; chitinase activity [GO:0004568]; apoptotic process [GO:0006915]; chitin catabolic process [GO:0006032]; immune system process [GO:0002376]; polysaccharide catabolic process [GO:0000272]; positive regulation of chemokine secretion [GO:0090197]; production of molecular mediator involved in inflammatory response [GO:0002532]"
"PGEN_.00g269400"	0.0105400644727064	0.723543723203777	0.298833324825765	"Scaffold_13"	26807126	26812211	NA	NA	NA	NA	NA
"PGEN_.00g269970"	0.0193893739392877	0.962867837059525	0.921236928344448	"Scaffold_13"	28368889	28386545	"Q54KD0"	"Y7407_DICDI"	"TPR repeat-containing protein DDB_G0287407"	""	""
"PGEN_.00g270150"	0.0132534388997231	0.560194441409402	0.00204380595106105	"Scaffold_13"	28869017	28869526	"Q5XGC9"	"SRFB1_XENTR"	"Serum response factor-binding protein 1 (SRF-dependent transcription regulation-associated protein)"	"GO:0005634; GO:0030490; GO:0030686; GO:0048471"	"90S preribosome [GO:0030686]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; maturation of SSU-rRNA [GO:0030490]"
"PGEN_.00g270620"	0.0136396275784925	0.0190611368833956	0.603918851556339	"Scaffold_13"	30121904	30122392	NA	NA	NA	NA	NA
"PGEN_.00g271180"	0.0188723862597594	0.640439427395116	0.473838112371109	"Scaffold_13"	31680505	31689129	"Q9ULJ7"	"ANR50_HUMAN"	"Ankyrin repeat domain-containing protein 50"	"GO:0005768; GO:0015031; GO:1990126"	"endosome [GO:0005768]; protein transport [GO:0015031]; retrograde transport, endosome to plasma membrane [GO:1990126]"
"PGEN_.00g271330"	2.25861417678572e-06	0.0709571818549223	0.0923677933697121	"Scaffold_13"	31941686	31993638	"Q6UX71"	"PXDC2_HUMAN"	"Plexin domain-containing protein 2 (Tumor endothelial marker 7-related protein)"	"GO:0016021"	"integral component of membrane [GO:0016021]"
"PGEN_.00g271680"	4.42262010123756e-14	0.000485084221402946	4.08880574255561e-12	"Scaffold_13"	33018431	33030805	"Q5U504"	"KLH40_XENLA"	"Kelch-like protein 40 (Kelch repeat and BTB domain-containing protein 5)"	"GO:0005737; GO:0031397; GO:0031398; GO:0031463; GO:0031672; GO:0031674; GO:0032436; GO:0048741; GO:0098528"	"A band [GO:0031672]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; I band [GO:0031674]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; skeletal muscle fiber development [GO:0048741]; skeletal muscle fiber differentiation [GO:0098528]"
"PGEN_.00g271690"	0.000327112843707849	9.81969973546555e-23	9.82623533233133e-23	"Scaffold_13"	33051729	33056559	NA	NA	NA	NA	NA
"PGEN_.00g272050"	1.83055468853852e-08	0.135193864334176	0.717469523338272	"Scaffold_13"	33865450	33891183	"F1RBN2"	"SPAG1_DANRE"	"Sperm-associated antigen 1A"	"GO:0005737; GO:0070286"	"cytoplasm [GO:0005737]; axonemal dynein complex assembly [GO:0070286]"
"PGEN_.00g273120"	0.0455507246879678	0.145911539572318	0.722467624329226	"Scaffold_13"	36730996	36746071	"O26153"	"IPK_METTH"	"Isopentenyl phosphate kinase (IPK) (EC 2.7.4.26)"	"GO:0005524; GO:0008299; GO:0016301; GO:0102043"	"ATP binding [GO:0005524]; isopentenyl phosphate kinase activity [GO:0102043]; kinase activity [GO:0016301]; isoprenoid biosynthetic process [GO:0008299]"
"PGEN_.00g273380"	0.0150709907652253	0.16625242825598	1.27906034153373e-07	"Scaffold_13"	37531219	37628736	"P25107"	"PTH1R_DIDVI"	"Parathyroid hormone/parathyroid hormone-related peptide receptor (PTH/PTHrP type I receptor) (PTH/PTHr receptor) (Parathyroid hormone 1 receptor) (PTH1 receptor)"	"GO:0004991; GO:0005887; GO:0007166; GO:0007188; GO:0007189; GO:0017046; GO:0042803; GO:0043621"	"integral component of plasma membrane [GO:0005887]; parathyroid hormone receptor activity [GO:0004991]; peptide hormone binding [GO:0017046]; protein homodimerization activity [GO:0042803]; protein self-association [GO:0043621]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell surface receptor signaling pathway [GO:0007166]"
"PGEN_.00g275080"	6.43001698311917e-108	0.139255201277033	6.05792037953452e-244	"Scaffold_13"	42455843	42493552	"Q92551"	"IP6K1_HUMAN"	"Inositol hexakisphosphate kinase 1 (InsP6 kinase 1) (EC 2.7.4.21) (Inositol hexaphosphate kinase 1)"	"GO:0000828; GO:0000832; GO:0001650; GO:0005524; GO:0005654; GO:0005829; GO:0032958; GO:0043647; GO:0046854; GO:0052723; GO:0052724; GO:0120163"	"cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; inositol hexakisphosphate 1-kinase activity [GO:0052723]; inositol hexakisphosphate 3-kinase activity [GO:0052724]; inositol hexakisphosphate 5-kinase activity [GO:0000832]; inositol hexakisphosphate kinase activity [GO:0000828]; inositol phosphate biosynthetic process [GO:0032958]; inositol phosphate metabolic process [GO:0043647]; negative regulation of cold-induced thermogenesis [GO:0120163]; phosphatidylinositol phosphorylation [GO:0046854]"
"PGEN_.00g276130"	2.1356326068163e-11	0.90380676294122	0.170270563091525	"Scaffold_14"	694621	759919	"Q0P4M4"	"CBPC2_XENTR"	"Cytosolic carboxypeptidase 2 (EC 3.4.17.-) (ATP/GTP-binding protein-like 2)"	"GO:0004181; GO:0005814; GO:0005829; GO:0008270; GO:0035610; GO:0036064"	"centriole [GO:0005814]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]; protein side chain deglutamylation [GO:0035610]"
"PGEN_.00g276560"	0.0136396275784925	0.00175969020125766	0.635314562875776	"Scaffold_14"	1546749	1553206	NA	NA	NA	NA	NA
"PGEN_.00g276890"	0.0322058713279222	0.271712526838316	0.0181050938506053	"Scaffold_14"	2084044	2093400	NA	NA	NA	NA	NA
"PGEN_.00g277360"	3.57466834432105e-17	0.58090120071781	0.110513272068221	"Scaffold_14"	3377810	3378106	NA	NA	NA	NA	NA
"PGEN_.00g277700"	0.0159637628268782	0.0751775837562471	6.61732033403694e-08	"Scaffold_14"	4004597	4007359	NA	NA	NA	NA	NA
"PGEN_.00g277910"	4.5254471541642e-46	2.95627480949376e-11	1.47145743606294e-28	"Scaffold_14"	4509691	4540589	"Q61165"	"SL9A1_MOUSE"	"Sodium/hydrogen exchanger 1 (Na(+)/H(+) exchanger 1) (NHE-1) (Solute carrier family 9 member 1)"	"GO:0002026; GO:0005516; GO:0005623; GO:0005654; GO:0005737; GO:0005739; GO:0005783; GO:0005789; GO:0005886; GO:0005887; GO:0006814; GO:0006883; GO:0006885; GO:0009986; GO:0010447; GO:0010613; GO:0010882; GO:0014070; GO:0014704; GO:0015385; GO:0015386; GO:0016020; GO:0016323; GO:0016324; GO:0030307; GO:0030315; GO:0030346; GO:0032869; GO:0035794; GO:0035994; GO:0036376; GO:0042383; GO:0043065; GO:0043066; GO:0045121; GO:0045760; GO:0045944; GO:0048306; GO:0048471; GO:0051259; GO:0051453; GO:0051930; GO:0055007; GO:0070417; GO:0070886; GO:0070997; GO:0071236; GO:0071257; GO:0071456; GO:0071468; GO:0071805; GO:0071872; GO:0086003; GO:0086092; GO:0090533; GO:0098719; GO:0098735; GO:1902533; GO:1902600; GO:1903281"	"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cation-transporting ATPase complex [GO:0090533]; cell [GO:0005623]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; intercalated disc [GO:0014704]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; potassium:proton antiporter activity [GO:0015386]; protein phosphatase 2B binding [GO:0030346]; sodium:proton antiporter activity [GO:0015385]; cardiac muscle cell contraction [GO:0086003]; cardiac muscle cell differentiation [GO:0055007]; cellular response to acidic pH [GO:0071468]; cellular response to antibiotic [GO:0071236]; cellular response to cold [GO:0070417]; cellular response to electrical stimulus [GO:0071257]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; cellular sodium ion homeostasis [GO:0006883]; negative regulation of apoptotic process [GO:0043066]; neuron death [GO:0070997]; positive regulation of action potential [GO:0045760]; positive regulation of apoptotic process [GO:0043065]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of calcium:sodium antiporter activity [GO:1903281]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cell growth [GO:0030307]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of mitochondrial membrane permeability [GO:0035794]; positive regulation of the force of heart contraction [GO:0098735]; positive regulation of transcription by RNA polymerase II [GO:0045944]; potassium ion transmembrane transport [GO:0071805]; protein complex oligomerization [GO:0051259]; proton transmembrane transport [GO:1902600]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of intracellular pH [GO:0051453]; regulation of pH [GO:0006885]; regulation of sensory perception of pain [GO:0051930]; regulation of the force of heart contraction [GO:0002026]; regulation of the force of heart contraction by cardiac conduction [GO:0086092]; response to acidic pH [GO:0010447]; response to muscle stretch [GO:0035994]; response to organic cyclic compound [GO:0014070]; sodium ion export across plasma membrane [GO:0036376]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transport [GO:0006814]"
"PGEN_.00g278430"	1.4945281078421e-08	0.273583391405707	0.589732145371419	"Scaffold_14"	5587776	5589550	NA	NA	NA	NA	NA
"PGEN_.00g278820"	1.67069610468078e-88	0.000694257070684539	1.01172382756703e-05	"Scaffold_14"	6530037	6533107	NA	NA	NA	NA	NA
"PGEN_.00g279140"	1.18777079513547e-16	3.37345096737783e-104	1.25437906418519e-90	"Scaffold_14"	6934908	6946622	"P50164"	"TRN2_HYONI"	"Tropinone reductase 2 (EC 1.1.1.236) (Tropinone reductase II) (TR-II)"	"GO:0009710; GO:0050358"	"tropinone reductase activity [GO:0050358]; tropane alkaloid biosynthetic process [GO:0009710]"
"PGEN_.00g279150"	1.57528980879597e-181	1.95614019757677e-13	2.97778336483659e-44	"Scaffold_14"	6951103	6982495	"Q11D10"	"ASSY_CHESB"	"Argininosuccinate synthase (EC 6.3.4.5) (Citrulline--aspartate ligase)"	"GO:0004055; GO:0005524; GO:0005737; GO:0006526"	"cytoplasm [GO:0005737]; argininosuccinate synthase activity [GO:0004055]; ATP binding [GO:0005524]; arginine biosynthetic process [GO:0006526]"
"PGEN_.00g279430"	0.00527619217318194	0.000727390779461467	6.00839056239141e-05	"Scaffold_14"	7687420	7753254	"A8Q2D1"	"NAS35_BRUMA"	"Zinc metalloproteinase dpy-31 (EC 3.4.24.-) (Nematode astacin 35) (Procollagen C-proteinase)"	"GO:0004222; GO:0005576; GO:0008270; GO:0042338"	"extracellular region [GO:0005576]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; cuticle development involved in collagen and cuticulin-based cuticle molting cycle [GO:0042338]"
"PGEN_.00g279710"	3.13137481516856e-15	0.792573678814274	0.475334962826341	"Scaffold_14"	8544876	8566105	NA	NA	NA	NA	NA
"PGEN_.00g279720"	0.0291326997621555	0.65966599947537	0.717469523338272	"Scaffold_14"	8574252	8589239	"O97764"	"QOR_BOVIN"	"Zeta-crystallin"	"GO:0003677; GO:0003730; GO:0003960; GO:0005829; GO:0008270; GO:0042178; GO:0050661; GO:0051289; GO:0070402"	"cytosol [GO:0005829]; DNA binding [GO:0003677]; mRNA 3'-UTR binding [GO:0003730]; NADP binding [GO:0050661]; NADPH binding [GO:0070402]; NADPH:quinone reductase activity [GO:0003960]; zinc ion binding [GO:0008270]; protein homotetramerization [GO:0051289]; xenobiotic catabolic process [GO:0042178]"
"PGEN_.00g279730"	2.63800087567427e-15	0.748335708993681	1.38531835254799e-19	"Scaffold_14"	8594867	8627802	"Q5R6S0"	"ABHGA_PONAB"	"Phosphatidylserine lipase ABHD16A (EC 3.1.-.-) (Alpha/beta hydrolase domain-containing protein 16A) (Abhydrolase domain-containing protein 16A) (HLA-B-associated transcript 5 homolog) (Monoacylglycerol lipase ABHD16A) (EC 3.1.1.23)"	"GO:0004620; GO:0006660; GO:0016021; GO:0047372; GO:0052651; GO:1905344"	"integral component of membrane [GO:0016021]; acylglycerol lipase activity [GO:0047372]; phospholipase activity [GO:0004620]; monoacylglycerol catabolic process [GO:0052651]; phosphatidylserine catabolic process [GO:0006660]; prostaglandin catabolic process [GO:1905344]"
"PGEN_.00g280110"	0.00490727451407537	0.78123875729327	0.654838082946611	"Scaffold_14"	9571834	9640463	"P16546"	"SPTN1_MOUSE"	"Spectrin alpha chain, non-erythrocytic 1 (Alpha-II spectrin) (Fodrin alpha chain)"	"GO:0003779; GO:0005509; GO:0005516; GO:0005886; GO:0005916; GO:0015630; GO:0016020; GO:0016328; GO:0019905; GO:0030018; GO:0030507; GO:0030863; GO:0031532; GO:0032437; GO:0032991; GO:0033270; GO:0043209; GO:0043231; GO:0044877; GO:0051693"	"cortical cytoskeleton [GO:0030863]; cuticular plate [GO:0032437]; fascia adherens [GO:0005916]; intracellular membrane-bounded organelle [GO:0043231]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; myelin sheath [GO:0043209]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; Z disc [GO:0030018]; actin binding [GO:0003779]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; protein-containing complex binding [GO:0044877]; spectrin binding [GO:0030507]; syntaxin binding [GO:0019905]; actin cytoskeleton reorganization [GO:0031532]; actin filament capping [GO:0051693]"
"PGEN_.00g280580"	0.00540912049882734	0.879660787867079	0.416738740023522	"Scaffold_14"	10724331	10750423	"R9UTQ8"	"PROHY_STRGD"	"L-proline trans-4-hydroxylase (P4H) (EC 1.14.11.57)"	"GO:0005506; GO:0016706; GO:0016999; GO:0017000"	"2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; iron ion binding [GO:0005506]; antibiotic biosynthetic process [GO:0017000]; antibiotic metabolic process [GO:0016999]"
"PGEN_.00g281820"	0.00329080548377532	4.70641693030056e-05	0.966960145863521	"Scaffold_14"	13528925	13529383	NA	NA	NA	NA	NA
"PGEN_.00g282790"	0.00189961899382509	0.206913504480766	0.36889048726466	"Scaffold_14"	15696568	15803149	"E9Q309"	"CE350_MOUSE"	"Centrosome-associated protein 350 (Cep350)"	"GO:0005634; GO:0005737; GO:0005813; GO:0005814; GO:0005819; GO:0008017; GO:0034453; GO:0042995"	"cell projection [GO:0042995]; centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; spindle [GO:0005819]; microtubule binding [GO:0008017]; microtubule anchoring [GO:0034453]"
"PGEN_.00g284070"	0.00382258393690529	0.0614575191625735	0.00115419427247492	"Scaffold_14"	19162051	19164292	NA	NA	NA	NA	NA
"PGEN_.00g284080"	1.51138215038351e-05	0.698748726025852	2.16309519682951e-13	"Scaffold_14"	19164984	19167683	NA	NA	NA	NA	NA
"PGEN_.00g284240"	0.000778911649694708	0.00087535644204413	0.78773971952717	"Scaffold_14"	20019895	20026199	NA	NA	NA	NA	NA
"PGEN_.00g284710"	1.23602227170897e-05	0.0060123210060919	3.74458183601611e-64	"Scaffold_14"	20971964	20979053	NA	NA	NA	NA	NA
"PGEN_.00g285330"	1.23649098782073e-17	0.000166253705858709	3.30910587839876e-05	"Scaffold_14"	22480283	22493744	NA	NA	NA	NA	NA
"PGEN_.00g285690"	0.0116750306645245	0.147138867384583	1.7320625054849e-13	"Scaffold_14"	23440542	23441231	NA	NA	NA	NA	NA
"PGEN_.00g286080"	0.00236466294934965	0.00969919975457538	0.845478223185777	"Scaffold_14"	24120924	24142993	NA	NA	NA	NA	NA
"PGEN_.00g288100"	0.00156376501682367	0.0766201197727233	0.00216383368880157	"Scaffold_14"	27687481	27731472	"Q54NA6"	"MYBL_DICDI"	"Myb-like protein L"	"GO:0003677; GO:0005634"	"nucleus [GO:0005634]; DNA binding [GO:0003677]"
"PGEN_.00g288770"	0.00369082061083786	0.801460375859917	9.22764142417359e-07	"Scaffold_14"	29002502	29018612	NA	NA	NA	NA	NA
"PGEN_.00g289090"	0.014230114852335	0.0140838487837403	0.986861722791369	"Scaffold_14"	29650979	29662232	"E9Q5G3"	"KIF23_MOUSE"	"Kinesin-like protein KIF23"	"GO:0000281; GO:0000915; GO:0003777; GO:0005524; GO:0005623; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005819; GO:0005871; GO:0005874; GO:0007018; GO:0008017; GO:0016887; GO:0030496; GO:0032467; GO:0045171; GO:0051256; GO:0072383; GO:0072686; GO:0090543; GO:0097149"	"cell [GO:0005623]; centralspindlin complex [GO:0097149]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; Flemming body [GO:0090543]; intercellular bridge [GO:0045171]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; actomyosin contractile ring assembly [GO:0000915]; microtubule-based movement [GO:0007018]; mitotic cytokinesis [GO:0000281]; mitotic spindle midzone assembly [GO:0051256]; plus-end-directed vesicle transport along microtubule [GO:0072383]; positive regulation of cytokinesis [GO:0032467]"
"PGEN_.00g290270"	0.0270369664698054	0.213175567886512	0.399230937636203	"Scaffold_14"	32548031	32552392	NA	NA	NA	NA	NA
"PGEN_.00g290300"	0.00195919427279018	0.307629301688654	0.046648571111853	"Scaffold_14"	32593238	32611384	"P69478"	"CHSTB_RAT"	"Carbohydrate sulfotransferase 11 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1) (C4S-1) (C4ST-1) (C4ST1)"	"GO:0000139; GO:0001537; GO:0001701; GO:0002063; GO:0007585; GO:0008146; GO:0009791; GO:0016021; GO:0016051; GO:0030166; GO:0030204; GO:0030206; GO:0030326; GO:0030512; GO:0033037; GO:0036342; GO:0042127; GO:0042733; GO:0043066; GO:0047756; GO:0048589; GO:0048703; GO:0048704; GO:0050659; GO:0051216"	"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate metabolic process [GO:0030204]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system morphogenesis [GO:0048704]; embryonic viscerocranium morphogenesis [GO:0048703]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585]"
"PGEN_.00g290440"	0.00034063797639134	7.91099248015468e-06	0.0263660802193592	"Scaffold_14"	32730787	32752148	"Q91V41"	"RAB14_MOUSE"	"Ras-related protein Rab-14"	"GO:0000139; GO:0003924; GO:0005525; GO:0005764; GO:0005769; GO:0005770; GO:0005791; GO:0005795; GO:0005802; GO:0005829; GO:0005886; GO:0006886; GO:0006895; GO:0007589; GO:0008543; GO:0016324; GO:0019003; GO:0030133; GO:0030140; GO:0030659; GO:0031489; GO:0031901; GO:0032456; GO:0032482; GO:0032880; GO:0042175; GO:0042742; GO:0043231; GO:0045176; GO:0045335; GO:0045995; GO:0048471; GO:0055037; GO:0090387; GO:0097208; GO:0098993"	"alveolar lamellar body [GO:0097208]; anchored component of synaptic vesicle membrane [GO:0098993]; apical plasma membrane [GO:0016324]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; lysosome [GO:0005764]; nuclear outer membrane-endoplasmic reticulum membrane network [GO:0042175]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; rough endoplasmic reticulum [GO:0005791]; trans-Golgi network [GO:0005802]; trans-Golgi network transport vesicle [GO:0030140]; transport vesicle [GO:0030133]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin V binding [GO:0031489]; apical protein localization [GO:0045176]; body fluid secretion [GO:0007589]; defense response to bacterium [GO:0042742]; endocytic recycling [GO:0032456]; fibroblast growth factor receptor signaling pathway [GO:0008543]; Golgi to endosome transport [GO:0006895]; intracellular protein transport [GO:0006886]; phagolysosome assembly involved in apoptotic cell clearance [GO:0090387]; Rab protein signal transduction [GO:0032482]; regulation of embryonic development [GO:0045995]; regulation of protein localization [GO:0032880]"
"PGEN_.00g291060"	0.000778911649694708	0.779417695251558	0.182307675945727	"Scaffold_14"	34119262	34119546	NA	NA	NA	NA	NA
"PGEN_.00g291710"	0.0488401458187546	0.221931319625655	0.559496457644659	"Scaffold_14"	35221347	35246903	"Q29496"	"CP3AO_SHEEP"	"Cytochrome P450 3A24 (EC 1.14.14.1) (CYPIIIA24)"	"GO:0004497; GO:0005506; GO:0005789; GO:0020037; GO:0070330"	"endoplasmic reticulum membrane [GO:0005789]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]"
"PGEN_.00g291910"	1.27059436128725e-182	0.786151097303722	1.38480073598601e-31	"Scaffold_14"	35949839	35966065	"Q4PJX1"	"ODR4_MOUSE"	"Protein odr-4 homolog (mODR-4)"	"GO:0008104; GO:0016021"	"integral component of membrane [GO:0016021]; protein localization [GO:0008104]"
"PGEN_.00g291920"	0.00135098043131589	4.47244894640964e-05	0.00510709680995733	"Scaffold_14"	35980565	35989129	NA	NA	NA	NA	NA
"PGEN_.00g292360"	1.62830704837643e-05	0.577757749927598	0.00274293815446852	"Scaffold_14"	36958778	36970352	NA	NA	NA	NA	NA
"PGEN_.00g293300"	0.0285918810143432	0.412452197741911	0.0855242179366486	"Scaffold_14"	38982767	38992866	NA	NA	NA	NA	NA
"PGEN_.00g293770"	1.7537595123665e-07	3.64048519281508e-18	9.45691886568665e-06	"Scaffold_14"	39827169	39841781	NA	NA	NA	NA	NA
"PGEN_.00g293980"	0.0403245681495575	0.0216971696235544	0.0191305718086504	"Scaffold_14"	40343126	40357058	"Q8NCH0"	"CHSTE_HUMAN"	"Carbohydrate sulfotransferase 14 (EC 2.8.2.35) (Dermatan 4-sulfotransferase 1) (D4ST-1) (hD4ST1)"	"GO:0000139; GO:0001537; GO:0008146; GO:0016021; GO:0016051; GO:0030208; GO:0042301; GO:0050655; GO:0070062"	"extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; phosphate ion binding [GO:0042301]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; dermatan sulfate biosynthetic process [GO:0030208]; dermatan sulfate proteoglycan metabolic process [GO:0050655]"
"PGEN_.00g294100"	0.00663159652855153	0.30934278168762	0.0162362776042043	"Scaffold_14"	40665427	40673757	NA	NA	NA	NA	NA
"PGEN_.00g294360"	1.87184156192269e-07	5.24232898703716e-06	0.0371944624902867	"Scaffold_14"	41219559	41225820	NA	NA	NA	NA	NA
"PGEN_.00g295480"	5.60559464634012e-41	0.411452458303515	1.64409321254238e-33	"Scaffold_14"	43606617	43620277	NA	NA	NA	NA	NA
"PGEN_.00g296790"	0.000128270893277243	0.0617981826960458	0.000196089387475557	"Scaffold_14"	44937049	44938190	NA	NA	NA	NA	NA
"PGEN_.00g299000"	0.00486902079818046	0.636591075578648	0.079796968727552	"Scaffold_15"	5115847	5179865	"Q9Y6R7"	"FCGBP_HUMAN"	"IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP)"	"GO:0070062"	"extracellular exosome [GO:0070062]"
"PGEN_.00g299380"	2.56559300898401e-13	0.0240846875451168	0.01106058565942	"Scaffold_15"	6117129	6186123	"C0HL13"	"LRP2_PIG"	"Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin)"	"GO:0001702; GO:0001843; GO:0002076; GO:0003139; GO:0003148; GO:0003223; GO:0005509; GO:0005886; GO:0005905; GO:0006898; GO:0007605; GO:0008144; GO:0008584; GO:0009897; GO:0009952; GO:0016021; GO:0016324; GO:0017124; GO:0017147; GO:0030001; GO:0030424; GO:0030425; GO:0030514; GO:0031526; GO:0031904; GO:0042632; GO:0042813; GO:0043235; GO:0045944; GO:0046849; GO:0048539; GO:0050769; GO:0051087; GO:0060068; GO:0060070; GO:0060349; GO:0060444; GO:0060612; GO:0060982; GO:0061156; GO:0061178; GO:0061304; GO:0070447; GO:0140058; GO:1904447; GO:1905167"	"apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; calcium ion binding [GO:0005509]; chaperone binding [GO:0051087]; drug binding [GO:0008144]; SH3 domain binding [GO:0017124]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; adipose tissue development [GO:0060612]; anterior/posterior pattern specification [GO:0009952]; bone marrow development [GO:0048539]; bone morphogenesis [GO:0060349]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; cholesterol homeostasis [GO:0042632]; coronary artery morphogenesis [GO:0060982]; folate import across plasma membrane [GO:1904447]; gastrulation with mouth forming second [GO:0001702]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; osteoblast development [GO:0002076]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; retinal blood vessel morphogenesis [GO:0061304]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]"
"PGEN_.00g299840"	0.00246643523910897	0.86000090138441	8.53785882851644e-06	"Scaffold_15"	7038040	7046342	NA	NA	NA	NA	NA
"PGEN_.00g300060"	0.00834250726427833	0.92913743529479	0.000321808674053942	"Scaffold_15"	7459230	7474370	"D8VNS7"	"FCNV1_CERRY"	"Ryncolin-1"	"GO:0005576; GO:0009405; GO:0090729"	"extracellular region [GO:0005576]; toxin activity [GO:0090729]; pathogenesis [GO:0009405]"
"PGEN_.00g303160"	0.000128270893277243	0.825022722058483	0.423428344688849	"Scaffold_15"	15001374	15010712	"A6NK53"	"ZN233_HUMAN"	"Zinc finger protein 233"	"GO:0003677; GO:0005634; GO:0006355; GO:0046872"	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"
"PGEN_.00g303230"	0.0407238620458474	0.929571831406455	0.42513924350366	"Scaffold_15"	15341188	15401281	NA	NA	NA	NA	NA
"PGEN_.00g303480"	0.026496538095202	0.0232911105088006	0.966456610892773	"Scaffold_15"	16094001	16102600	NA	NA	NA	NA	NA
"PGEN_.00g303970"	0.000601588351271002	0.55474982847488	0.880234528810389	"Scaffold_15"	17928215	17933387	"Q99715"	"COCA1_HUMAN"	"Collagen alpha-1(XII) chain"	"GO:0003429; GO:0005576; GO:0005595; GO:0005615; GO:0005788; GO:0007155; GO:0030020; GO:0030199; GO:0031012; GO:0035987; GO:0062023; GO:0070062; GO:1903561"	"collagen type XII trimer [GO:0005595]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; endodermal cell differentiation [GO:0035987]; growth plate cartilage chondrocyte morphogenesis [GO:0003429]"
"PGEN_.00g304170"	0.00633973459200335	3.03742437839111e-11	0.000886523603580024	"Scaffold_15"	18153244	18175524	"Q9NSC2"	"SALL1_HUMAN"	"Sal-like protein 1 (Spalt-like transcription factor 1) (Zinc finger protein 794) (Zinc finger protein SALL1) (Zinc finger protein Spalt-1) (HSal1) (Sal-1)"	"GO:0000122; GO:0000792; GO:0000978; GO:0001227; GO:0001657; GO:0001658; GO:0001822; GO:0003281; GO:0003337; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0006355; GO:0007507; GO:0008013; GO:0008406; GO:0010369; GO:0021553; GO:0021889; GO:0021983; GO:0030177; GO:0030325; GO:0031129; GO:0035019; GO:0042473; GO:0042733; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0048566; GO:0060173; GO:0061034; GO:0072073; GO:0072092"	"chromocenter [GO:0010369]; cytoplasm [GO:0005737]; heterochromatin [GO:0000792]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; beta-catenin binding [GO:0008013]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; adrenal gland development [GO:0030325]; branching involved in ureteric bud morphogenesis [GO:0001658]; embryonic digestive tract development [GO:0048566]; embryonic digit morphogenesis [GO:0042733]; gonad development [GO:0008406]; heart development [GO:0007507]; inductive cell-cell signaling [GO:0031129]; kidney development [GO:0001822]; kidney epithelium development [GO:0072073]; limb development [GO:0060173]; mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0003337]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; olfactory bulb interneuron differentiation [GO:0021889]; olfactory bulb mitral cell layer development [GO:0061034]; olfactory nerve development [GO:0021553]; outer ear morphogenesis [GO:0042473]; pituitary gland development [GO:0021983]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of transcription, DNA-templated [GO:0006355]; somatic stem cell population maintenance [GO:0035019]; ureteric bud development [GO:0001657]; ureteric bud invasion [GO:0072092]; ventricular septum development [GO:0003281]"
"PGEN_.00g304250"	0.00993253798745698	0.314910735124238	1.03548926889551e-06	"Scaffold_15"	18341336	18341860	NA	NA	NA	NA	NA
"PGEN_.00g304260"	0.00430751763269992	0.314824811377977	0.113028264113489	"Scaffold_15"	18342004	18342573	NA	NA	NA	NA	NA
"PGEN_.00g305300"	0.0218132619432483	0.801460375859917	0.160439567821411	"Scaffold_15"	20883767	20894227	NA	NA	NA	NA	NA
"PGEN_.00g305680"	0.0153161923027104	0.191794819458757	3.49365845767882e-09	"Scaffold_15"	21853239	21888214	"O88873"	"GMEB2_RAT"	"Glucocorticoid modulatory element-binding protein 2 (GMEB-2)"	"GO:0000978; GO:0000981; GO:0001228; GO:0003713; GO:0005634; GO:0005737; GO:0006357; GO:0043565; GO:0045944; GO:0046872"	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]"
"PGEN_.00g308970"	0.00590963707571896	1.60921177529929e-11	8.13902919127236e-06	"Scaffold_15"	30256878	30261165	"Q93075"	"TATD2_HUMAN"	"Putative deoxyribonuclease TATDN2 (EC 3.1.21.-)"	"GO:0005634; GO:0005654; GO:0016888; GO:0036498; GO:0046872"	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; endodeoxyribonuclease activity, producing 5'-phosphomonoesters [GO:0016888]; metal ion binding [GO:0046872]; IRE1-mediated unfolded protein response [GO:0036498]"
"PGEN_.00g311190"	3.9876290544e-09	0.59044533246329	0.000512838904794042	"Scaffold_15"	36259441	36264805	"B8NM66"	"USTA_ASPFN"	"Ribosomally synthesized cyclic peptide ustiloxin B precursosr (Ustiloxin B biosynthesis protein A) [Cleaved into: YAIG-I; YAIG-II; YAIG-III; YAIG-IV; YAIG-V; YAIG-VI; YAIG-VII; YAIG-VIII; YAIG-IX; YAIG-X; YAIG-XI; YAIG-XII; YAIG-XIII; YAIG-XIV; YAIG-XV; YAIG-XVI]"	""	""
"PGEN_.00g311750"	4.57000090505302e-09	0.00027198764726015	3.74688416315205e-12	"Scaffold_15"	37693159	37710893	NA	NA	NA	NA	NA
"PGEN_.00g312420"	0.00329080548377532	0.589330034617844	0.031024265384004	"Scaffold_15"	39331617	39382427	NA	NA	NA	NA	NA
"PGEN_.00g312440"	0.00134195206544972	0.366893942856766	0.671779134427608	"Scaffold_15"	39426630	39540564	"Q4V8B0"	"OXR1_RAT"	"Oxidation resistance protein 1 (Protein C7)"	"GO:0005730; GO:0005739; GO:0006979; GO:0007628; GO:0016491; GO:0043524; GO:0051402; GO:0071447; GO:1900408; GO:1902083; GO:1903204"	"mitochondrion [GO:0005739]; nucleolus [GO:0005730]; oxidoreductase activity [GO:0016491]; adult walking behavior [GO:0007628]; cellular response to hydroperoxide [GO:0071447]; negative regulation of cellular response to oxidative stress [GO:1900408]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of peptidyl-cysteine S-nitrosylation [GO:1902083]; neuron apoptotic process [GO:0051402]; response to oxidative stress [GO:0006979]"
"PGEN_.00g312460"	0.0101267862003665	0.813369922513086	1.07743993755034e-05	"Scaffold_15"	39551379	39573571	"Q9NRA2"	"S17A5_HUMAN"	"Sialin (H(+)/nitrate cotransporter) (H(+)/sialic acid cotransporter) (AST) (Membrane glycoprotein HP59) (Solute carrier family 17 member 5) (Vesicular H(+)/Aspartate-glutamate cotransporter)"	"GO:0005351; GO:0005764; GO:0005765; GO:0005829; GO:0005886; GO:0005887; GO:0006811; GO:0006820; GO:0006865; GO:0009617; GO:0015136; GO:0015538; GO:0015739; GO:0016020; GO:0016021; GO:0030054; GO:0030672"	"cell junction [GO:0030054]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]; carbohydrate:proton symporter activity [GO:0005351]; sialic acid transmembrane transporter activity [GO:0015136]; sialic acid:proton symporter activity [GO:0015538]; amino acid transport [GO:0006865]; anion transport [GO:0006820]; ion transport [GO:0006811]; response to bacterium [GO:0009617]; sialic acid transport [GO:0015739]"
"PGEN_.00g312690"	0.000604925825389172	0.000785721959660744	2.21950279544421e-05	"Scaffold_15"	40337744	40343589	"Q6AZB8"	"HARB1_DANRE"	"Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)"	"GO:0004518; GO:0005634; GO:0005737; GO:0046872"	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]"
"PGEN_.00g315900"	0.0049216073768174	0.00024706512977294	0.356287550068921	"Scaffold_16"	292	512	NA	NA	NA	NA	NA
"PGEN_.00g316040"	4.82543743380373e-17	9.07392821166048e-08	1.91809658133796e-11	"Scaffold_16"	438200	459444	NA	NA	NA	NA	NA
"PGEN_.00g316050"	0.000977101690941986	0.801460375859917	2.02905881955566e-05	"Scaffold_16"	459215	459469	NA	NA	NA	NA	NA
"PGEN_.00g316170"	1.34656420915597e-07	0.045073755564789	0.79758901471678	"Scaffold_16"	790566	822937	"Q5ZIJ9"	"MIB2_CHICK"	"E3 ubiquitin-protein ligase MIB2 (EC 2.3.2.27) (Mind bomb homolog 2) (RING-type E3 ubiquitin transferase MIB2)"	"GO:0004842; GO:0005737; GO:0007219; GO:0008270; GO:0016567"	"cytoplasm [GO:0005737]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567]"
"PGEN_.00g316200"	5.41752365011091e-06	2.37651656173825e-11	9.52003756504195e-08	"Scaffold_16"	891188	960534	"O00411"	"RPOM_HUMAN"	"DNA-directed RNA polymerase, mitochondrial (MtRPOL) (EC 2.7.7.6)"	"GO:0001018; GO:0003723; GO:0003899; GO:0005739; GO:0005759; GO:0006390; GO:0006391; GO:0007005; GO:0032991; GO:0034245; GO:0042645; GO:0043565"	"mitochondrial DNA-directed RNA polymerase complex [GO:0034245]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; mitochondrial promoter sequence-specific DNA binding [GO:0001018]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; mitochondrial transcription [GO:0006390]; mitochondrion organization [GO:0007005]; transcription initiation from mitochondrial promoter [GO:0006391]"
"PGEN_.00g316430"	3.0420745400588e-82	5.75112589640619e-22	1.25557186926522e-67	"Scaffold_16"	1807747	1819568	NA	NA	NA	NA	NA
"PGEN_.00g316450"	0.00238055734925803	0.988357836392412	0.686471767497261	"Scaffold_16"	1843382	1846777	NA	NA	NA	NA	NA
"PGEN_.00g316700"	0.0132010450309142	0.00797605091212127	0.131436547570054	"Scaffold_16"	2546783	2571814	"O15162"	"PLS1_HUMAN"	"Phospholipid scramblase 1 (PL scramblase 1) (Ca(2+)-dependent phospholipid scramblase 1) (Erythrocyte phospholipid scramblase) (MmTRA1b)"	"GO:0001228; GO:0003677; GO:0005154; GO:0005509; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0005887; GO:0006659; GO:0006915; GO:0006953; GO:0010628; GO:0016020; GO:0017121; GO:0017124; GO:0017128; GO:0019899; GO:0030168; GO:0033003; GO:0035456; GO:0042609; GO:0045071; GO:0045089; GO:0045121; GO:0045944; GO:0048471; GO:0051607; GO:0060368; GO:0062023; GO:0070062; GO:2000373"	"collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane raft [GO:0045121]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; CD4 receptor binding [GO:0042609]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; enzyme binding [GO:0019899]; epidermal growth factor receptor binding [GO:0005154]; phospholipid scramblase activity [GO:0017128]; SH3 domain binding [GO:0017124]; acute-phase response [GO:0006953]; apoptotic process [GO:0006915]; defense response to virus [GO:0051607]; negative regulation of viral genome replication [GO:0045071]; phosphatidylserine biosynthetic process [GO:0006659]; plasma membrane phospholipid scrambling [GO:0017121]; platelet activation [GO:0030168]; positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity [GO:2000373]; positive regulation of gene expression [GO:0010628]; positive regulation of innate immune response [GO:0045089]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of Fc receptor mediated stimulatory signaling pathway [GO:0060368]; regulation of mast cell activation [GO:0033003]; response to interferon-beta [GO:0035456]"
"PGEN_.00g320660"	0.00854090302818708	0.0358985995260045	0.649102935514123	"Scaffold_16"	13198838	13199848	NA	NA	NA	NA	NA
"PGEN_.00g321190"	0.0109659882902616	0.941087652395417	0.134467999836885	"Scaffold_16"	14739729	14789048	"Q8JZW5"	"SH2D5_MOUSE"	"SH2 domain-containing protein 5"	"GO:0014069; GO:0030054"	"cell junction [GO:0030054]; postsynaptic density [GO:0014069]"
"PGEN_.00g322650"	0.00365354169520244	0.145911539572318	5.63900666906101e-51	"Scaffold_16"	18248077	18261946	"P22699"	"GUN6_DICDI"	"Endoglucanase (EC 3.2.1.4) (Cellulase) (Endo-1,4-beta-glucanase) (Spore germination protein 270-6)"	"GO:0005576; GO:0008810; GO:0009847; GO:0030245; GO:0030248; GO:0030435"	"extracellular region [GO:0005576]; cellulase activity [GO:0008810]; cellulose binding [GO:0030248]; cellulose catabolic process [GO:0030245]; spore germination [GO:0009847]; sporulation resulting in formation of a cellular spore [GO:0030435]"
"PGEN_.00g324750"	0.0107260486015872	0.796281023780364	0.0521358715302041	"Scaffold_16"	25080811	25091629	"Q2YDW7"	"KMT5A_MOUSE"	"N-lysine methyltransferase KMT5A (EC 2.1.1.-) (H4-K20-HMTase KMT5A) (Histone-lysine N-methyltransferase KMT5A) (EC 2.1.1.-) (Lysine-specific methylase 5A) (PR/SET domain-containing protein 07) (PR-Set7) (PR/SET07) (SET domain-containing protein 8)"	"GO:0000122; GO:0002039; GO:0003714; GO:0005654; GO:0005694; GO:0005829; GO:0007049; GO:0016279; GO:0018024; GO:0018026; GO:0043516; GO:0045892; GO:0051301"	"chromosome [GO:0005694]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; histone-lysine N-methyltransferase activity [GO:0018024]; p53 binding [GO:0002039]; protein-lysine N-methyltransferase activity [GO:0016279]; transcription corepressor activity [GO:0003714]; cell cycle [GO:0007049]; cell division [GO:0051301]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-lysine monomethylation [GO:0018026]; regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043516]"
"PGEN_.00g326070"	0.0169176050285366	0.4728308379175	0.425500993372291	"Scaffold_16"	28622353	28656089	"Q5U249"	"ELYS_XENLA"	"Protein ELYS (Protein MEL-28) (xELYS)"	"GO:0003677; GO:0005643; GO:0005654; GO:0005737; GO:0015031; GO:0051028"	"cytoplasm [GO:0005737]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; mRNA transport [GO:0051028]; protein transport [GO:0015031]"
"PGEN_.00g326670"	2.02264552084426e-05	0.593060461918539	0.324828332229131	"Scaffold_16"	30127325	30131037	NA	NA	NA	NA	NA
"PGEN_.00g326780"	0.00524621172046386	0.883185081153361	0.450908041018187	"Scaffold_16"	30246816	30251730	NA	NA	NA	NA	NA
"PGEN_.00g326880"	0.0269347640600576	0.97729332228858	0.0298255247700431	"Scaffold_16"	30367125	30497348	"Q8IS64"	"ECE_LOCMI"	"Endothelin-converting enzyme homolog (ECE) (EC 3.4.24.-)"	"GO:0004175; GO:0004222; GO:0005886; GO:0008270; GO:0016021"	"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; endopeptidase activity [GO:0004175]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
"PGEN_.00g328130"	0.00407017601865373	0.546231338919083	0.804380965667166	"Scaffold_17"	1845177	1986168	NA	NA	NA	NA	NA
"PGEN_.00g328290"	1.34738628505389e-09	0.619037622669197	2.0846048735504e-05	"Scaffold_17"	2395545	2400683	NA	NA	NA	NA	NA
"PGEN_.00g328960"	1.98231221812466e-06	1.2745391470121e-05	3.62843563289569e-26	"Scaffold_17"	4818154	4836910	"B3EWZ8"	"ECT_ACRMI"	"Ectin (Fragment)"	"GO:0005576"	"extracellular region [GO:0005576]"
"PGEN_.00g329000"	0.0339047336438429	0.70779179520149	0.000907881695878855	"Scaffold_17"	4903143	4929945	NA	NA	NA	NA	NA
"PGEN_.00g329510"	0.000263091564012033	0.627230084431166	1.8876844922012e-07	"Scaffold_17"	6825594	6845919	"Q0VAA2"	"LR74A_HUMAN"	"Leucine-rich repeat-containing protein 74A (Leucine-rich repeat-containing protein 74)"	""	""
"PGEN_.00g329970"	0.000888984543271366	0.600503758106834	0.307171955789342	"Scaffold_17"	8116995	8129976	NA	NA	NA	NA	NA
"PGEN_.00g330670"	7.94200103895014e-05	0.540448707038274	0.00170023500436928	"Scaffold_17"	10206452	10242544	"O60229"	"KALRN_HUMAN"	"Kalirin (EC 2.7.11.1) (Huntingtin-associated protein-interacting protein) (Protein Duo) (Serine/threonine-protein kinase with Dbl- and pleckstrin homology domain)"	"GO:0004674; GO:0005085; GO:0005089; GO:0005524; GO:0005654; GO:0005829; GO:0006468; GO:0007165; GO:0007186; GO:0007399; GO:0007528; GO:0007595; GO:0007613; GO:0008344; GO:0015629; GO:0016192; GO:0035023; GO:0035176; GO:0035556; GO:0042711; GO:0043065; GO:0043547; GO:0046872; GO:0046959; GO:0048013; GO:0051056; GO:0060125; GO:0060137; GO:0061003; GO:0070062"	"actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; adult locomotory behavior [GO:0008344]; ephrin receptor signaling pathway [GO:0048013]; G protein-coupled receptor signaling pathway [GO:0007186]; habituation [GO:0046959]; intracellular signal transduction [GO:0035556]; lactation [GO:0007595]; maternal behavior [GO:0042711]; maternal process involved in parturition [GO:0060137]; memory [GO:0007613]; negative regulation of growth hormone secretion [GO:0060125]; nervous system development [GO:0007399]; neuromuscular junction development [GO:0007528]; positive regulation of apoptotic process [GO:0043065]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of GTPase activity [GO:0043547]; protein phosphorylation [GO:0006468]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]; social behavior [GO:0035176]; vesicle-mediated transport [GO:0016192]"
"PGEN_.00g331050"	0.0120582368448577	0.801460375859917	0.356101946124546	"Scaffold_17"	11519061	11551078	"O35274"	"NEB2_RAT"	"Neurabin-2 (Neurabin-II) (Neural tissue-specific F-actin-binding protein II) (PP1bp134) (Protein phosphatase 1 regulatory subunit 9B) (Spinophilin) (p130)"	"GO:0001932; GO:0001975; GO:0003006; GO:0003779; GO:0004672; GO:0004864; GO:0005654; GO:0005737; GO:0005886; GO:0005912; GO:0007015; GO:0007568; GO:0007612; GO:0008022; GO:0008157; GO:0010243; GO:0014069; GO:0014070; GO:0015629; GO:0016358; GO:0016477; GO:0019722; GO:0019900; GO:0021766; GO:0021987; GO:0030027; GO:0030042; GO:0030175; GO:0030308; GO:0030425; GO:0030426; GO:0030864; GO:0031175; GO:0031749; GO:0032355; GO:0032515; GO:0032587; GO:0032591; GO:0034695; GO:0035094; GO:0035690; GO:0035902; GO:0042127; GO:0042493; GO:0043005; GO:0043025; GO:0043197; GO:0043200; GO:0044325; GO:0044326; GO:0044327; GO:0044877; GO:0046847; GO:0048545; GO:0050804; GO:0051015; GO:0060179; GO:0061458; GO:0071315; GO:0071364; GO:0071392; GO:0071407; GO:0097338; GO:1901653; GO:1903078; GO:1903119; GO:1903829; GO:1904372; GO:1904373; GO:1904386; GO:1990778; GO:1990780; GO:2000474"	"actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytoplasmic side of dendritic spine plasma membrane [GO:1990780]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; dendritic spine head [GO:0044327]; dendritic spine membrane [GO:0032591]; dendritic spine neck [GO:0044326]; filopodium [GO:0030175]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; ruffle membrane [GO:0032587]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; D2 dopamine receptor binding [GO:0031749]; ion channel binding [GO:0044325]; kinase binding [GO:0019900]; protein C-terminus binding [GO:0008022]; protein kinase activity [GO:0004672]; protein phosphatase 1 binding [GO:0008157]; protein phosphatase inhibitor activity [GO:0004864]; protein-containing complex binding [GO:0044877]; actin filament depolymerization [GO:0030042]; actin filament organization [GO:0007015]; aging [GO:0007568]; calcium-mediated signaling [GO:0019722]; cell migration [GO:0016477]; cellular response to drug [GO:0035690]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to estradiol stimulus [GO:0071392]; cellular response to morphine [GO:0071315]; cellular response to organic cyclic compound [GO:0071407]; cellular response to peptide [GO:1901653]; cerebral cortex development [GO:0021987]; dendrite development [GO:0016358]; developmental process involved in reproduction [GO:0003006]; filopodium assembly [GO:0046847]; hippocampus development [GO:0021766]; learning [GO:0007612]; male mating behavior [GO:0060179]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of cell growth [GO:0030308]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; neuron projection development [GO:0031175]; positive regulation of cellular protein localization [GO:1903829]; positive regulation of protein localization to actin cortical patch [GO:1904372]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to actin cytoskeleton [GO:1903119]; protein localization to cell periphery [GO:1990778]; regulation of cell population proliferation [GO:0042127]; regulation of opioid receptor signaling pathway [GO:2000474]; regulation of protein phosphorylation [GO:0001932]; reproductive system development [GO:0061458]; response to amino acid [GO:0043200]; response to amphetamine [GO:0001975]; response to clozapine [GO:0097338]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to immobilization stress [GO:0035902]; response to kainic acid [GO:1904373]; response to L-phenylalanine derivative [GO:1904386]; response to nicotine [GO:0035094]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243]; response to prostaglandin E [GO:0034695]; response to steroid hormone [GO:0048545]"
"PGEN_.00g332240"	2.45516206544044e-05	0.859597413096865	3.32841429608373e-13	"Scaffold_17"	15397223	15410451	NA	NA	NA	NA	NA
"PGEN_.00g333150"	0.00378080000200323	0.459470609641493	0.0751506110613257	"Scaffold_17"	18069850	18105664	"Q01320"	"TOP2A_MOUSE"	"DNA topoisomerase 2-alpha (EC 5.6.2.2) (DNA topoisomerase II, alpha isozyme)"	"GO:0000228; GO:0000287; GO:0000712; GO:0000793; GO:0000819; GO:0002244; GO:0003677; GO:0003682; GO:0003916; GO:0003918; GO:0005080; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005814; GO:0006265; GO:0006266; GO:0006974; GO:0007059; GO:0007143; GO:0008022; GO:0008094; GO:0008144; GO:0008301; GO:0009330; GO:0019035; GO:0019899; GO:0030261; GO:0030263; GO:0032991; GO:0040016; GO:0042752; GO:0042803; GO:0042826; GO:0043065; GO:0043130; GO:0043565; GO:0044774; GO:0045870; GO:0045944; GO:0046982; GO:0048511; GO:0051309; GO:1905463; GO:1990904"	"centriole [GO:0005814]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) complex [GO:0009330]; nuclear chromosome [GO:0000228]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; viral integration complex [GO:0019035]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA binding, bending [GO:0008301]; DNA topoisomerase activity [GO:0003916]; DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity [GO:0003918]; DNA-dependent ATPase activity [GO:0008094]; drug binding [GO:0008144]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; magnesium ion binding [GO:0000287]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase C binding [GO:0005080]; sequence-specific DNA binding [GO:0043565]; ubiquitin binding [GO:0043130]; apoptotic chromosome condensation [GO:0030263]; cellular response to DNA damage stimulus [GO:0006974]; chromosome condensation [GO:0030261]; chromosome segregation [GO:0007059]; DNA ligation [GO:0006266]; DNA topological change [GO:0006265]; embryonic cleavage [GO:0040016]; female meiosis chromosome separation [GO:0051309]; female meiotic nuclear division [GO:0007143]; hematopoietic progenitor cell differentiation [GO:0002244]; mitotic DNA integrity checkpoint [GO:0044774]; negative regulation of DNA duplex unwinding [GO:1905463]; positive regulation of apoptotic process [GO:0043065]; positive regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045870]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of circadian rhythm [GO:0042752]; resolution of meiotic recombination intermediates [GO:0000712]; rhythmic process [GO:0048511]; sister chromatid segregation [GO:0000819]"
"PGEN_.00g333540"	0.0330100298227017	0.722974837374853	0.194424887793499	"Scaffold_17"	19207496	19252244	"Q86TI4"	"WDR86_HUMAN"	"WD repeat-containing protein 86"	""	""
"PGEN_.00g333690"	4.38182916225311e-10	1.63792683341268e-05	3.01064396424771e-07	"Scaffold_17"	19655402	19663314	NA	NA	NA	NA	NA
"PGEN_.00g334400"	0.000150261103128458	0.324459626699347	0.178602019675029	"Scaffold_17"	21776739	21871098	"O01761"	"UNC89_CAEEL"	"Muscle M-line assembly protein unc-89 (Obscurin) (Uncoordinated protein 89)"	"GO:0004672; GO:0005089; GO:0005524; GO:0010628; GO:0014722; GO:0017048; GO:0019902; GO:0030241; GO:0031034; GO:0031430; GO:0031672; GO:0034613; GO:0040017; GO:0045214; GO:0045989; GO:0060298; GO:0071688; GO:0090736; GO:1905552; GO:1905905"	"A band [GO:0031672]; M band [GO:0031430]; ATP binding [GO:0005524]; MATH domain binding [GO:0090736]; phosphatase binding [GO:0019902]; protein kinase activity [GO:0004672]; Rho GTPase binding [GO:0017048]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; cellular protein localization [GO:0034613]; myosin filament assembly [GO:0031034]; pharyngeal gland morphogenesis [GO:1905905]; positive regulation of gene expression [GO:0010628]; positive regulation of locomotion [GO:0040017]; positive regulation of protein localization to endoplasmic reticulum [GO:1905552]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; regulation of skeletal muscle contraction by calcium ion signaling [GO:0014722]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]; striated muscle myosin thick filament assembly [GO:0071688]"
"PGEN_.00g335030"	0.00932642606527654	0.859256512095868	0.417666845289677	"Scaffold_17"	24196175	24260130	"O70589"	"CSKP_MOUSE"	"Peripheral plasma membrane protein CASK (EC 2.7.11.1) (Calcium/calmodulin-dependent serine protein kinase)"	"GO:0001953; GO:0004674; GO:0005516; GO:0005524; GO:0005604; GO:0005634; GO:0005652; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0005911; GO:0006357; GO:0008022; GO:0010839; GO:0014069; GO:0016020; GO:0016323; GO:0016363; GO:0030165; GO:0030425; GO:0031982; GO:0032024; GO:0032991; GO:0042043; GO:0042734; GO:0043025; GO:0044877; GO:0045121; GO:0045202; GO:0045944; GO:0060170; GO:0061003; GO:0061045; GO:0070509; GO:0072659; GO:0090280; GO:0090288; GO:0097060; GO:0097440; GO:0098685; GO:0098846; GO:2000300"	"apical dendrite [GO:0097440]; basement membrane [GO:0005604]; basolateral plasma membrane [GO:0016323]; cell-cell junction [GO:0005911]; ciliary membrane [GO:0060170]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; nuclear lamina [GO:0005652]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; podocyte foot [GO:0098846]; postsynaptic density [GO:0014069]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; Schaffer collateral - CA1 synapse [GO:0098685]; synapse [GO:0045202]; synaptic membrane [GO:0097060]; vesicle [GO:0031982]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; neurexin family protein binding [GO:0042043]; PDZ domain binding [GO:0030165]; protein C-terminus binding [GO:0008022]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877]; calcium ion import [GO:0070509]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of cellular response to growth factor stimulus [GO:0090288]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of wound healing [GO:0061045]; positive regulation of calcium ion import [GO:0090280]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of insulin secretion [GO:0032024]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to plasma membrane [GO:0072659]; regulation of synaptic vesicle exocytosis [GO:2000300]; regulation of transcription by RNA polymerase II [GO:0006357]"
"PGEN_.00g336570"	0.00120274161243738	0.0149401515489603	0.152189879685497	"Scaffold_17"	28113726	28124073	"Q04205"	"TENS_CHICK"	"Tensin"	"GO:0003779; GO:0005737; GO:0005856; GO:0005912; GO:0009986"	"adherens junction [GO:0005912]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; actin binding [GO:0003779]"
"PGEN_.00g336580"	0.0260289634678098	0.633513514701837	0.354606205412768	"Scaffold_17"	28200066	28201961	"Q99PP7"	"TRI33_MOUSE"	"E3 ubiquitin-protein ligase TRIM33 (EC 2.3.2.27) (Ectodermin homolog) (RING-type E3 ubiquitin transferase TRIM33) (Transcription intermediary factor 1-gamma) (TIF1-gamma) (Tripartite motif-containing protein 33)"	"GO:0003677; GO:0005634; GO:0008270; GO:0016567; GO:0016740; GO:0017015; GO:0030514; GO:0070410; GO:0070412"	"nucleus [GO:0005634]; co-SMAD binding [GO:0070410]; DNA binding [GO:0003677]; R-SMAD binding [GO:0070412]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; negative regulation of BMP signaling pathway [GO:0030514]; protein ubiquitination [GO:0016567]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]"
"PGEN_.00g338700"	0.0214480809835366	0.000485084221402946	0.17563825690675	"Scaffold_17"	33440016	33440837	NA	NA	NA	NA	NA
"PGEN_.00g341840"	0.044345555595683	0.873761443022515	0.950322537239316	"Scaffold_18"	7663999	7675542	NA	NA	NA	NA	NA
"PGEN_.00g342450"	1.40367055153237e-20	0.636084371320491	2.91219874256901e-20	"Scaffold_18"	9065419	9065829	NA	NA	NA	NA	NA
"PGEN_.00g342460"	2.11445939226256e-08	0.933939856797909	1.65613999537915e-16	"Scaffold_18"	9065848	9066189	NA	NA	NA	NA	NA
"PGEN_.00g343660"	0.0081005660450608	0.1173117850818	0.904678644360368	"Scaffold_18"	11869136	11922756	"Q96PH1"	"NOX5_HUMAN"	"NADPH oxidase 5 (EC 1.6.3.-)"	"GO:0001525; GO:0001935; GO:0005509; GO:0005783; GO:0005789; GO:0005886; GO:0006915; GO:0006952; GO:0008283; GO:0010155; GO:0015252; GO:0016175; GO:0020037; GO:0034599; GO:0042554; GO:0043012; GO:0043020; GO:0050660; GO:0050661; GO:0050663; GO:0055114; GO:0061640; GO:2000379"	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; NADPH oxidase complex [GO:0043020]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; flavin adenine dinucleotide binding [GO:0050660]; heme binding [GO:0020037]; NADP binding [GO:0050661]; proton channel activity [GO:0015252]; superoxide-generating NADPH oxidase activity [GO:0016175]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell population proliferation [GO:0008283]; cellular response to oxidative stress [GO:0034599]; cytokine secretion [GO:0050663]; cytoskeleton-dependent cytokinesis [GO:0061640]; defense response [GO:0006952]; endothelial cell proliferation [GO:0001935]; oxidation-reduction process [GO:0055114]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; regulation of fusion of sperm to egg plasma membrane [GO:0043012]; regulation of proton transport [GO:0010155]; superoxide anion generation [GO:0042554]"
"PGEN_.00g343750"	0.00134536905166488	0.126896946375668	0.634011369682876	"Scaffold_18"	12008562	12026590	NA	NA	NA	NA	NA
"PGEN_.00g343970"	0.0466096205450703	0.818375654287426	0.00197675100375548	"Scaffold_18"	12542108	12543320	NA	NA	NA	NA	NA
"PGEN_.00g344620"	0.0495009108261607	0.52615177618353	5.15525605229357e-07	"Scaffold_18"	14564174	14590582	"Q9Z0E6"	"GBP2_MOUSE"	"Guanylate-binding protein 2 (EC 3.6.5.-) (GTP-binding protein 2) (GBP-2) (mGBP-2) (mGBP2) (Guanine nucleotide-binding protein 2) (Interferon-induced guanylate-binding protein 2)"	"GO:0000139; GO:0003924; GO:0005525; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0009617; GO:0015629; GO:0020005; GO:0031410; GO:0034504; GO:0035458; GO:0042803; GO:0042832; GO:0044406; GO:0048471; GO:0050830; GO:0071222; GO:0071346"	"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; symbiont-containing vacuole membrane [GO:0020005]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein homodimerization activity [GO:0042803]; adhesion of symbiont to host [GO:0044406]; cellular response to interferon-beta [GO:0035458]; cellular response to interferon-gamma [GO:0071346]; cellular response to lipopolysaccharide [GO:0071222]; defense response to Gram-positive bacterium [GO:0050830]; defense response to protozoan [GO:0042832]; protein localization to nucleus [GO:0034504]; response to bacterium [GO:0009617]"
"PGEN_.00g345410"	1.02307055572594e-68	4.14603088324134e-07	5.68276820468256e-53	"Scaffold_18"	16460541	16500267	"Q29485"	"PLMN_ERIEU"	"Plasminogen (EC 3.4.21.7) [Cleaved into: Plasmin heavy chain A; Activation peptide; Plasmin heavy chain A, short form; Plasmin light chain B]"	"GO:0004252; GO:0005576; GO:0007596; GO:0042730; GO:0048771"	"extracellular region [GO:0005576]; serine-type endopeptidase activity [GO:0004252]; blood coagulation [GO:0007596]; fibrinolysis [GO:0042730]; tissue remodeling [GO:0048771]"
"PGEN_.00g349360"	8.51815089833887e-05	0.192045597442309	0.00111353634477617	"Scaffold_18"	27429968	27442133	NA	NA	NA	NA	NA
"PGEN_.00g349440"	0.0351908077209877	0.43070614985613	8.07398056489326e-07	"Scaffold_18"	27686936	27710873	NA	NA	NA	NA	NA
